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ABSTRACT 
 
 
 
Structural Studies of the Ro Ribonucleoprotein and the Metalloregulator CsoR.       
(August 2007) 
Arati Ramesh, B.S., St. Ann’s College, Hyderabad; 
M.S., University of Pune 
Chair of Advisory committee: Dr. James C. Sacchettini 
 
  
Ro ribonucleoproteins are antigenic protein-RNA particles that are the major 
targets of the immune reaction in autoimmune disorders like systemic lupus 
erythematosus.  The Ro protein has been implicated in cellular RNA quality control, due 
to its preference for binding misfolded non-coding RNAs such as pre5S ribosomal 
RNAs and U2 small-nuclear RNAs besides binding cytoplasmic RNAs called Y RNAs.  
Although well characterized in eukaryotes, an understanding of Ro in prokaryotes is 
lacking.  To gain structural insight into Ro-RNA interactions we have determined a high 
resolution crystal structure of Rsr, a Ro ortholog from the bacterium D. radiodurans.  
The structure of Rsr reveals two domains- a flexible, RNA binding HEAT repeat domain 
and a cation binding vonWillebrand factor A domain.  Structural differences between 
Rsr and Xenopus laevis Ro at the misfolded non-coding RNA binding site suggest a 
possible conformational switch in Ro that might enable RNA binding.  Structural and 
biochemical characterization reveals that Ro binds cytoplasmic small RNAs called Y 
RNAs with low nanomolar affinity, to form ~700kDa multimers.  Formation of these 
multimers suggests one possible mode by which Ro RNAs may be targeted towards 
downstream processing events. 
 Metal responsive transcriptional regulators sense specific metals in the cells and 
regulate the expression of specific operons involved in export, import or sequestration of 
the metal.  CsoR is a copper(I) specific transcriptional regulator of the cso operon which 
 iv 
consists of a putative copper export pump, CtpV.  In copper limiting conditions, CsoR 
binds the operator/promoter region of the cso operon.  In increased concentrations of 
copper (I), CsoR binds copper (I) with high affinity and is released from the 
operator/promoter site, causing derepression of the cso operon.  To gain structural 
insight into CsoR function, we have solved the crystal structure of copper(I) bound 
CsoR.  The structure reveals a homodimer with a subunit bridging copper site.  The 
trigonal planar geometry and the presence of cysteine and histidine ligands at the metal 
site are favorable for copper(I) binding.  The structure reveals a novel DNA binding fold 
in CsoR, making it the founding member of a new structural class of metalloregulators.             
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CHAPTER I 
INTRODUCTION: STRUCTURAL BIOLOGY OF NUCLEIC ACID 
BINDING PROTEINS 
 
1.1 INTRODUCTION TO STRUCTURAL BIOLOGY 
Proteins, nucleic acids, lipids and other macromolecules form the basic building blocks 
of all cellular life forms.  Structural biology aims to understand the architecture of these 
building blocks and the spatial arrangement of atoms in the macromolecules encountered 
in living organisms.  The underlying molecular mechanisms of cellular processes cannot 
be fully understood without a thorough knowledge of the molecular architecture of these 
biological macromolecules.  
The roots of macromolecular structural studies can be traced as far back as the 
middle of the 20th century.  Most of the early work focused on X-ray structure 
determination of enzymes (1) and proteins that bind relatively simpler ligands (2).  
Pioneering work using X-ray crystallography in the 1950s, helped us understand the 
structure of the DNA double helix (3).  Structural studies since then, along with 
biochemical and genetic studies have contributed greatly to our understanding of enzyme 
function, metabolic pathways and many other biological processes.  Application of 
structure based studies has given rise to the relatively new field of rational drug design 
where macromolecular structures are used as a starting point for the design of inhibitors.  
This has been particularly helpful in understanding disease causing organisms and 
developing new drugs against them. 
With advancement in technology and the emergence of newer techniques like 
nuclear magnetic resonance (NMR), electron microscopy (EM) and fluorescence, our 
understanding of macromolecular structure has multiplied exponentially.  There are 
currently 39,815 structures available in the protein data bank (PDB, www.rcsb.org).  
Structural studies today address complex problems that range from understanding the 
 
This dissertation follows the style of Journal of Biological Chemistry. 
1
 architecture and mechanisms of membrane bound proteins to large macromolecular 
complexes that could involve many different proteins. 
Protein-nucleic acid interactions play critical roles in a variety of cellular 
processes.  Fundamental processes like transcription, translation and regulation of gene 
expression all involve interactions between proteins and nucleic acids (4), (5).  The 
understanding of these processes has been tremendously aided by the numerous 
structural biology approaches, which have provided visual, multidimensional snapshots 
into their functional mechanisms.  Of the currently known structures, at least 1,751 are 
of protein nucleic-acid complexes (www.rcsb.org).  From these studies, some common 
themes have emerged, that highlight the architectural features that proteins possess in 
order to interact favorably with nucleic-acids.  Some of these common themes and 
structural motifs are discussed here.                      
 
1.2 STRUCTURAL STUDIES ON DNA-PROTEIN COMPLEXES 
Double stranded DNA has a relatively uniform structure.  The sugar-phosphate 
backbone is highly negatively charged and the core consists of base-pairs that stack 
against each other (6).  At the major and minor grooves of the DNA, these stacked bases 
are exposed.  The sequence of the bases along the DNA dictates the chemistry of the 
DNA surface.  When transcription factors need to bind a specific sequence of DNA, it is 
this chemical surface that they need to recognize (7).  Interactions between protein and 
DNA could be in the form of hydrogen bonds, van der Waal’s interactions, salt-bridge 
interactions and stacking interactions (7).  Hydrogen bonds could involve both side-
chains and backbone of the protein and the bases as well as the backbone of the DNA 
(8).  Multiple hydrogen bond interactions as seen in the Arginine-Guanine pair (Nδ and 
the Nε of the guanidinium group hydrogen bonding with guanine in a bidentate manner) 
and the Asparagine-Adenine or Glutamine-Adenine pair contribute to the specificity of 
the interaction (8).  van der Waal’s interactions give rise to steric constraints which 
further add to the specificity of interaction.  Salt-bridges formed between the phosphate 
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backbone of the DNA and basic residues from the protein have also been shown to 
stabilize protein-DNA interaction (8).  Stacking of residues like tryptophan and 
phenylalanine between base pairs has been shown in some cases (8), as discussed below. 
 Proteins that regulate transcription must possess the ability to respond to the 
effector molecule and in turn modulate their interactions with a specific DNA sequence.  
Structural studies in the past few decades have increased our understanding of at least 
some mechanisms governing such interactions.  Structural studies have shown that 
transcriptional regulators could interact with DNA in a variety of ways, using either α-
helices, β-sheets or loops (7).  Commonly found DNA binding motifs are discussed here. 
The helix-turn-helix (HTH) motif consists of two short helices at a ~120º angle, 
separated typically by a tight four-residue turn (9), (10).  The second helix, called the 
recognition helix inserts into the DNA major groove to contact the base pairs as well as 
the backbone phosphates.  High resolution structures of the bacteriophage lambda 
repressor/operator complex (PDB ID 1LMB, Figure 1.1a) show the interaction between 
the HTH motif and DNA (9).  In the lambda repressor, in addition to the HTH motif, an 
N-terminal arm makes contacts with the DNA backbone.  The angle at which the 
recognition helix interacts with the DNA differs between different protein-DNA 
complexes (11), with the maximum interaction between protein and DNA bases 
occurring when the axis of the inserted helix is parallel to the phosphate backbone (11).  
This type of interaction can be seen in the three-helix family of DNA and RNA binding 
proteins like the Mat α homeodomain proteins in yeast (12), Figure 1.1b.  The DNA 
bound to such domains typically does not undergo distortion (7).   
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The winged helix motif is a variation of the helix-turn-helix motif and usually has an H1-
B1-H2-H3-W1-B2-B3-W2 topology (13), Figure 1.1c.  Helices H2 and H3 resemble an 
HTH motif with the H3 being the recognition helix that interacts with DNA.  Two wing-
like loops (W1 and W2) are present on either side of the recognition helix, of which at 
least one (W1) has been shown to make additional contacts with the DNA (13).  A 
crystal structure of the mouse GA binding protein in complex with the GGA motif (PDB 
ID 1AWC) shows the details of interactions between a winged helix domain and the 
major groove of DNA (Figure 1.1c).  The winged helix domain has been found in many 
families of metal responsive transcriptional regulators, for example the copper sensing 
repressor CueR from E. coli and the iron sensing IdeR protein from M. tuberculosis (14), 
(15). 
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 Figure 1.1  Helix-turn-helix motifs to bind DNA 
 
a. Crystal structure of lambda repressor /operator complex (1LMB) with a helix-
turn-helix motif (red).  The recognition helix interacts with the major groove of the 
DNA (grey).  Monomers are shown in blue and green.  b. Crystal structure of a 
Mat-α2 homeodomain/operator complex (1APL) shows a three helical bundle with 
the recognition helix (red) inserted into the major groove of the DNA (grey).  
Monomers are shown in blue and green.  c. Crystal structure of a domain of the 
transcriptional regulator GABP in complex with DNA (1AWC) shows a winged 
helix domain with the recognition helix and wing (red) interacting with the major 
groove of the DNA (grey).  
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Other helical motifs that interact with the major groove of the DNA are the basic region 
leucine zipper (bzip) motif and the helix-loop-helix (HLH) motif (16), (17).  These 
motifs are found in dimeric eukaryotic proteins (7).  The bzip motif typically consists of 
long, ~60 residue α-helices that form coiled coils (Figure 1.2a).  A structure of the 
human proto-oncogene product C-Jun in complex with the cyclic AMP recognizing 
element (CRE) DNA shows interactions between a bzip motif and the major groove of 
DNA (PDB ID 1JNM, Figure 1.2a).  The C-terminal dimer interface is stabilized by 
hydrophobic interactions between leucine residues.  The N-terminal portion of the α-
helix is inserted into the major groove of the DNA (7).  The HLH family of proteins also 
dimerizes, but each monomer in the symmetric homodimer is composed of two α-
helices joined by a loop so that the dimer interface consists of a four-helix bundle (17).  
The structure of the mouse transcription factor Max, in complex with its cognate DNA 
(PDB ID 1AN2, Figure 1.2b) shows that the HLH motif interacts with DNA in the same 
way as the bzip motif. 
Proteins like the Lac and purine repressors from E. coli interact with the minor 
groove of the DNA (18) (19), although base stacks are not optimally exposed in the 
minor groove (6).  To accommodate the protein side chains in the minor groove, the 
DNA undergoes sufficient distortion.  For example, the Purine repressor PurR binds 
DNA, causing a 45º kink, unwinding and base unstacking in the DNA (PDB ID 1PNR, 
Figure 1.3).  The protein forms a dimer with helices from each monomer coming 
together to interact with the minor groove.  Leucine residues from the protein are 
intercalated into the base-stack to facilitate the kink in the DNA (19).  Each monomer 
also possesses a separate helix-turn-helix motif forming a ‘head’ which interacts with the 
neighboring major groove (19). 
Helical DNA binding folds in proteins could also be stabilized by metal 
coordination in close proximity to the DNA binding site (20), (21).  The zinc finger motif 
proteins contain multiple modules of an ~ 30 residue DNA binding domain (Figure 1.4) 
(20).  A crystal structure of the mouse Zif268 transcription factor in complex with DNA  
6
 Figure 1.2  α-helical domains to bind DNA 
a. Crystal structure of the Jun/Cre complex (1JNM) shows a basic region leucine 
zipper (bzip) motif.  Coiled coils formed by two monomers (blue and green) are 
stabilized by a leucine zipper core.  The C-terminal portion of the helices (red) 
interacts with the major groove of the DNA (grey).  b.  Crystal structure of the 
transcription factor Max in complex with DNA (1AN2) shows a dimer (blue and 
green) with each monomer consisting of a helix-loop-helix motif.  The dimerization 
interface resembles the leucine zipper and the ends of the helices (red) insert into 
the major groove of the DNA (grey).  
7
 Figure 1.3  α-helical domains to bind minor groove of DNA 
Crystal structure of the purine repressor PurR bound to DNA (1PNR) shows a 
dimer (blue and green) with recognition helices (red) from each monomer coming 
together to bind the minor groove of the DNA (grey).  To accommodate the helices 
at the minor groove, the DNA undergoes a huge distortion with a kink and 
unwinding.  Helices from each monomer (red) separately contact the major grooves 
too.  
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 Figure 1.4  Zinc coordinating motifs to bind DNA 
a.  Crystal structure of Zif268/DNA complex (1AAY) shows multiple modules of 
zinc finger motifs.  The recognition helix (red) from each module interacts with 
subsequent major grooves of the DNA (grey).  The zinc finger itself is stabilized by 
a zinc ion (yellow).  b.  Crystal structure of the yeast transcriptional factor Gal4 in 
complex with DNA (1D66) shows a homodimer (blue and green).  The dimerization 
domain interacts with the minor groove of the DNA (grey) and recognition helices 
(red) from each monomer interact with the different major grooves.     
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 While the majority of DNA-binding motifs are α-helical, DNA recognition also 
takes place through β-sheets.  Proteins with the ribbon-helix-helix motif form dimers 
with a β-strand from each monomer coming together to form a two stranded antiparallel 
β-sheet (Figure 1.5) (22), (23).  The crystal structure of the omega repressor from S. 
pyrogenes (PDB ID 2CAX, Figure 1.5) shows that a β-sheet inserts into the major 
groove of the DNA such that the plane of the sheet is parallel to the DNA backbone (22).  
The side chains normal to the plane of the β-sheet interact with the base-pairs (22).  The 
Arc repressor of bacteriophage P22 forms a dimer of dimers with each protomer 
contributing a β-strand that interacts with the DNA major groove (24).  Similarly, a 
nickel responsive transcriptional regulator NikR, from E. coli recognizes DNA through a 
ribbon-helix-helix motif (23).  Recognition of DNA through a β-sheet also occurs at the 
minor groove as seen for TATA binding proteins (TBP) (25).  The yeast TBP inserts a 
ten stranded β-sheet into the minor groove of the TATA box DNA, causing huge 
distortion of the DNA, along with unwinding and bending (PDB ID 1YTB, Figure 1.5).  
The bending and distortion of the DNA is facilitated by phenylalanine side chains that 
are intercalated into the DNA base-pair stacks (25). 
One family of DNA binding proteins recognizes DNA through loop regions (26).  
This family of p53-like transcription factors consists of a β-sheet immunoglobulin-like 
domain.  The crystal structure of human NFκB p53 homodimer in complex with DNA 
10
Figure 1.5  β-sheet motifs to bind DNA 
a.  Crystal structure of the omega repressor/DNA complex (2CAX) shows 2 β-
strands (red) from each monomer (blue and green) coming together to form a β-
sheet.  The β-sheet interacts with the major groove of the DNA (grey).  b.  Crystal 
structure of the yeast TATA binding protein in complex with the TATA box 
(1YTB) shows parts of a 10 stranded β-sheet (red) interacting with the minor 
groove of the DNA (grey).  The DNA undergoes a kink with unwinding and base 
unstacking.    
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shows interactions via side-chains at the dimerization interface of the protein (PDB ID 
1A3Q, Figure 1.6).  The α-helical region is rotated away from the dimerization 
interface, leaving loop regions to interact with the major groove of the DNA (26).
 Prokaryotic transcriptional regulators belong to the helix-turn-helix, winged helix 
and β-ribbon families, barring few exceptions.  They bind to cognate DNA sites that are 
almost invariably palindromic or pseudopalindromic (7).   
  
1.3 STRUCTURAL STUDIES OF PROTEIN-RNA COMPLEXES 
RNAs can adopt a variety of structures in single-stranded as well as double stranded 
conformations.  Secondary structural elements like hairpins, loops, single or more 
nucleotide bulges are commonly found in RNAs (27), (28).  Double stranded RNA 
helices are found in the A form in which the centre of the base pair is displaced by ~4Å 
as compared to the classical B-form helix (29). As a consequence, the minor groove is 
wide (~11Å) and shallow (~3Å) in the A form and the major groove very narrow (~3Å) 
and deep (~13Å), in contrast to the wide and less deep major groove in B-form helices 
(29). This classical picture has been confirmed in investigations of RNA double helical 
tracts by crystallography (30) and NMR (31).  While proteins interacting with DNA 
often do so by forming specific hydrogen bonds between the bases and the side chains of 
an alpha-helix inserted into the accessible major groove of the B-form DNA, the much 
narrower and deeper groove of the A-form RNA helix is less accessible to the α-helices 
of RNA binding proteins. Often, unpaired nucleotides stacked inside an RNA helix or 
bulged outside the helix represent inviting targets for site-specific recognition of RNA 
by proteins (32). 
 RNAs play a variety of roles in both eukaryotic and prokaryotic cells (33), (34), 
(35).  Besides the messenger RNAs (mRNA) that are involved in message transfer, a 
host of non-coding RNAs like ribosomal RNAs (rRNA), transfer RNAs (tRNA), small 
nuclear RNAs (snRNA), small nucleolar RNAs (snoRNA), micro RNAs (miRNA), anti-
sense RNAs etc. have been discovered (33).  The various roles played by these RNAs 
12
 Figure 1.6  Loop regions to bind DNA 
Crystal structure of human NF-kB bound to DNA (1A3Q) shows major interactions 
between loop regions (red) and the major groove of the DNA (grey). 
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range from being structural molecules to splicing and gene regulation.  As expected, 
proteins that interact with RNAs are involved in a huge variety of cellular processes.  As 
a result, proteins may need to distinguish between RNA and DNA, single stranded and 
double stranded RNA and even different structural elements like hairpin loops, bulges 
and pseudoknots. 
 The interaction of RNA binding proteins with RNA has been shown to involve a 
wide variety of very elegant structural features in both the protein as well as the RNA 
and these features often vary  from subtle to the obvious. High resolution structure 
determination by X ray Crystallography and Nuclear Magnetic Resonance (NMR), two 
of the most comprehensive techniques used to study the structure of RNAs and RNA 
binding proteins, has made it possible to understand structural phenomena in a very 
elaborate and accurate manner.  Several different structural motifs have been identified 
in RNA binding proteins (32).  
 The most commonly found and most well studied RNA-binding motif is the 
βαββαβ - RNP consensus sequence (RNP-CS) RNA-binding domain (RBD) (32) 
(Figure 1.7).  The motif comprises of 90-100 amino acids and the consensus sequence 
(also called RNA recognition motif or RRM) is evolutionarily conserved.  Proteins with 
this domain localize to the nucleus, nucleolus, cytoplasm or cytoplasmic organelles, 
interact with a variety of RNAs like pre-mRNA, pre-rRNA, snRNA and mRNA and 
comprise the largest family of RNA-binding proteins (36).  The RNP-CS can be 
identified in the amino acid sequence of a protein by the presence of the highly 
conserved RNP1 octamer (K/R G F/Y G/A F V X F/Y) and RNP2 hexamer (L/I F/Y V/I 
G/K N/G L) sequences which have an array of aromatic residues and a number of 
hydrophobic residues (36). The two RNP sequences are separated by ~ 30 residues.  
RBDs are often present as multiple modules in proteins, possibly to increase the 
specificity of interaction by creating multiple interacting surfaces (36).  Modules of 
RBDs are typically connected by a 10 to 15 amino-acid linker region.  This linker region 
itself has been shown to interact with RNA, often being unstructured in the apo form of 
the protein and becoming ordered in the RNA bound form (32), (37).  Primarily, 
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interactions between RNA and the RRM proteins occur via the insertion of multiple 
loops into the minor groove of RNA (Figure 1.7).  Additional interactions come from 
the side-chains on the face of the β-sheet with the RNA being placed along the face of 
the β-sheet.  The number of β-strands that make up the β-sheet varies.  In the human U1 
snRNP A protein, an antiparallel four-stranded β sheet packs against two perpendicularly 
oriented α helices (38).  The RNP 1 in the β3 segment and the RNP 2 in the β1 segment 
are juxtaposed to create an interface packed with aromatic residues.  Positively charged 
residues are located on the loops at one end of the β-sheet and mutations in this region 
have a significant effect on RNA binding. As seen in most other RRM proteins, the 
linker region between the two RNPs is highly disordered in the crystal structure of the 
apo-protein.  The structure of this domain in complex with a 21 nucleotide synthetic 
RNA representing the U1 snRNA hairpin (39) shows that the most significant 
differences between the structures in the apo and complex state, are in the loops 
connecting β2-β3 and helix2-β4 (39).  The linker region gets ordered when bound to 
RNA.  The 10 nucleotide loop of the RNA fits into the groove between the β2-β3 loops 
and interacts with the RNP sequences as a single stranded RNA (39). The RNA binds 
the β sheet in a large area which is more exposed and open like a platform rather than a 
buried niche. The arginine residues in the RNP motifs form hydrogen bonding 
interactions with the RNA base pairs.  Various stacking interactions between nucleotide 
bases and aromatic residues from the protein additionally stabilize the complex. The 
residues that stack with the RNA bases typically are held in place by hydrogen bonds 
between their backbones.  The sugar-phosphate backbone of the RNA interacts with the 
positively charged surface of the protein. Hydrogen bonds between backbones of 
residues position the aromatic residues to stack against pyrimidine rings. This possibly 
decreases the flexibility of the large rings and tightens the RNA protein interaction. This 
probably also confers specificity to the interaction since it involves side-chains and not 
backbone interactions.  Despite the common structural fold of RBD proteins, they bind a 
host of different RNAs.  Information about specificity seems to lie in the residues just 
before the RNP2 and just after the RNP1, in the loop regions extending beyond the 
15
aromatic residues which make contacts with the side-chains. 
 Another commonly found RNA binding motif is the αββαβ- K homology (KH) 
domain (32).  This domain is characterized by a conserved octapeptide sequence- Ile-
Gly-X2-Gly-X2-Ile.  Many repeats of this sequence are often present in the protein. 
Although initially identified in hnRNP K, the domain was found to be prevalent in 
numerous other RNA associated proteins like Mer 1p, the ribosomal S3 proteins and the 
yeast alternative splicing factor (40), (32). The KH domain consists of a three stranded 
β-sheet exposed on one surface and two α-helices on the opposite side forming a helix 
turn helix motif (41).  The KH domain assumes the same overall topology as the RBD 
with minor differences.  However, the mode of interaction with RNAs is very different 
in these two domains.  RNAs interact with the KH domain not along the face of the β-
sheet as seen in RBDs but on the helical side of the domain (32), (Figure 1.7).  The short 
loop between the two helices has been shown to make critical contacts with the RNA 
and often goes from an unstructured to a more ordered form upon RNA binding.  A 
structure of KH domain from hnRNP K in complex with ssDNA (42) shows that besides 
RNAs, this domain could also interact with DNA via the helix turn helix motif.  This 
interaction involves both the backbone and the bases of the DNA. Base contacts are 
made both by stacking against aromatic residues as well as by hydrogen bonding.  
Although there seems to be a common theme in the way the RBD and KH domains 
interact with RNAs, individual proteins of conserved families have been seen to develop 
special interactions with their substrates (37).  This may provide another determinant of 
specificity.  
  Yet another commonly found RNA binding domain is the all helical Pumilio 
Homology Domain (PUM HD) or Puf Domain.  The Puf domain is named after the 
members of the Puf family of proteins which regulate expression of mRNA expression 
by binding the 3′ untranslated regions (UTRs) of their mRNA targets (43).  This RNA 
binding domain consists of eight to nine α-helical repeats. The substrate RNAs typically 
contain two conserved boxes Box A (GUUGU) and Box B (AUUGUA). The UGU 
sequence has been shown to be essential for interactions with the protein.  The structure 
16
Figure 1.7  The RNA recognition motif (RRM) and the K-homology domain 
a.  Crystal structure of spliceosomal U2A-U2B in complex with U2 snRNA (1A9N) 
is shown.  A 4-stranded antiparallel β-sheet forms part of the RNA (shown in grey) 
binding surface.  Loops (red) between β-strands and a β-strand and α-helix insert 
into the minor groove of the RNA.  b.  Crystal structure of the KH domain of 
neuronal splicing factor Nova1 in complex with a 25nt. RNA hairpin (2ANN) is 
shown.  The RNA (grey) interacts with the helical side (red) of the KH domain.  
The loop (black arrow) connecting the two helices becomes ordered upon binding 
RNA.    
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of HsPUM HD bound to a 10mer NRE RNA fragment (43) shows that the interactions 
between the PUM HD and the RNA take place along an extended, concave surface 
(Figure 1.8).  The bases of the RNA face the protein interface with the RNA backbone 
facing away from the protein. Bases from the RNA are involved in stacking interactions 
with residues from the α-helical repeats of the protein.  Hydrogen bonding interactions 
are present between the bases and residues at the concave interface, in addition to 
multiple van der Waal’s contacts that further stabilize the interaction.  Superposition of 
the backbone atoms of the protein in the apo and RNA bound form do not suggest any 
significant conformational changes in the protein upon binding RNA.  The structural 
studies reveal the possible determinant of specificity for this domain, since majority of 
contacts are made with the bases of the RNA and not with the sugar-phosphate 
backbone.  In some respects, this domain resembles the TROVE domain found in the 
Telomerase, Ro and Vault RNPs (44).  The TROVE domain itself is a ~ 300 amino acids 
long domain with multiple short helices connected by short loops.  Some TROVE 
domain proteins also have the RNP consensus sequences characteristic of the RRM, 
though the role of the RNPs in these domains is not clear (44).  
 Double stranded RNA-binding proteins (DRBPs) form a class of proteins with 
specificity towards double-stranded RNAs (45).  These proteins contain an αβββα type 
double-stranded RNA binding domain (DRBD) characterized by the presence of an 
evolutionarily conserved motif (46).  Proteins of this family may contain up to five 
DRBDs, each being ~ 65 to 68 amino-acids long (45).  The crystal structure of the 
dsRBD from Xenopus laevis dsRNA binding protein A in complex with dsRNA (PDB 
ID 1DI2) shows that three β-strands form an antiparallel β-sheet against which the two 
α-helices are packed (47), (Figure 1.9).  Majority of the contacts with RNA involve 
2’OH and phosphate groups instead of the sequence specific interactions with the bases 
(47).  A structure of the Drosophilla Stauffen DRBD in complex with an RNA loop (48), 
(PDB ID 1EKZ) shows how proteins belonging to this family could not only interact 
with dsRNA but also with ssRNA with elaborate secondary structure elements, but not 
with ssDNA, dsDNA and ssRNA.     
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Figure 1.8  The RNA binding Pumilio homology domain 
Crystal structure of the human pumilio homology domain in complex with the 
NRE1-19 RNA (1M8W) is shown.  The extensive RNA binding interface (red) is 
concave and lined with aromatic residues and charged residues.  The aromatic 
residues are involved in stacking against RNA bases (grey).  Electrostatic and van 
der Waal’s interactions further stabilize the complex.      
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Figure 1.9  The double stranded RNA binding domain (dsRBD) 
a.  Crystal structure of dsRNA binding protein A from X. laevis, in complex with 
dsRNA (1DI2) is shown.  The protein forms antiparallel β-sheet with the α-helices 
interacting with primarily the backbone of the RNA (grey).  b.  NMR structure of 
the third dsRBD from drosophila Staufen in complex with an RNA hairpin (1EKZ) 
is shown.  The dsRBD interacts with the minor groove and backbone of dsRNA 
(grey) via conserved residues in two loops (red).  An α-helical region (red) 
additionally interacts with the single stranded hairpin region of the RNA (black 
arrow).      
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1.4 OVERVIEW OF DISSERTATION CHAPTERS 
With Chapter I as an introduction to the general themes in protein nucleic-acid 
interactions, in the following chapters the structural studies performed on two nucleic 
acid binding proteins are described.  To obtain high resolution structural information, X-
ray crystallography has been used.  In chapter II the study of the RNA-binding Ro 
protein from Deinococcus radiodurans has been described.  The Ro protein is involved 
in binding misfolded RNAs as well as a class of non-coding small cytoplasmic RNAs 
called the Y RNAs.  There is growing evidence that Ro may play a role in the RNA 
quality control in cells.  These structural studies elucidate the conformational changes 
that might take place in the Ro protein to facilitate RNA binding.  This study also 
provides clues to the function of Ro in prokaryotes. 
In chapter III, the study of a metal responsive transcriptional regulator, CsoR 
from Mycobacterium tuberculosis is described.  CsoR binds to a specific 
operator/promoter region of DNA in its apo form.  CsoR responds to free Cu(I) ions in 
the cell and causes derepression of the copper sensitive (cso) operon.  In this way, it 
regulates the expression of a putative Cu(I) sensing P-type ATPase and other proteins.  
These structural studies reveal the mode of Cu(I) binding by CsoR and suggest possible 
determinants of Cu(I) specificity in CsoR.  Structure based comparisons suggest that 
CsoR uses a novel structural fold to interact with DNA.  
 In both Chapters II and III, fundamentals of protein crystallography have been 
discussed, using examples from our studies on Ro and CsoR.   
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CHAPTER II 
STRUCTURAL STUDY OF THE Ro PROTEIN 
2.1 INTRODUCTION 
 
2.1.1 Introduction to RoRNPs 
RoRNPs are a class of RNA protein complexes found in most vertebrate cells.  The 
major protein component of the RoRNPs has been shown to be a 60kDa protein named 
Ro (49).  The RNA components of the Ro RNPs are a class of small cytoplasmic non-
coding RNAs called Y RNAs, which are transcribed by RNA polymerase III and range 
in size from 69 to 112 nucleotides (50).  RoRNPs were discovered more than four 
decades ago.  Research since then has been directed towards understanding these RNPs, 
due to an intense medical interest in these RNPs.  
 
2.1.2 Disease pathology associated with RoRNPs 
Ro RNPs were first identified in patients suffering from autoimmune disorders like 
Systemic Lupus Erythematosus (SLE) and Sjögrens syndrome (SS) (51), (52), (53).  
Systemic autoimmune disorders like SLE are caused when the immune system wrongly 
recognizes the healthy cells and tissue in the body as “foreign” and targets them by 
producing autoantibodies.  As seen for most autoimmune disorders, the damage is not 
limited to any particular part of the body, affecting the heart, kidneys, skin, joints etc. 
(54).  Nephritis, pleuritis, arthritis and unusual sensitivity to light are common symptoms 
of lupus like autoimmune disorders.  The sera of patients suffering from such 
autoimmune disorders have a higher than normal titre of autoantibodies which recognize 
Ro RNPs (53).  Anti-Ro antibodies are also associated with neo-natal Lupus 
Erythematosus (NLE) in which trans-placental movement of antibodies takes place from 
mothers suffering from lupus to their babies (55).  NLE is often associated with 
congenital heart block and other cardiac, hepatic and dermatological disorders.  Lerner et 
al. have shown that the protein component of the Ro RNPs is required for the 
antigenicity since the Anti-Ro antibodies do not recognize the RNA components alone 
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(52).  The immune response is heterogeneous and in some cases, the antibodies 
recognize only the native protein and not the denatured polypeptides (56).  Currently, no 
cure is known for SLE and SS and the only treatment available is symptomatic, using 
immunosuppressants and corticosteroids (57).  A better understanding of the antigenic 
RoRNPs has resulted from studies in other organisms. 
 
2.1.3 Role of RoRNPs in eukaryotes 
In eukaryotes, Ro and Y RNAs have been identified in all vertebrates and the nematode 
Caenorhabditis elegans (58), (59), (60).  The number of distinct Y RNAs bound by Ro 
varies between different species. Humans and X. laevis, for example contain four known 
Y RNAs, mouse cells contain only two and C. elegans contains only one Y RNA (61), 
(58).  Y RNAs in humans have been implicated in DNA replication (62).  It has been 
shown that a subset of Ro RNPs also contains other protein components for example the 
50kDa La protein which binds to newly synthesized polymerase III transcripts like a 
number of nascent small RNAs including Y RNAs (63).  Another protein seen to 
associate with Ro is the 52kDa Ro protein, though the association between the 60kDa 
and 52kDa Ro has not been very well established (64), (65).  Ro as well as Y RNAs 
have been found in the cytoplasm as well as the nucleus (66).  
In mice, the absence of Ro leads to the development of a lupus-like syndrome, 
characterized by autoantibodies against chromatin and ribosomes and glomerulonephritis 
and photosensitivity (67) leading to the proposal that there may be a normal function of 
Ro that is important for the prevention of autoimmune reactions.  Also, mouse 
embryonic stem cells lacking Ro are highly sensitive to ultraviolet radiation (68).  Both 
Ro and Y RNA accumulate in the cells after UV irradiation , showing a drastic change in 
the cellular distribution from cytoplasmic to nuclear (68).  In mouse embryonic cells, Ro 
also binds misfolded spliceosomal U2 small nuclear RNAs (68).  These misfolded U2 
snRNAs are characterized by the formation of an abnormal helix not found in the normal 
U2 snRNAs.  This abnormal helix has been shown to be required for Ro binding by the 
misfolded U2 snRNAs (68).  It is not yet known whether these misfolded U2 snRNAs 
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assemble into functional snRNPs that retain the normal splicing activity or get degraded 
before being assembled.   
 Another well characterized ortholog of Ro is from Xenopus laevis.  In oocytes of 
X. laevis, Ro has been identified in complex with mutant 5S rRNAs in addition to the 
four Y RNAs found in Xenopus somatic cells (69). These mutant 5S rRNAs contain 
additional nucleotides at the 3' end, consistent with the failure of RNA polymerase III to 
terminate at the first transcription termination signal, and also contain one or more point 
mutations compared to the major oocyte 5S rRNA sequence (69).  It has been shown that 
the mutations in the sequence of these mutant pre 5S rRNAs results in a structural 
change in the RNA, allowing the formation of an alternate structure which differs from 
the normal pre 5S rRNAs (70), (71).  This helical region along with the 3’ single 
stranded extension has been shown to interact with Ro (72).  5S rRNAs are small non-
coding RNAs that from part of the large subunit of the ribosome and are essential for 
translation (73).  X. laevis has ~20,000 genes that code for 5S rRNA, presumably for the 
large numbers of ribosomes required during the early developmental stages.  These 
misfolded pre5S rRNAs recognized by Ro are unfit to follow the pathway to maturation 
and eventually get degraded (69), (74). 
Misfolded RNAs bound by Ro contain a single-stranded 3’ extension which has 
been shown to form part of the Ro binding site (72).  Binding of Ro with these misfolded 
rRNAs and U2 snRNAs has led to the proposal that Ro may function as part of a novel 
quality control or discard pathway for misfolded RNAs.  Interestingly, mice have been 
shown to have a large number of U2 snRNA genes just as X. laevis has an exceptionally 
large number of 5S rRNA genes.  Based on this observation it has been proposed that a 
sudden, high abundance of RNAs in the cell could be associated with a requirement of 
the cell to deal with RNA folding problems (68).  Ro may play a role by binding the 
misfolded RNAs and helping them either fold or get degraded, through a yet unknown 
mechanism.  In in vitro experiments it has been seen that Ro also binds the normal pre5S 
rRNAs and U2 snRNAs (72), though in physiological conditions these RNAs are likely 
to be bound by other proteins (75), (76), (77), (78).  Although reasonably well 
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characterized in eukaryotes, little is known about the role of Ro in prokaryotic 
organisms. 
 
2.1.4 Role of RoRNPs in prokaryotes 
 Following the explosion of genome sequencing projects, orthologs of Ro have been 
found in the genome sequences of many organisms like the algae Chlamydomonas 
reinhardtii, the cyanobacteria Nostoc punctiforme and Synechococcus, the eubacteria 
Deinococcus radiodurans and Mycobacterium smegmatis, the planctomycete Pirellula 
and the mycobacteriophage Bxz1 (79), (80), (81).  Although present in only few 
prokaryotes, the Ro protein is highly conserved in all the species where it has been 
identified so far, with ~35% sequence identity between any two Ros.  The genome 
sequences of Mycobacterium smegmatis, a non-virulent strain of mycobacteria and 
Bxz1, a mycobacteriophage specific for M. smegmatis also contain an ortholog of Ro.  
Whether Y RNAs or Y RNA-like RNAs exist in M. smegmatis and Bxz1 is still a 
question and one of the goals of this project is to try to answer this question.  Of all the 
Ro proteins from lower organisms, the Ro ortholog from D. radiodurans, called Rsr 
(Ro-sixty related) is the best characterized. 
D. radiodurans is a polyextremophillic eubacterium which can survive unusual 
amounts of heat, cold, dehydration and radiation (82).  D. radiodurans has been shown 
to tolerate close to 5000 Gy of UV radiation which is ~85 times that tolerable by E. coli 
and 500 times that tolerable by humans.  It has been shown that the Rsr protein 
contributes to the resistance of D.radiodurans to UV irradiation (83).  D. radiodurans 
cells lacking Rsr are more sensitive to UV radiation than wild-type cells and this 
phenotype can be partly complemented by Rsr expressed under the control of a 
heterologous promoter.  Rsr binds several small RNAs encoded upstream of rsr, which 
accumulate following UV irradiation (83).  These RNAs, of which at least one is 
predicted to assume a secondary structure that resembles a Y RNA, can be 
immunoprecipitated along with Rsr using anti-Rsr antibodies (83).  Studies in the last 
decade have shown that the amazing ability of D. radiodurans to tolerate such high 
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doses of radiation could be attributed to a number of different strategies that it uses to 
deal with UV damaged DNA (82).  D. radiodurans has a high genome copy number 
providing additional copies of essential genes that might get damaged.  A tight ringlike 
nucleoid prevents the diffusion of damaged DNA, probably increasing the accessibility 
of damaged DNA to repair enzymes (84).  Increased concentration of Manganese ions 
(Mn2+) post UV irradiation possibly allows scavenging of harmful reactive oxygen 
species that accumulate (85).  Besides these passive strategies, there are a variety of 
DNA repair enzymes that are triggered post UV damage.  These are shown to be both 
RecA dependent and RecA independent repair processes like non-homologous end 
joining (NHEJ) and single strand annealing (SSA) (86), (87), (88))  
  Based on the studies in D. radiodurans and mouse embryonic stem cells it has 
been proposed that Ro RNPs might contribute to recovery of cells following UV 
irradiation by acting as a sink for damaged RNAs (68).  The relation between the role of 
Ro in cell survival after UV irradiation and quality control of small RNAs is not fully 
understood.  Along with the genetic and biochemical characterization of RoRNPs, 
structural studies in the last decade have significantly increased our understanding of 
Ro-RNA interaction.  
 
2.1.5 Structural understanding of RoRNP function 
Studies on the Y RNAs recognized by Ro in different species have shown that all Y 
RNAs are predicted to form similar secondary structures (89) with two distinct regions, a 
conserved domain with almost identical sequences among different species and a 
variable domain which differs in sequence and predicted structure among species.  Based 
on RNAase cleavage experiments, mutational analysis and secondary structure 
predictions all Y RNAs are characterized by a helical stem formed by base pairing of the 
5’ and 3’ ends (89). In this stem, there is a highly conserved region, the nucleotide 
sequence of which is similar in all species. This helix and specifically a bulged cytidine 
in the helix have been shown to be the Ro binding site (49). Another asymmetric loop in 
the base paired stem, ~2 bases from the helix has been shown to be essential for Ro 
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binding. It has been proposed that this loop might be required to widen the helix to allow 
access of Ro to the binding site.  Recently, Christov et al. have shown that Y RNAs are 
required for chromosomal DNA replication in humans (62).  Mutations in the Ro 
binding site of the YRNAs do not affect DNA replication, suggesting that there are other 
regions of the Y RNA besides the conserved stem that are involved (62).   
Recent structural studies on the eukaryotic ortholog of Ro from X. laevis have 
shown that Ro is composed of two domains (90).  One is an elliptical domain formed by 
numerous repeats of pairs of antiparallel α- helices called HEAT repeats (91).  HEAT 
(named after Huntingtin, Elongation factor 3, A subunit of protein phosphatase 2A and 
TOR1) repeats are found in a variety of proteins, many involved in cytoplasmic transport 
processes like GCN1 (transport of tRNA substrates), VP15 (vesicle mediated protein 
transport) and importins (nuclear-cytoplasmic import and export pathways) (91).  While 
most of these proteins are large in size, the HEAT repeat domain itself could vary from 4 
repeats to 36 repeats.  X. laevis Ro containes 19 HEAT repeats (90).  The second domain 
of Ro resembles the collagen-binding A domain of vonWillebrand Factor (vWFA 
domain) consisting of a Rossman fold with a β-sheet sandwiched between multiple α-
helices (90).  The vWFA domain has been well studied in cell-adhesion and extracellular 
matrix proteins like Integrins, Matrilins and has been identified in many other proteins 
like the Anthrax toxin receptors and protease regulators etc. (92).  In most of these 
proteins the vWFA domain is involved in mediating protein-protein interactions.  
Approximately 46% of known vWFA domains also include a divalent cation binding, 
noncontiguous sequence motif called the MIDAS motif (Metal Ion Dependent Adhesion 
Site motif) (93).  In prokaryotes, more than 80% of known vWFA domains contain at 
least an imperfect MIDAS motif (93).  It has been shown that coordination of the 
divalent ion at this site is completed by the interacting protein partner, involving a 
conserved Aspartate or Glutamate residue (94).  In this way the MIDAS motif is thought 
to act as a ‘structural glue’.  
The crystal structure of X. laevis Ro in complex with a fragment of Y RNA 
containing the conserved Ro binding site shows that Ro binds Y RNAs at the outer 
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surface of the helical domain (90).  This structure of Y RNA bound Ro from X. laevis 
(90) provides little information about the variable domain of the Y RNA and its 
interactions with the Ro protein since only the conserved stem of the Y RNA was used 
in the crystallization experiment.  A second RNA binding site has been identified in Ro, 
at the positively charged central cavity (90), (72).  In the structure of RNA bound Ro 
from X. laevis, this site is surrounded largely by the elliptical domain, with the vWFA 
domain on one end being large enough only to fit a single stranded RNA.  It has been 
shown that this central cavity is the binding site for the single stranded tails of mutant 
pre-5SrRNAs and U2 snRNAs (90).  These studies suggest that Ro possesses two RNA 
binding sites, one to bind Y RNAs and the other to bind its misfolded RNA substrates.  
Mutational and structural analysis have also shown that at least part of the mutant pre-
5SrRNA binding site on X. laevis Ro overlaps the Y RNA binding site, leading to a 
proposed role for Y RNAs in regulating the binding of Ro to other RNAs like the mutant 
pre-5SrRNAs or other damaged RNAs (90), (72).  The mechanism of Ro binding to 
misfolded RNA substrates is not yet understood.   
In this chapter, we describe the structural studies and biochemical 
characterization of the prokaryotic ortholog of Ro, namely Rsr from D. radiodurans.  To 
obtain structural information to a high resolution, we have used X-ray crystallography.  
As described in Ramesh A et al., (95) our results show that “while the overall structure 
of Rsr resembles the architecture of X. laevis Ro, there are major structural differences 
between the two proteins.  The most notable difference is at the interface of the two 
domains, where large movements are evident in the α-helices close to the interface.  
Movement of these helices results in an enlarged central cavity, suggesting that the 
structural flexibility of Ro proteins probably aids in switching between ‘open’ and 
‘closed’ states which may be required for entry, stabilization and release of the RNA 
substrates at the conserved central cavity.  We have also characterized the binding of Rsr 
to Deinococcus Y RNA in vitro, using a fluorescence based assay.  Our results reveal 
that Rsr binds Y RNA with at least low-nanomolar affinity and forms a complex with 
1:1 stoichiometry.  While the apo-Rsr protein is monomeric even at very high 
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concentrations, electron microscopy and size exclusion chromatography show that upon 
binding Y RNA Rsr forms multimers of approximately 12 molecules of the 1:1 Rsr:Y 
RNA complex”.         
 
 
2.2 RESULTS AND DISCUSSION 
 
2.2.1 Sequence based analysis of Ro orthologs 
Multiple sequence alignment of Ro proteins from different organisms shows the 
presence of conserved motifs.  At least one conserved RNA recognition motif (RRM) 
could be identified (Figure 2.1).  RRMs are a loosely conserved 80 to 90 amino-acid 
long region, found in proteins that participate in diverse reactions involving RNAs like 
polyadenylation, splicing, RNA transport and translation (96), (97), (98).  The RRM is 
characterized by the presence of one hexameric and one octameric Ribonucleoprotein 
(RNP) consensus sequence.  In Rsr, these comprise residues 100 to 105 and residues 132 
to 139.  These RNP consensus motifs are rich in Leucine and Phenylalanine residues 
which typically stack against the RNA bases. 
 From SMART (Simple Modular Architecture Research Tool) predictions, 
including searches within the Pfam database, only one major domain is confidently 
predicted for Ro.  This domain is called the TROVE domain after Telomerase, Ro and 
Vault (44).  This domain is found in TEP1, Ro60 and Vault proteins, that are RNA-
binding components of Telomerase, Ro and Vault RNPs respectively and is predicted to 
be the site of RNA binding (44).  In Ro proteins, the RRM lies within the TROVE 
domain. 
 Sequence analysis also shows that Ro orthologs contain strictly conserved residues 
even outside the TROVE domain (from residue 360 to 520).  
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 Figure 2.1  Sequence analysis of Ro orthologs 
Multiple sequence alignment of Ro proteins using ClustalW with the GONNET 
weight matrix is shown.  D. radiodurans, Mycobacteriophage Bxz1, M. smegmatis, 
X. laevis and H. sapiens Ro proteins are shown with strictly conserved residues in 
green, identical residues in yellow and similar residues in cyan.  Red arrow marks 
the beginning of the vWFA domain and asterisk marks the MIDAS residues.  
Magenta brackets mark the ends of the predicted TROVE domain which contain 
RNP1 and RNP2 (blue lines).  Black boxes mark conserved Glycines at flexible 
hinges in Rsr.  
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2.2.2 Structure solution of Rsr 
The best crystal of Rsr (Figure 2.2) diffracted X rays to a resolution of 1.89Å.  The first 
approach was to solve the structure of Rsr using Molecular replacement, with the 
structure of X. laevis Ro as a search model.  The two proteins share 37% identity.  To aid 
in the Molecular replacement process, a homology model of Rsr was first created using 
the web-based program- CPHmodels (99).  The coordinates of the homology model were 
then used for the Molecular replacement.  The number of molecules in the asymmetric 
unit is 1 for both the X. laevis and Rsr crystals, hence a single molecule was searched 
for.  Programs like Molrep and Amore and phaser did not find a solution.  Considering 
that the two proteins could differ in structure whereby the two domains of Ro could be 
oriented differently with respect to each other, the search model was split into two 
domains and then used for molecular replacement.  This also did not yield any clear 
solutions. 
 Seleno-methionine substituted Rsr was used for structure solution by 
Multiwavelength Anomalous Dispersion.  The MAD data was complete to 2.6Å and the 
statistics for data collection are shown in Table 2.1.  13 out of 14 sites selenium sites 
were located by phenix.hyss and the corresponding statistics are shown in Table 2.2.  
Refinement of sites and density modification by AutoSHARP substantially improved the 
electron density map.  This density modified map was used as the input for TEXTAL 
and the resultant partial model is shown in Figure 2.3.  Manually cutting and pasting 
small regions from the CPH homology model created previously, helped to improve the 
partial model created by TEXTAL.  The reasonably complete model was then rigid-body 
refined against the native 1.89Å data and subsequently refined by simulated annealing 
starting at a temperature of 5000K, to obtain a higher resolution density map.  At various 
steps, composite omit maps were used to improve the map quality and check for model-
bias.  5% of the reflections were kept aside for cross validation of the model through the 
refinement process.  Towards the last stages of model refinement, water molecules were 
added at a 3σ density cut off, using the corresponding automatic feature in phenix.refine.  
The added waters were then manually checked and refined.  Waters lying on the axis of  
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Figure 2.2  Crystals of Rsr 
a.  Small crystalline pellets formed by 6his-Rsr are shown.  b. A single crystal of 
6his-Rsr formed in Na/K Tatrate as precipitant is shown.  c. A single crystal of 
cleaved Rsr, grown in PEG 4000 is shown under heavy precipitation of salts.    
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Table  2.1  Data collection statistics for Rsr and 6his-Rsr:DrY RNA crystals 
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Table  2.2  Statistics of the selenium sites in Rsr 
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Figure 2.3  Initial model of Rsr built by TEXTAL 
Clearly recognizable features like β stands (boxed) and α helices (red arrows) in the 
initial model are shown.   
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crystallographic symmetry were refined with “half” occupancy.  Strong positive electron 
density at 6σ contour level was observed, surrounded by residues that are conserved in 
sequence across the Ro orthologs.  This site corresponds to the divalent metal site in X. 
laevis Ro.  Since the crystallization solution for Rsr contains 200mM calcium acetate, a 
calcium ion was fit and refined in this position.  The final model refined to an Rwork of 
22.3% and an Rfree of 26.2% suggesting good correlation between the model and the 
data.  The refinement statistics are shown in Table 2.3.        
The final model comprises residues 36 to 531 out of the total 531 residues, one 
Ca2+ atom and 400 molecules of water.  The model possesses good stereochemistry as 
judged by the Ramachandran Plot of the backbone φ and ψ angles (Figure 2.4).  99% of 
residues lie in the favoured regions and 1% in the generously allowed regions.  Clear 
electron density was not visible for residues 1 to 35 which are presumably disordered in 
the crystals.  Multiple sequence alignment of Ro from various organisms (Figure 2.1) 
shows that this N-terminal stretch of 35 residues is highly variant in all Ro orthologs 
except for six conserved residues.  In the crystal structure of Ro from X. laevis,  this 
region is placed on the outer surface of the protein, away from the RNA binding sites 
and forms two short β-strands which pack against a β-strand of the C-terminal domain 
(90).  The crystallographic asymmetric unit consists of one monomer of Rsr and 
applying crystallographic symmetry does not generate any higher oligomer of Rsr with 
significant buried surface area.  This, along with size-exclusion studies performed on 
purified Rsr suggests that Rsr is a monomer.   
 
2.2.3  The overall structure of D. radiodurans Rsr 
The overall structure of Rsr resembles a ring spanning ~ 76 Å in diameter and ~ 32 Å in 
thickness (Figure 2.5).  Rsr possesses two distinct domains: an N-terminal domain 
including residues 36 to 351 and a C-terminal domain including residues 352 to 531.  
The N-terminal domain comprises of numerous short helices (H1 to H18) which form a 
ringlike arrangement, and one beta-strand (β1).  The ringlike arrangement of helices 
encloses a central cavity with dimensions of 18 to 20 Å and is lined by charged residues 
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Table  2.3  Refinement statistics for the Rsr structure 
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 Figure 2.4  Ramachandran Plot of the Rsr crystal structure 
Backbone torsion angles of the Rsr structure are shown.    
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 Figure 2.5  Overall structure of D. radiodurans Rsr 
a.  The N-terminal ring domain (pink) consists of helices H1 to H18 and one beta 
strand- β1.  The C-terminal vWFA domain (blue) consists of a β2 to β7, sandwiched 
between helices H19 to H23.  The Calcium ion is shown as a red sphere.  Conserved 
residues in the central cavity (Arg128, Lys172, Tyr173, Arg176, Glu247, Arg273 
and Arg309) and on the outer surface of the ring domain (Arg116, Lys117, Arg151, 
Arg152, Lys187, His189, Lys191) are shown as sticks.  b.  Side view of Rsr when 
looking from H10-H11.  c.  Side view of Rsr when looking from H12-H16.   
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from the loops connecting successive helices from H2 to H18.  The majority of residues 
pointing into this cavity, for example - Arg128, Lys172, Tyr173, Arg176, Glu247, 
Arg273 and Arg309 are strictly conserved among the Ro orthologs.  In Ro from X. 
laevis, this site has been implicated in binding single stranded RNAs with these 
conserved residues directly interacting with an extended conformation of a single strand 
of RNA (90).  Notably, on the outer surface of the helical ring domain there is another 
cluster of positively charged residues (Arg116, Arg117, Arg151, Arg152, Lys187, 
His189, Lys191), some of which are highly conserved in Ro orthologs.  In X. laevis Ro, 
this site has been implicated in Y RNA binding (90). 
The short repeats of antiparallel helices as seen in the N-terminal domain of Rsr 
are similar to the HEAT repeats seen in the nuclear transport proteins like the importin 
family of proteins (91), (100), (101).  Figure 2.6 shows the arrangement of HEAT 
repeats in other proteins.  The structural similarity between these HEAT repeat domains 
and the N-terminal region of Rsr suggests a similar functional mechanism for the domain 
in these proteins.    
The C-terminal domain of Rsr resembles a vonWillebrand Factor A (vWFA) 
domain similar to that found in cell-adhesion and extra-cellular matrix proteins (93).  
The vWFA domain is a Rossman fold, characterized by a β sheet sandwiched between 
α-helices.  In Rsr, the β-sheet is formed by six parallel β-strands (β2 to β7) and is 
sandwiched by parallel helices H19, H20 and H23 on one side and helices H21, H22 on 
the other (Figure 2.5).  Interestingly, in Rsr this C-terminal β –sheet interacts with the β-
strand (β1) from the N-terminal domain, to form a seven stranded sheet.  The vWFA 
domain is found in a variety of other proteins, where it assumes a common fold (shown 
in Figure 2.7).  Frequently, the vWFA domain is the site of protein-protein interaction, 
for example, in the vonWillebrand Factor this domain helps the adhesion of platelets to 
fibrillar collagen underlying injured vascular endothelium and in the Inserted (I) domain 
of Integrins, this domain is involved in interactions with collagen (92).    
About 46% of known vWFA domains also contain a non-contiguous sequence 
motif called the MIDAS motif, which forms a divalent metal binding site (102).  
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 Figure 2.6  HEAT repeats in nuclear transport proteins 
a.  HEAT repeats (salmon) in crystal structure of importin-β bound to IBB domain 
of importin-α (not shown), 1QGK.  b.  HEAT repeats (salmon) in the crystal 
structure of karyopherin β2-transportin in complex with Ran (not shown), IQBK. 
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Figure 2.7  vWFA domains in proteins 
a.  vWFA domain in the crystal structure of the I domain of integrin bound to Mn2+ 
(1JLM).  A six stranded parallel β-sheet (blue) sandwiched between α-helices 
(salmon).  b.  Crystal structure of the A3 domain of the von Willebrand factor, 
1AO3 shows a 6-stranded β-sheet (blue) between α-helices (salmon).  c.  vWFA 
domain in the crystal structure of the human capillary morphogenesis protein 2, an 
anthrax toxin receptor, 1SHT.  A six stranded β-sheet (blue) is sandwiched between 
α-helices (salmon).   
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Similarly, the C-terminal domain in Rsr also includes the divalent cation binding, 
MIDAS (Metal Ion Dependent Adhesion Site) motif.  This motif consists of residues 
D367XSXS…T…D462, all of which are strictly conserved in all Ro orthologs.  In Rsr, a 
peak of strong positive electron density corresponding to the 6σ contour level in a 
difference density map was proximal to a site surrounded by the MIDAS residues.  A 
Ca2+ ion was fit into this site based on the fact that the crystallization condition contains 
200mM Calcium acetate (Figure 2.8).  The Ca2+ ion is coordinated by Oγ of Ser369, Oγ 
of  Ser371, two structured water molecules (HOH 3 and HOH 6), Oε2 of Glu464 and Oε1 
and Oε2 of Glu464 from a crystallographically symmetry related molecule.  The 
distances between the Ca2+ ion and the ligands range from 2.3 to 2.6Ǻ.  Two residues of 
the MIDAS motif- Asp367 and Asp462 form the second coordination sphere around the 
Calcium ion and bind the metal coordinating waters.  Several crystal structures are 
available, of vWFA domains containing the MIDAS motif.  This feature of  a metal 
coordinating ligand belonging to a symmetry related molecule has been observed in 
other crystal forms of the MIDAS motifs in vWFA domains and Integrin I domains 
(103), (104) where it has been proposed that in physiological conditions the coordinating 
ligand may belong to a binding partner of the protein. While a disulphide bond between 
Cys374 of symmetry related molecules of Rsr was observed, this is likely to be an 
artifact of crystallization where a high concentration of protein was used.  In the RNA 
bound structure of X. laevis Ro, the metal site is occupied by a Mg2+ ion and the metal 
coordination is completed by an acetate molecule from the crystallization solution.  It 
has been suggested that the acetate may mimic an aspartate or glutamate residue from a 
yet unidentified binding partner of Ro (90).  In the apo structure of X. laevis Ro, this 
domain is structurally identical to the metal bound X. laevis and Rsr structures (72).  The 
authors have refined a water molecule in place of the metal.   
In both Integrins and the cell-adhesion proteins, the vWFA domain is the site for 
protein-protein interactions with a conserved cation binding MIDAS site acting as a 
structural ‘glue’, bringing protein ligands closer to the vWFA domain (94).  The 
coordination of the metal is made complete by ligands from the interacting partner.  In 
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Figure 2.8  Close-up of the divalent metal site 
Coordination sphere around Calcium (red sphere) bound to Rsr is shown.  The 
Calcium coordinating residues – Ser 369, Ser 371, two waters, Glu464 (sticks) along 
with Glu464’ from the symmetry related molecule (yellow stick) are shown.  The 
second coordination sphere around Calcium, consisting of MIDAS residues Asp 367 
and Asp 462 which stabilize the water molecules are shown as sticks.   
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many cases, metal binding at the MIDAS site is also associated with large 
conformational changes at a distant site across the domain (105).  Based on the similarity 
in the fold of the C-terminal domain of Rsr to other vWFA domains, it is possible that 
this conserved domain of Rsr along with the metal site helps to mediate interactions 
between Rsr and other proteins.  Also, since Rsr has been shown to bind small RNAs 
that are damaged or targeted for degradation (83), it is possible that binding partners of 
Rsr include nucleases, helicases and other RNA processing enzymes. Also, isolation of 
Ro RNPs from eukaryotic cells often pulls down other proteins like the La protein and 
the 52kDa Ro protein.  If at all Ro interacts directly with these proteins, it is possible that 
the vWFA domain mediates these interactions.   
 
2.2.4 Rsr binds Y RNA with low nanomolar affinity 
To characterize the binding of Rsr to D. radiodurans Y RNA, a fluorescence based assay 
was used.  Rsr has eight tryptophans, five of which are strictly conserved in all Ro 
homologs (Figure 2.9).  Also, the structure of X. laevis Ro bound to RNA (90) suggests 
that one or more tryptophans are involved in stacking interactions with RNA.  Besides 
the full length DrY RNA, truncations of DrY RNA were used in this experiment (Figure 
2.10).  These included 35- mer and 33-mer fragments representing the putative Rsr 
binding site of DrY RNA (DrY RNA35),  and a 39-mer fragment with an engineered, 
stable GAAA tetraloop (called DrY RNAGAAA).  By monitoring the quenching of 
intrinsic tryptophan fluorescence upon titrating RNA, binding isotherms were obtained 
(Figure 2.9).  The binding assay was performed in buffer containing 25mM Hepes pH 
7.0, 150mM sodium chloride and 10mM magnesium chloride
.  
The minimum detectable 
amount of Rsr was found to be 25nM, hence the assay was done at 50nM concentration 
of Rsr.  Relevant corrections for RNA fluorescence, photobleaching and inner-filter 
effect of RNA were performed as described in section 2.3.12.  Using this assay it was 
found that Rsr binds DrY RNA35 and DrY RNAGAAA with at least 16±3nM and 36nM 
affinity respectively with a stoichiometry of 1:1. The affinity for the full length DrY 
RNA is lower, with a Kd = 280nM.  This could be the effect of the variable domain of 
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Figure 2.9  Binding studies on Rsr and Y RNA  
a.  Tryptophan residues are shown on the Rsr structure, as sticks.  b. Fluorescence 
emission spectra (315 to 400nm) obtained upon excitation at 295nm are shown.  
Quenching of fluorescence occurs with increasing concentrations of Y RNA.  c. Plot 
of fractional saturation (θ) vs. Y RNA concentration (µM) obtained from the 
emission at 335nm.  Binding with DrYRNA35 (black), DrY RNA123 (red), DrY 
RNAGAAA (dotted black) are shown.  Error bars represent standard deviation from 
the mean of three independent samples. The equilibrium dissociation constant Kd 
equals ~ 16 ± 3 nM for DrY RNA35, 36nM for DrY RNAGAAA and 280nM for Dr 
YRNA123.  Stoichiometry of binding is 1:1.  d.  Binding isotherm for Rsr TROVE 
domain with Dr YRNA35 is shown. Kd = 100nM.   
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 Figure 2.10  Potential secondary structures of Y RNAs as predicted by mFOLD 
a.  The structure of full length DrY RNA123 is shown and the variable domain and 
conserved Ro binding regions are marked.  b.  Ro binding region of  X.laevis Y 
RNA is shown.  c.  mFOLD secondary structure predictions of the 35-mer (DrY 
RNA35), 39-mer (DrY RNAGAAA) and 33-mer ( DrY RNA33).  d.  Native PAGE 
analysis of DrY RNA35 (lane1), DrY RNAGAAA (lane2) and DrY RNA123 (lane3) 
shows presence of predominantly one conformation.  
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 the Y RNA which is absent in the tighter-binding truncations.  It is possible that the 
conformational flexibility of the variable domain may affect the binding by Rsr whereas 
in physiological conditions this variable domain may be associated with other cellular 
components.  Since this assay could not be performed at a lower concentration of Rsr 
because of the detection limit, the calculated Kd is likely to represent the apparent Kd.  
RNA binding affinity was weaker in the presence of 250mM lithium sulfate instead of 
150mM sodium chloride, suggesting a salt-dependence of Ro-RNA binding. 
 
Consistent 
with our findings, dissociation of RNAs from Ro at higher ionic strength has also been 
shown for human Ro ribonucleoprotein particles (106).  Binding of Rsr to DrY RNA35 is 
comparable to that reported for X. laevis Ro and Y RNA interactions.  X. laevis Ro binds 
Y RNA and the Ro binding region with ~5nM affinity.  In X. laevis it as been shown that 
mutation of the conserved Histidine residue (H189 in Rsr and H187 in X. laevis Ro) to 
Serine, on the outer positively charged surface of Ro, decreases the affinity for Y RNA.  
In Rsr, this is being tested. 
To study the binding of Y RNA by the TROVE domain alone, in the absence of 
the vWFA domain, TROVE was purified from inclusion bodies as described in the 
methods section.  After removal of Empigen BB from the protein sample, fluorescence 
assays were performed.  Figure 2.9 shows the binding of the TROVE domain with DrY 
RNA35 with an apparent Kd = ~ 100nM.  Although the TROVE domain alone binds Y 
RNA, the affinity is almost 6-fold weaker than that of full length Rsr.  This suggests that 
the vWFA domain may be involved in stabilizing the Y RNA binding conformation of 
the TROVE domain.  As seen in the crystal structure, the TROVE domain consists of 
multiple HEAT repeats and is expected to be conformationally flexible (107).  The 
presence of the vWFA domain may aid in closing-in of the HEAT repeats to stabilize the 
ringlike conformational of the TROVE domain that may be suitable for RNA binding.            
 
2.2.5 Rsr shows large domain movements when compared with apo or RNA bound 
Ro from X. laevis 
Consistent with our results that molecular replacement using X. laevis Ro (1YVP and 
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1YVR) with the diffraction data from Rsr was unsuccessful, the comparison showed 
very obvious structural differences between the two proteins.  The overall shape of the 
two proteins is significantly different, with Rsr forming a more rounded ring shaped N-
terminal domain compared to the elliptical N-terminal domain of X. laevis Ro (Figure 
2.11).  The side views of the two proteins clearly show the flat ring formed by Rsr 
compared to the V-shaped, distorted ring formed by the X. laevis Ro.  The surface 
rendering of Rsr when colored by electrostatic potential shows two distinct patches of 
positive residues, one on the outer face of the ring domain corresponding to the Y RNA 
binding site of X. laevis Ro and the other lining the central cavity which corresponds to 
the single stranded RNA binding region in X. laevis Ro.  While the residues in these 2 
sites are conserved, in X. laevis Ro the distribution of the positive surface is more 
continuous between the 2 sites, unlike the separate clusters seen in Rsr.  The difference 
in charge distribution could account for the variations in RNA sequences that bind Rsr 
versus X. laevis Ro.  In both proteins, the vWFA domain is mostly negatively charged.   
Superimposition of the entire proteins as rigid bodies, using COOT (108) 
demonstrated that the relative position of the two domains with respect to one another 
was quite different, with RMS deviations based on Cα positions equal to 3.8 Å.  The 
superimposition using the Y RNA binding region as reference, is shown in Figure 2.12.  
A much better fit was obtained when the domains were treated as two rigid bodies and 
superimposed on the corresponding domains from X. laevis Ro with RMS differences of 
2.8 Å for the N-terminal and 2.1 Å for the C-terminal domains.      
Superimposition of the vWFA domains of Rsr and X. laevis Ro (Figure 2.13) 
shows no pronounced changes within the domain.  One difference is in the loop region 
between residues Gln373 to Pro385.  This loop is close to the metal binding site and the 
changes seen could be a result of the presence of the larger Ca2+ ion in the metal site as 
compared to a Mg2+ ion.  
However, superimposition of the N-terminal domains showed marked differences 
between the structures at the interface of the N and C terminal domains (Figure 2.12 
and Figure 2.14).  In Rsr, the stretch of residues from Gly52 to Ala58 that forms a β-
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 Figure 2.11  Comparison of Rsr and X. laevis Ro surfaces 
a.  The electrostatic surface potential rendering of Rsr shows two distinct positively 
charged surfaces (blue) corresponding to the residues shown as sticks in Figure 2A.  
The vWFA like domain is mostly negatively charged (red).  b. The surface of X. 
laevis Ro shows a continuous patch of positive charge on the ring domain and a 
vWFA domain that is mostly negatively charged.  c. Side views of Rsr (left panel) 
and X. laevis Ro (right panel) show obvious difference in shape and thickness, with 
Rsr forming a flat disc with an accessible surface area of 23570 Å2 as compared to 
the cup shaped X. laevis Ro with an accessible surface area of 23297 Å2. 
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 Figure 2.12  Superimpositon of Rsr and X. laevis Ro structures with the Y RNA 
binding region as reference 
 
a. Superimposition of Rsr (pink and blue) on X. laevis Ro (yellow) shows large 
movements of the vWFA domain and helices close to the central cavity.  Black 
arrows mark the direction of movement.  b. Close-up of superimposed helical 
domains of Rsr (pink) and X. laevis Ro (yellow) shows H15 to H18 in Rsr are 15Å 
away from H3 - H4 (black line) whereas in X. laevis Ro this distance is ~5Å.  The β1 
region of Rsr forms an alternate loop conformation in X. laevis Ro (boxed region).  
The conserved tyrosines (Tyr55 in Rsr , Tyr47 in X. laevis Ro) have been shown as 
sticks.  Conserved glycine residues have been shown as cyan spheres.   
51
 Figure 2.13  Superimposition of Rsr on X. laevis Ro with vWFA domains as 
reference 
a.  Superimposition of Rsr (pink and blue) and X. laevis Ro (yellow) shows 
displacement of the ring domain, marked by the black arrow.  b.  Close-up of the 
superimposed C-terminal domains of Rsr (blue) and X. laevis Ro (yellow) have been 
shown along with the β1 region of Rsr and the corresponding loop from X. laevis 
Ro.  In Rsr Tyr55 is placed away from the metal site and is stabilized by 
interactions with a water molecule and Glu498 whereas in X. laevis Ro the 
corresponding Tyr47 interacts with a metal coordinating water molecule.  
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 Figure 2.14  Comparison of Rsr and X. laevis Ro structures with respect to the RNA 
bound 
A. Superimposition of Rsr (pink and blue) and RNA bound X. laevis Ro (yellow) 
using helical domains as reference shows displacement of vWFA domain and 
helices H15 to H18.  Direction of displacement is shown as black arrows.  Double 
stranded Y RNA fragment (green), ssRNA (navy) and Mg2+ ion (magenta) bound to 
X. laevis structure are shown.  B. RNA (pink stick representation) bound to X. 
laevis Ro (surface representation) is shown. 
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strand (β1) is stabilized as a part of the seven stranded β-sheet from the vWFA domain 
whereas the corresponding region in X. laevis Ro forms a loop.  In X. laevis Ro, a 
conserved tyrosine residue (corresponding to Tyr55 in Rsr) in this loop has been shown 
to form the second coordination sphere around the MIDAS metal, forming a  hydrogen-
bond with one of the metal- coordinating water molecules. However, in Rsr this region is 
far from the metal site with Tyr55 pointing away from the β-sheet and forming hydrogen 
bonds with a water molecule and Glu498 (Figure 2.12).   
Comparison of the N-terminal domains also shows a much larger central cavity 
in Rsr with the 4-helix bundle formed by H15 to H18 being placed > 15Å away from 
helices H3 - H4 as compared to the structure of X. laevis Ro where this distance is ~ 5Å 
(Figure 2.12).  This 4-helix bundle undergoes >34º rotation away from the central cavity 
as compared to X. laevis Ro.  The different placement of these helices in Rsr could 
potentially modulate RNA binding by influencing the size of the central cavity.  
Considering that the α-helices H17 - H18 are in close contact with the C-terminal 
domain, changes in the placement of these helices may get transmitted to the C-terminal 
vWFA domain.  It is possible that this structure of Rsr with the 4-helix bundle formed by 
H15 to H18 placed away from the central cavity, may represent an “open” state poised to 
allow entry or release of the RNA substrates from the central cavity.  In the presence of 
the RNA substrate as seen in the X. laevis Ro bound to the ssRNA (90) the 4-helix 
bundle may swing in towards the cavity, accompanied by the movement of the vWFA 
domain which may further affect the down-stream events of RNA processing.  
To understand the basis of such flexibility in the structure of Rsr, a detailed 
analysis of its sequence was done.  Rsr has a distribution of highly conserved Glycine 
residues close to the regions that involve structural changes (Figure 2.12).  One example 
is the Gly51-Gly52 motif preceeding the β-strand (β1) which is present in an alternate 
loop conformation in X. laevis Ro.  Another Gly144-Gly145 motif precedes the region 
connecting helices H6 and H7.  This region corresponds to a loop in  X. laevis Ro that 
becomes ordered upon Y RNA binding (90).  Especially notable are Gly267 (conserved 
Proline or Glycine at this position) which precedes the 4-helix bundle (H15 to H18), and 
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the Gly-X-X-Gly-X-X-Gly (276-279-282) motif that is present on the C-terminus of 
helix H15.  Glycine-rich motifs in other proteins have been shown to be the site of 
structural flexibility (109),(110).  The positions of these Glycines in Rsr possibly 
represent hinge regions which allow helices H15 to H18 to undergo displacement away 
from the central cavity.  The N-terminal domain of Rsr is composed of HEAT repeats 
very similar to that found in some nuclear-transport proteins like importin-β.  Various 
crystallographic, biochemical and molecular dynamics simulation studies strongly 
support a “spring-loaded” model for ligand binding which involves the movement of 
some helices with respect to the others with a critical role for glycine and proline 
residues as hinge residues (107).  Our proposal that the structure of Rsr represents the 
“open” form and the conformational differences we see at the RNA binding central 
cavity agrees well with this well-described mechanism for ligand binding by HEAT 
repeat domains in nuclear transport proteins.  To confirm this prediction, extensive 
mutational analysis of these hinge glycine residues is required, along with reliable assays 
that could help measure the flexibility of specific regions of the protein in solution.  
Fluorescence based assays to measure conformational changes are sensitive, but the 
ability to introduce probes into desired locations within the protein is crucial for the 
outcome of these experiments and often the most challenging part.  In Rsr, the presence 
of multiple reactive groups along with the presence of an extensive and buried interface 
adds yet another level of complexity.   
 
2.2.6 Potential implications of the Rsr structure on its interactions with different 
RNA substrates 
To understand the features of Rsr that allow its interaction with different RNA 
substrates, we compared the structure of Rsr with the X. laevis Ro bound to Y RNA and 
single-stranded (ss) RNA (1YVP) (Figure 2.14) .  At the Y RNA binding site, residues 
that interact with the nucleotides G1 to A10 in the first strand of X. laevis Y RNA are 
structurally conserved between the two proteins.  His189, Tyr179, Arg148, Arg151, 
Tyr146 in Rsr are present in similar conformations as in X. laevis Ro and possibly 
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interact with Y RNA in the same manner as seen in X. laevis Ro.  Some residues that 
interact with Y RNA in X. laevis Ro are not conserved, like residues Lys187 and 
Asp141.  Although the Y RNA substrates of Ro from different species are predicted to 
form identical secondary structures (111), there are subtle differences in their sequence 
even within the conserved Ro binding region.  It is possible that the non-conserved 
positions at the Y RNA binding site of Ro account for the diversity in the Ro binding 
regions of Y RNAs from different species.  
Ro in X. laevis has also been shown to bind ssRNAs at the central cavity 
(72),(90).  A comparison of this site with Rsr shows that most residues that interact with 
ssRNA in X. laevis Ro, are conserved.  Mutagenesis in X. laevis Ro has identified the 
conserved residues corresponding to Lys172, Arg176 to be important in binding ssRNA 
(90).  These along with residues Thr123 and Arg174 interact through hydrogen bonds 
with the phosphate backbone of the ssRNA.  Significantly, residues of X. laevis Ro 
corresponding to the conserved residues Arg273, Arg296 and Arg309 interact with the 
ssRNA bases but are not critical for binding the ssRNA.  In Rsr, these residues lie on the 
helices H15 to H16 which are displaced away to form a significantly larger central 
cavity.  This suggests that Rsr may bind a variety of RNA substrates in the central cavity 
by changing the size of the cavity and using the conserved residues in the flexible helices 
to interact with these RNAs while the primary residues forming the primary, most-
stabilizing interactions with the RNA come from the more rigid regions of the protein.        
Previous studies in various organisms (68),(69),(72) have shown that besides Y 
RNAs, Ro also binds U2 snRNAs and pre-5SrRNAs.  Also, in D. radiodurans at least 
four different RNAs which associate with Rsr, accumulate post-UV irradiation.  Only 
one of these resembles a Y RNA (83).  It is possible that recognition of such a variety of 
RNAs by Ro is a result of structural adaptation of the protein, made possible by a series 
of highly conserved motifs which serve as flexible joints in the protein backbone.   
The structure of Rsr reveals many conserved Glycine-rich motifs and the 
positions of these motifs coincide with regions of Rsr which show a marked difference 
from the previously described structure of Ro from X. laevis.  These large structural 
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differences are most pronounced in the region surrounding the central cavity that has 
been shown to bind ssRNA in X. laevis.  The outward movement of helices at the 
interface of the two domains results in a significantly larger central cavity.  Other 
proteins which possess a repeated antiparallel helix-turn-helix or HEAT-repeat domain 
similar to the N-terminal domain of Rsr, have been shown to be highly flexible and it has 
been suggested that flexibility may be an intrinsic feature of such domains (112).  Also, 
one of the major changes seen in the Rsr structure is the switch in the conserved β1 
region between a beta-strand versus the loop conformation seen in X. laevis Ro.  Based 
on the observation that a conserved tyrosine residue from this region forms the second 
coordination site around the MIDAS metal in the vWFA domain of X. laevis Ro but is 
placed away from the site in Rsr, we speculate that the vWFA domain may play a role in 
mediating structural changes via this region, all the way to the RNA-binding central 
cavity.    
 
2.2.7 Rsr: DrY RNA35 complex forms large multimers in solution 
To further characterize the Rsr:DrY RNA35 complex, we performed size exclusion 
chromatography using a Superose 6 column (range of 5 to 5000 kDa).  The elution 
profiles are shown in Figure 2.15.  Fractions containing RNA showed a 260/280 ratio 
greater than 1.  Fractions containing protein showed a 260/280 ratio less than 1.  
Fractions containing the complex of Rsr and RNA showed a 260/280 ration greater than 
1 and were detected on a dot-blot stained with Anti-6histidine Antibodies.  Details are 
provided in the methods section.  Our results show that Rsr forms multimers upon 
binding DrY RNA35.  To get a more accurate measure of the size of these multimers, 
similar runs were performed on a Superdex 200 column (Figure 2.16).  The multimers 
are of an average size > 700kDa and are composed of ~ 12 molecules of Rsr:Dr Y RNA.  
Consistent with the tryptophan fluorescence assays described above, the ratio of 
absorbance 260/280 of the multimers corresponds to a 1:1 complex of Rsr: Y RNA.  
While the multimer formation occurs in the presence of both Dr Y RNA as well as DrY 
RNA35, Rsr alone and DrY RNA35 alone even over a wide range of concentrations (1µM 
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 Figure 2.15  Size exclusion profiles from a Superose 6 column 
A plot of Absorbance at 280nm (blue) and 260nm (red) versus Elution volume 
shows the elution characteristics of DrY RNA35 alone (top panel), Rsr alone (middle 
panel) and the Rsr:DrY RNA35 complex with excess unbound DrY RNA35 (bottom 
panel). Black asterisk marks the fractions corresponding to multimers of Rsr:DrY 
RNA35 complex. 
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Figure 2.16  Size exclusion profiles from a Superdex-200 column 
a.  A plot of Absorbance at 280nm versus Elution volume shows the elution 
characteristics of Rsr alone (blue), DrY RNA35 alone (red), the Rsr:DrY RNA35 
complex and excess unbound DrY RNA35 (green) and Rsr:DrY RNA35 complex and 
excess unbound DrY RNA35 in buffer supplemented with 10mM metal chelator 
EDTA (yellow).  Black asterisk marks the peak corresponding to multimers of 
Rsr:DrY RNA35 complex.  b.  Calibration curve obtained from the elution profile of 
a mix of five standard proteins : Thyroglobulin (670kDa), Bovine gamma globulin 
(150kDa), Chicken ovalbumin (44kDa), Equine myoglobin (17kDa) and Vitamin 
B12 (1.3kDa).    
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to ~500µM) did not show formation of multimers and eluted at the expected monomeric 
sizes (representative curves are shown in Figure 2.16).  Similar experiments performed 
in the presence of saturating amounts of magnesium ion or with an excess of metal 
chelator EDTA showed identical multimer formation suggesting that the formation of 
multimers is independent of the presence of metal ions at the vWFA domain of Rsr.  Our 
observations suggest that while the multimers are stable in solution the equilibrium shifts 
more towards smaller oligomers (for example a 1:1 complex) when the size exclusion 
column is run at flow rates lower than 0.5ml/min.  Dissociation of the multimer also 
occurs at higher concentrations of salt, which is presumably due to disruption of ionic 
interactions between Rsr and DrY RNA as seen in the fluorescence assays.   
 To confirm that the formation of the 700kDa multimer is based on specific 
interactions and not a consequence of non-specific aggregation, the fractions 
corresponding to multimers were analyzed by electron microscopy.  Electron 
microscopy was performed by Christos G. Savva and Dr. Andreas Holzenburg at the 
Microscopy and Imaging Center (MIC) in Texas A&M University.  Electron 
micrographs confirmed the presence of particles displaying symmetrical patterns in 
projection.  Representative class averages obtained from 1600 particles (Figure 2.17) 
suggest 2- to 4- fold rotational symmetry residing within the multimers measuring up to 
180Å along the long axis.  In addition, some classes did not reveal any rotational 
symmetry in projection.  The observed heterogeneity within the Rsr:DrY RNA 
population has so far hampered 3-dimensional reconstruction efforts.   
Since the formation of multimers occurs in the presence of both the full length Y 
RNA as well as the conserved region of Y RNA and the fluorescence assays suggest a 
1:1 complex between Rsr and Y RNA, it is likely that the multimer formation does not 
involve additional RNA-RNA or RNA-Protein interactions.  This suggests that upon Y 
RNA binding, Rsr adopts an alternate conformation which promotes oligomerization.  
This feature of forming large, ordered multimers in the presence of Y RNA has not been 
reported yet for other Ro orthologs.  Formation of higher-order oligomers upon binding 
single-stranded DNA has been observed for the Human RecQ helicase (113).  The 
60
  
Figure 2.17  Electron microscopic analysis of single Rsr:DrY RNA35 particles 
a.  Electron micrograph of negatively stained Rsr:DrY RNA multimers shows 
ringlike formations.  b.  Representative class averages displaying no symmetry (1), 
2-fold (2), 3 and 4-fold (3, 4) rotational symmetry. Scale bar corresponds to 20 nm.  
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RecQ-ssDNA complex forms oligomeric ringlike structures surrounding a central pore, 
the site where annealing of complementary strands of DNA could take place.  This 
higher-order oligomerization in the presence of ssDNA has been shown to regulate the 
enzyme, switching the activity from DNA unwinding to DNA strand annealing.  
Although the RNA binding properties of Ro have been extensively characterized (72), it 
is not known what events take place after Ro binds Y RNA and what triggers those 
events to take place.  It is possible that formation of these multimers acts as a trigger to 
set off the downstream processing events, which in the case of D. radiodurans is likely 
to be the removal of UV damaged RNA.  Human RoRNPs from pull-down assays using 
Anti-Ro antibodies are shown to form ~320kDa sized particles (106). 
 
2.2.8 Crystallization and structure determination of Rsr:DrY RNA complex 
Although complete only to low resolution, the diffraction data obtained from crystals of 
the Rsr:DrY RNA complex (Figure 2.18) was used for Molecular replacement.  Initially 
the Rsr structure and eventually the RNA bound structure of X. laevis Ro were used as 
search models for the molecular replacement runs.  One of the major complications in 
these runs was the correct estimation of the number of molecules in the asymmetric unit 
of the Rsr:DrY RNA complex crystals.  Calculations using the Mathews Coefficient 
program in the ccp4 suite suggested anywhere between 10 to 14 molecules in the 
asymmetric unit (Figure 2.18), adding another level of complexity to the MR runs.  
Phaser, MolRep and Amore failed to find solutions when 12 molecules were searched 
for.  To improve the chances of a successful MR run, the quality of diffraction data 
needs to be improved. 
Crystals of the complex also grew in the presence of Seleno-methionine 
substituted Rsr and diffracted up to 7Å.  Three wavelength MAD data was collected and 
used for phase calculation using phenix.hyss and Solve.  No heavy atom sites were 
located by either program.  Inherent disorder in the crystals due to heterogeneity of the 
sample, handling of the crystals, packing in the crystal lattice could be some of the 
reasons for the poor quality diffraction.        
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Figure 2.18  Crystallographic analysis of Rsr:DrY RNA35 complex 
a.  Crystals of 6hisRsr:DrY RNA35 grown in 30% Methyl Pentanediol, 0.2M 
Ammonium acetate, 0.1M Sodium citrate pH5.6.  b.  Calculation of Mathew’s 
coefficient searching for a 77000 Dalton molecule in the Rsr:DrY RNA35 unit cell 
suggests ~ 12 to 14 molecules in the asymmetric unit.  
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2.3 EXPERIMENTAL APPROACH AND DESIGN 
 
2.3.1 Construction of an E. coli overexpression plasmid for Rsr and purification of 
Rsr 
The Rsr coding region was amplified by PCR from D. radiodurans genomic DNA 
(purchased from ATCC) and cloned into pET28b (Novagen).  The primers and 
restriction sites used are listed in Table 2.4.  The resultant plasmid was transformed into 
E. coli BL21 (DE3) and grown in LB media and 50µg/ml of kanamycin to mid-log 
phase.  IPTG was then added to a final concentration of 0.5mM and the cells were 
allowed to grow for ~18h at 25ºC.  The temperature of 25ºC for cell growth after IPTG 
induction was obtained after analytical experiments were performed at 37 ºC, 25 ºC and 
16 ºC.  At 37ºC Rsr was expressed as insoluble aggregates where as at 16 ºC there was 
no expression.  Small scale analytical experiments were also done to find the E. coli 
strain best suited for Rsr over-expression. Rsr was over expressed in both BL21 (DE3) 
and Rosetta (DE3) cells but not in plysS+ strains. 
 
2.3.2 Cloning of the TROVE domain of Rsr 
The N-terminal residues (#24 to 360) were amplified by PCR and cloned into different 
vectors to obtain N-terminal and C-terminal 6-histidine tagged constructs. The primers, 
vectors and restriction sites used are listed in Table 2.4. Based on the structure of Rsr, 
since the N-terminal 35 residues were disordered, a second construct of the TROVE 
domain was made, comprising residues 36 to 360 to help in making the protein soluble.  
This however did not help and the construct was still expressed as inclusion bodies in E. 
coli.  
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Table 2.4  Cloning strategy for various Rsr and DrY RNA constructs 
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2.3.3 Purification of Rsr 
Cells were lysed using the French press, in 25mMHepes, 150mMNaCl, 2-βME, 1X 
Protease Inhibitor cocktail SetV (Calbiochem).  After centrifugation at 15000Xg for 60 
minutes, the supernatant subjected to Ni2+ affinity chromatography.  Following washes 
with buffer containing Hepes, NaCl, 2 βME and the buffer supplemented with 20mM 
Imidazole, elution was carried out using a linear gradient of Imidazole ranging from 
20mM and 400mM in the buffer.  Fractions corresponding to approximately 100mM 
Imidazole contained Rsr, the purity of which was greater than 90% as judged by 
Coomassie-stained 4-20% Tris-HCl SDS-PAGE gels.  The protein was concentrated 
using Amicon-Ultra centrifugal filters- MWCO 10kDa.  Initial Crystal screens 
performed at a protein concentration of 1mg/ml and 3mg/ml showed that only drops 
containing phosphates/sulfates/cacodylate in the crystallization condition were clear, 
suggesting that phosphates/sulfates/cacodylate may be necessary to keep the protein 
soluble.  To identify the most suitable buffer to maintain Rsr in a stable and soluble 
form, small-scale dialysis was performed against different buffers ( buffer1: 50mM 
Phosphate 7.0, 150mM NaCl, 2mM DTT, buffer2: 500mM Phosphate 7.0, 150mM 
NaCl, 2DTT, buffer 3: 50mM Phosphate 7.0, 500mM NaCl, 2DTT, buffer4: 100mM 
Cacodylate 7.0, 150mM NaCl, 2mM DTT, buffer5: 500mM Cacodylate 7.0, 150mM 
NaCl, 2DTT ) with 3ml of Rsr( at 2mg/ml concentration) in dialysis cassettes.  Since Rsr 
stayed most soluble in buffer containing 50mM Phosphate 7.0, 500mM NaCl and 2mM 
DTT, these components were used in subsequent purifications of Rsr.  
Cells were lysed in buffer A (25 mM Phosphate pH 7.0, 500mM Sodium chloride 
and 2 mM βME ) by french press.  The lysate was centrifuged at 15000rpm and the 
supernatant subjected to Ni2+ affinity chromatography.  Following washes with buffer A 
(~ 20X column volume) and buffer A supplemented with 20mM Imidazole (30X column 
volume), elution was carried out using a linear gradient of imidazole ranging from 
20mM and 400mM in buffer A over 30X column volume.  Fractions corresponding to 
~100mM Imidazole contained Rsr, the purity of which was greater than 90% as judged 
by Coomassie-stained 4-20% Tris-HCl SDS-PAGE gels (Figure 2.19).  Fractions 
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 Figure 2.19  Purification of Rsr 
a.  Plot of absorbance at 280nm versus volume shows the elution profile of Rsr from 
a Nickel column. Steps corresponding to increasing concentrations of Imidazole 
(green) are shown. Pure Rsr elutes at >100mM Imidazole. SDS-PAGE analysis of 
the fractions confirms the presence of Rsr in the fractions.  b.  Elution profile post-
Thrombin cleavage of 6his-Rsr is shown. Cleaved Rsr elutes at 20mM Imidazole 
whereas uncleaved Rsr elutes at ~100mM Imidazole.  c.  SDS-PAGE analysis of 
samples used for crystallization shows >90% pure 6his-Rsr, cleaved Rsr and ~80% 
pure 6his-TROVE. D.  Dot blot stained with Anti-6his Antibodies confirms the 
purity of the samples of cleaved and uncleaved Rsr.   
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containing Rsr were cleaved with Thrombin (purchased from Calbiochem) at a 
concentration of 5 Units of Thrombin per milligram of Rsr during dialysis against 25mM 
Phosphate pH 7.0, 150mM sodium chloride and 2mM βME.  The dialysed sample 
contained Rsr with and without the 6-histidine tag and these were separated again by 
Ni2+ affinity chromatography, with Rsr being eluted with 20mM imidazole (Figure 
2.19).  This fraction was concentrated using amicon centrifugal filters and buffer 
exchange with 25mM Phosphate pH 7.0, 150mM NaCl and 2mM DTT was done during 
concentration. All mutant proteins were purified the same way.  Protein concentration 
was calculated using absorbance at 280nm and extinction coefficient equal to 57660 M-
1cm-1 (114).  To analyze its oligomeric state, Rsr was subjected to size exclusion 
chromatography on a Superdex-S200 column.  Rsr migrated as a single monomeric 
species on the column when compared to the standard calibration curve (Figure 2.16).  
To avoid precipitation of the protein which accompanies lengthy purification 
protocols with multiple chromatography steps, the first step of Nickel affinity 
purification of 6his Rsr was optimized to obtain >90% purity of the sample. This was 
more important in this case since the purification post-Thrombin cleavage resulted in the 
desired protein being eluted in the lower concentrations of eluent (Imidazole).  
Optimization of the 1st purification step was done by introducing longer wash steps at 
0mM, 20mM Imidazole and an extra 55mM Imidazole step.       
 
2.3.4 Use of Crystallization screens to find the optimal buffer for Rsr 
Initial purification of Rsr in 25mM Hepes pH7.0, 250mMNaCl and 2mM βME on a Ni2+ 
affinity column resulted in pure protein which would slowly precipitate over a period of 
12 hours.  This pure protein could not be concentrated beyond 3mg/ml.  This hindered 
crystal growth since one of the requirements of Crystal formation is that the sample be 
stable enough to last the period of crystal growth.  Preliminary screens setup with Rsr at 
2mg/ml in 25mM Hepes pH7.0, 250mM NaCl, 2mM βME resulted in 95% of the drops 
forming brown precipitation within a day.  The remaining 5% of the drops remained 
clear for more than 5 days. The common factor among these 5% of clear conditions was 
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the presence of Phosphate/ Sulfate/ Cacodylate salts.  Sulfate and Cacodylate share 
similar chemical properties as Phosphate thereby behaving like Phosphate mimics, often 
present in crystals in place of the physiological relevant Phosphate ion.  Dialysis of 
purified Rsr for 3 days against different solutions containing Phosphate/ Sulfate and 
Cacodylate with varying amounts of Sodium Chloride resulted in clear protein solution 
only in the presence of 25mM Phosphate pH7.0, 150mM NaCl and 2mM βME.  In this 
buffer, Rsr could be concentrated to >25mg/ml and remained stable for more than 1 
week at crystallization temperatures (18ºC), hence this buffer was used to purify the 
protein for subsequent crystallization experiments.  The requirement of Phosphate salts 
to stabilize purified protein has been shown for other RNA binding proteins.  This 
approach of using crystallization screens to find the optimal buffer for the stability of a 
protein has broad general applications.  
 
2.3.5 Expression and purification of TROVE domain 
All constructs of the TROVE domain were expressed in the Rosetta(DE3) plysS strain of 
E. coli.  The cells were lysed using French press in buffer containing 25mM phosphate 
pH 7.0, 500mM NaCl and 2mM βME.  Following lysis and a clearing spin at 3000Xg, 
the supernatant was centrifuged at 10000Xg for 20 minutes.  Partially purified TROVE 
protein was present in the pellet as inclusion bodies. Since all constructs were expressed 
as insoluble aggregates, the N-terminal 6his tagged protein was used for subsequent 
experiments.  The inclusion bodies were solubilized in 0.5% Empigen BB, a zwitterionic 
detergent.  Following solubilization, the sample was loaded on a Ni2+ affinity column 
and eluted with buffer containing ~100mM Imidazole.  The fractions containing pure 6-
his TROVE were dialysed against 25mM phosphate pH 7.0, 150mM NaCl, 2mM DTT.  
To facilitate removal of Empigen BB, Bio-beads (Calbiochem) were added to the 
dialysis buffer and many buffer exchanges were done, each supplemented with fresh bio-
beads. 
 Since the predicted TROVE domain is expressed as inclusion bodies in E. coli 
cells, Trypsin digestion of Rsr was performed, to identify a domain in Rsr that could be 
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expressed in the soluble fraction.  SDS-PAGE analysis of Trypsin digested Rsr shows at 
least two prominent domains (Figure 2.20).  The major band on the gel migrates smaller 
than the predicted TROVE domain, and it is likely that cloning this region and 
expressing it in E. coli could be a good starting point to study the domains of Rsr 
individually.    
 
2.3.6 Crystallization of Rsr 
Crystals are ordered arrays of the sample protein/macromolecule arranged in a lattice 
(115).  The crystalline state is described as a metastable state between the super-
saturated solution and precipitate or insoluble states (115), (116).  Hence, crystallization 
is more likely when the starting sample used is at a concentration close to super 
saturation in the given buffer.  The process of crystallization involves the precipitation of 
the sample at a very controlled and slow rate so that along the path of precipitation, the 
sample could form crystals and be trapped in the metastable crystalline state (115).  
Consistent with this, commonly used crystallization agents are typically precipitation 
agents like high concentrations of salt (ammonium sulfate, sodium phosphate, sodium 
malonate), hygroscopic polymers (Polyethylene glycol, polyethylene imine) and 
alcohols (Methyl pentane-diol, ethanol) (115).  In many cases, crystallization is also 
caused by varying the pH of the solution, driving it towards the pI of the protein where 
the protein tends to be most unstable (115).  The important step in the crystallization 
experiment is to control the process so as to not remain in the completely stable and 
soluble state indefinitely, but not be driven towards precipitation too rapidly.          
Initial screening for Rsr crystals was done using the 6-histine tagged protein at a 
concentration of 10mg/ml.  Two types of crystals were obtained.  Microcrystals (Figure 
2.2) grew in conditions containing Polyethylene glycol as the precipitant and cube 
shaped crystals were obtained by the sitting drop method in Intelli plates, in 1.14M 
Sodium-Potassium tartrate and 0.1MHepes pH 7.5 (Magnesium free screen 1, condition 
#52, Lawrence Livermore, Berkeley).  These crystals could not be reproduced in home-
made conditions or fresh solution supplied by the Lawrence Livermore Laboratory.  To 
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Figure 2.20 Trypsin digestion of Rsr 
Time course of Trypsin digestion of Rsr shows two prominent domains, one of 
approximately 30kDa and the other around 20kDa in molecular weight.  
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confirm that the crystallized protein was intact 6-histidine Rsr, the crystal was dissolved 
in SDS-PAGE loading buffer.  The sample was run on an SDS-PAGE, followed by 
Western blotting on a nitrocellulose membrane and detected with Anti-6his-Antibodies.  
Since the crystals with 6-histidine Rsr were irreproducible, screening for crystals was 
done post cleavage with Thrombin protease.  Rod shaped crystals for native Rsr without 
the 6-his tag were grown by the sitting drop method in Intelli plates, in a crystallization 
solution consisting of 0.1 M imidazole pH 8.0, 12% polyethylene glycol 8000 and 0.2M 
calcium acetate.  Diffraction quality crystals (Figure 2.2) were obtained by mixing 4 µL 
of crystallization solution with 2 µL protein at a concentration of 400 µM, and 
equilibrating against 100 µL of crystallization solution.  
To obtain phase information for structure determination, seleno-methionine (Se-met) 
substituted Rsr was produced in E. coli B834 (DE3) cells.  Briefly, the cells were 
transformed with the pET28b-Rsr construct, grown in LB media to mid-log phase, 
transferred to M9 minimal media supplemented with L-amino acids (Sigma, 50 mg/L), 
L-seleno-methionine (Acros, 50 mg/L), glucose (0.4% w/v), calcium chloride  0.1 mM), 
magnesium sulfate (4 mM), thiamine (5 µg/mL) and kanamycin (50 µg/mL), induced 
with 0.5 mM IPTG and allowed to grow for 18 h at 25 ˚C.  Following harvesting of 
culture, the same purification protocol was followed as for the native Rsr except 
increasing the concentration of DTT from 2mM to 5mM in the final buffer prior to 
crystallization.  Crystals for Se-met substituted Rsr were obtained in the same condition 
as that of native Rsr.  
 
2.3.7 Preparing crystals for data collection 
To minimize the harmful effects of the penetrating X-ray beam on the crystal, data 
collection is typically performed with the crystal placed in a stream of liquid nitrogen, at 
a temperature of 100K (117).  To prevent freezing of the solvent in the crystals and 
subsequent fracturing of the crystals, the crystals are picked using inert nylon loops and 
soaked for 1-30 seconds in a solution of cryoprotectant which prevents freezing (115).  
This is an important optimization step, often involving trial and error since many crystals 
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do not survive or do not diffract in commonly used cryoprotectants like 10 to 40% 
glycerol, 10 to 40% Ethylene glycol, Polyethylene Glycol etc.  Some cryoprotectants are 
oil based compounds like paraffin oil, silicone oil, FOMBLIN, and the highly viscous 
paratone (115).  The viscosity of the cryoprotectants often causes mechanical damage to 
fragile crystals. The few crystals of 6his Rsr obtained in the initial screen were flash 
frozen in liquid nitrogen using a mix of 70% paratone and 30% PCR Mineral oil as 
cryoprotectant.  This home-made mix of two oil based compounds served as a good 
cryoprotectant as well as decreased the viscosity of the paratone which was necessary to 
maintain the crystals intact. The crystals of cleaved Rsr were flash frozen in liquid 
nitrogen using 25% glycerol in mother liquor as a cryoprotectant.  The Se-met Rsr 
crystals were flash frozen in liquid nitrogen using paratone as the cryo-protectant.  The 
solution of 25% glycerol in mother liquor that was used successfully for the native Rsr 
crystals did not yield good diffraction for the Se-met crystals. 
 
2.3.8 X-ray data collection and data processing 
X-rays are penetrating electromagnetic radiation in the 0.5Å to 100nm range (117).  
Since the atomic bond distances in biological macromolecules are of the order of 1 to 
3Å, the wavelength of X-rays is ideal to resolve atoms separated by similar distances 
(117).  X-rays interacting with matter get absorbed to result in vibration of electrons with 
the same frequency as the incident waves (117).  The vibrating electrons, when returning 
to the ground state emit X- radiation similar in energy and wavelength to the incident 
radiation.   
X-ray diffraction is a phenomenon when X-rays are scattered from a particle in 
different directions, such that the scattered rays have the same wavelength as the 
incident rays (117), (118). Scattered X-rays from a regular arrangement of scattering 
particles undergo constructive interference along some directions. The X-rays scattered 
in particular directions are called orders of diffraction (h), with the direction closest to 
the unscattered ray being the first order of diffraction (117).  If there are enough particles 
repeating in a lattice (as in a crystal), the emitted X-rays undergo substantial constructive 
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interference, resulting in a proportional increase in the intensity/amplitude of the X-ray.  
When sufficient intensity has been gained, the X-ray makes a characteristic diffraction 
spot on a detector like photographic film, or modern day detectors like charge-couple 
devices etc. (117).  For every such diffracted X-ray that produces a diffraction spot, there 
is an associated amplitude and phase angle (117), (118).  The amplitude and phase angle 
for the diffracted X-rays represent the Fourier transform of the scattering density 
(electrons, in this case) (117).  Fourier transform is a mathematical expression used to 
describe the harmonics of any repeating function, for example the repeating density of 
electrons from identical molecules that make up a crystal (117).  All the scattering that 
contributes to the diffraction in a given direction can be can be summed up, to obtain a 
quantity called the Structure Factor, Fh which is a complex number with an amplitude A 
(= |Fh|) and phase (= αh) (117). 
Fh = |Fh| exp[iαh] = 0∫ρ(x) exp [2piihx] dx  
Similarly, ρ(x) can be derived from the inverse Fourier transform summed over all the 
scattered X-rays, if the scattering factor Fh is known (117).  ρ(x) represents the repeating 
factor in the crystal, which is the density of scatterers or the electron density.  In the X-
ray diffraction experiment, the measurable quantity is the intensity of the scattered X-
ray.  Intensity is proportional to the square of the amplitude, so the amplitude of the 
diffracted X-ray can be calculated (117).  However, information about the phase angle of 
the X-rays is lost in the diffraction experiment, giving rise to the phase problem in 
crystallography.  Phases, therefore, have to be calculated using other methods, some of 
which are described in the following section.  In the diffraction experiment, the greater 
the change in direction of the scattered rays from the direction of the incident rays, the 
finer the spacing that can be resolved between the scatterers (117), (118).  The spacing 
between the scatterers is called d-spacing and is related to a parameter called resolution.  
Resolution is expressed in Angstroms since spacing in between scatteres in 
macromolecular crystals is of that order (118).  At a given wavelength, with n being an 
integral value, resolution (d) is related to the scattering angle (θ) by Bragg’s Law (118):  
2d sinθ = nλ    
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The repeating arrangement of molecules in the crystal lattice gives rise to 
symmetry.  Two objects are related by symmetry if one molecule is subjected to an 
operation (like rotation, inversion, mirror image formation) and as a result is 
superimposable on the other molecule.  Restrictions due to the chirality of amino-acids 
allow only rotational operations to exist in protein crystals (117).  In 3-dimensional 
crystals, different rotational symmetries could exist along the x, y and z axis.  
Constraints of the crystal lattice allow only 2-, 3-, 4- and 6- fold rotational symmetries to 
exist in macromolecular crystals and the possible kinds of symmetry that can be 
possessed by crystals are described together as the crystallographic point-groups (119).  
Besides the rotational symmetry, crystals also possess a symmetry called the lattice 
translational symmetry generated by repetition of the macromolecule along 3 different 
axes (117).  Lattice translation along with rotational symmetry gives rise to complex 
symmetries within crystals.  A combination of rotational and translational symmetries 
gives rise to screw symmetry (117).  The three lattice translations, along the x, y and z 
axis define the Unit Cell (117).  The Unit Cell can be imagined to be a block which 
when translated along the x, y and z directions gives rise to the entire crystal lattice.  The 
3 lattice translations are defined as a, b and c and the angles between them are defined as 
α, β and γ. The different types of Unit Cells found in crystals, have been grouped 
together to describe 7 Crystal Systems (117).  Calculation of the symmetry in the crystal 
is a necessary and important step in structure determination.  The diffraction pattern 
obtained from a crystal reflects on the symmetry present in the crystal, hence looking at 
the pattern of diffraction spots, one can calculate the inherent symmetry within the 
crystal (118).  This can be done manually, by looking at the precession frames of the 
diffraction data or using programs that are trained with the known rules of symmetry 
calculation (118).  The minimum unit beyond which no symmetry exists is called the 
Asymmetric Unit (118).  It is enough to solve the structure of the asymmetric unit since 
the rest of the crystal can be generated by applying the correct symmetry.  
The 6-his Rsr crystals were exposed to synchrotron X-rays at beamline19ID, 
Argonne National Labs.  The best crystal (Figure 2.2) diffracted to ~5Å.  The best 
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crystal of native Rsr diffracted to 1.89Å at beamline 23-ID while the best crystal of Se-
met Rsr diffracted to 2.6 Å at beamline 23-ID at the Argonne Labs, IL. 
Rsr crystals showed C2 symmetry belonging to the monoclinic crystal system 
(119).  The monoclinic system is characterized by a minimum of one 2-fold symmetry 
axis.  Conventionally, b is parallel to the 2-fold axis and a and c are perpendicular to the 
2-fold axis (119).  α and γ = 90º and β ≠ 90º.  The C2 space group is a lattice that is face 
centered on the face whose edges are a and b (119).  The equivalent points or symmetry 
related points in the unit cell are: (x, y, z), (-x,y,-z), (1/2+x,1/2+y,z), (1/2-x,1/2+y,-z).  
Rsr crystals belong to the conventional monoclinic space group with unit cell 
dimensions of a = 103.56 Å, b = 87.61 Å, and c = 70.62 Å, α= 90.0º, β= 96.57º, γ= 
90.0º.  The Se-met Rsr crystals possess C2 symmetry and the data was isomorphous to 
the native Rsr diffraction data, with cell dimensions of a =105.41Å, b =89.39Å, and c 
=70.55Å, α =90.0º, β =96.8º, γ =90.0º.  Data statistics are compiled in Table 2.1.  
Completeness of the Rsr data, defined as ratio of the number of unique relections 
measured to the total number of unique reflections, was equal to 98% for the overall data 
and 85.3% at a resolution of 1.89Å.  A single molecule of Rsr was calculated to compose 
the Asymmetric Unit.  The Mathews volume, which represents the volume of the crystal 
per unit mass of the protein, was calculated as 2.7 with a solvent content of 54.8%.  This 
is typical for most proteins, the range being 1.9 to 4.2. 
 
2.3.9 Structure determination 
As described above, the scattered X-rays from a crystal possess the same energy as the 
incident X-rays and are in phase with the incident rays (117).  However, when certain 
heavy atoms (with unusually large number of electrons) are present in the crystal,  if the 
wavelength of incident light is close to the transition energy of the heavy atom, then the 
vibration of the electrons goes out of step and the scattered X-rays are out-of-phase with 
the incident rays (117). This phenomenon is called anomalous scattering.  Due to this 
out-of-phase scattering, the normal condition of Fh,k,l and F-h,-k,-l being equal in 
magnitude and opposite in phase (called Friedel’s Law) is violated (117).  In anomalous 
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scattering, the Friedel pairs Fh,k,l and F-h,-k,-l are not opposite in phase.  The difference 
between |Fhkl| and |F-h,-k,-l| is called the Bijvoet amplitude difference (117), (118).  At the 
wavelength close to the absorption edge of transition for the heavy atom, the heavy atom 
displays anomalous scattering but at wavelengths far from the absorption edge, the 
heavy atom displays normal scattering (118). 
Tunable X-ray sources like synchrotrons allow crystals to be exposed to different 
wavelengths close to and far from the absorption edge of the heavy atom, therefore 
allowing data collection to determine phases using Multiwavelength Anomalous 
Dispersion (MAD) (118).   This MAD technique was used to solve the phase problem 
for Rsr.  The 3 wavelengths used are listed in Table 2.1. The peak and inflection 
wavelengths are at and close to the absorption edge for selenium and the remote 
wavelength is far away from the edge.  From the MAD data, the Bijvoet amplitude 
differences are calculated, the squares of which are used as coefficients to calculate the 
Patterson function (118).  The Patterson function is a Fourier transform which is 
described using only intensities and is independent of phases.  For a small number of 
scatterers, the Patterson function can be directly calculated from the observed intensities.  
Since the number of heavy atoms in the crystal is much smaller than the total number of 
atoms, the Patterson function is used to locate the positions of the heavy atoms (118).  
On the Patterson map, the positions between pairs of anomalous scatterers show up as 
cross-peaks. 
 Another method for phase calculation is called Molecular Replacement (117) 
which relies on an already available homologous structure, called the search model.  
Based on the assumption that there is enough structural similarity between the search 
model and the unknown structure, the first step is to perform rotational and translational 
operations on the search model to fit it into the Unit Cell of the unknown protein.  For 
this, an accurate calculation of the Unit Cell of the unknown protein is essential, along 
with an accurate measure of the contents of the asymmetric unit.  For example, if 2 
molecules are calculated to be present in the asymmetric unit of the unknown protein, 
then 2 molecules of the search model need to be placed in the Unit Cell of the unknown 
77
protein.  Once an operation has been found that places the search model in the Unit Cell 
of the unknown protein, the operation is applied to every atom of the search model to 
obtain new coordinates which represent an initial calculated model for the unknown 
protein.  The new coordinates can be described as:  xX=RxM +T, where R is the 
rotational operation and T is the translational operation, xX denotes the coordinates for 
the unknown protein and xM denotes the coordinates of the search model (117).  The new 
coordinates are used to calculate structure factors with the observed intensities (since 
those are obtained from the diffraction experiment) and the calculated phases.  The 
model of the unknown protein at this stage is biased towards the search model.  Bias 
minimization is done till features exclusive to the unknown protein and not present in the 
search model can be identified in the electron density.  At every step, comparison is 
made between the amplitudes of the calculated and observed structure factors.  As the 
new model approaches the correct structure, the calculated phases improve to give a less 
biased and more reliable structure.   
 After the electron density has been calculated, model building is done using the 
known rules of protein structures like bond lengths, types of amino acids, planarity of 
the peptide bond etc.  Automated model building programs are trained on these known 
parameters and can be given electron density as input to build the model.  One such 
model building program called TEXTAL (120) was used for Rsr.  TEXTAL uses a 4-
step process for model building.  First, it locates the model in the correct space in the 
electron density and then builds the Cα chain using CAPRA (C-Alpha Pattern 
Recognition Algorithm).  In the third step, the side chains are placed in density 
according to the sequence of the protein which is provided as input for the program.  In 
the fourth step, refinement is done to match the model with the calculated electron 
density.  The accuracy of model building by TEXTAL greatly increases if the data (and 
hence electron density) provided as input are in the same resolution range as the 
structures that constitute its training set.   After the initial step of automated model 
building, corrections to the model can be made either manually or using programs like 
the Iterative Build feature in the Phenix package (121).  For Rsr, both methods were 
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employed to obtain the best results. 
 Structural refinement involves adjustment of the structure to best match the 
observed crystallographic data, i.e. the amplitudes of the structure factors.  Typically the 
model is refined for the coordinates, the B values for every atom and the occupancies.  
The B- value is a measurement of the displacement of an atom due to thermal motion or 
disorder (117), (118).  For successful refinement, enough good quality data is required 
along with a model that agrees reasonably well with the electron density.  Refinement is 
usually done in stages, starting with rigid body refinement, where the coordinates are 
moved as one or more rigid bodies to fit better into the electron density (118).  Known 
structural information like constraints in the backbone angles, planar side chains, steric 
clashes etc. allow restrained refinement to be performed (118).  The protein is still 
treated as a flexible entity, but penalties are given to movement of the structure too far 
from ideal values.  This method of restrained refinement greatly reduces the number of 
parameters to be refined.  At various stages of refinement, difference density maps are 
created, where sites wrongly filled with model show up as negative density and sites 
with density but no model show up as positive density.  These difference maps are used 
as a guide for model correction.  Another method of refinement called simulated 
annealing involves shaking up a structure and allowing it to slowly relax to a minimum 
(117).  All the atoms are given a random displacement and allowed to relax.  In cases 
where refinement is stuck with no obvious improvements to be made to the model, 
simulated annealing could be performed.  At the final stages of refinement, water 
molecules are added into positive peaks in the difference density maps, for example 
those positive peaks that correspond to the 3σ contour level.  This can be done manually 
or using features like the add waters feature in phenix.refine (121).  At this stage, 
densities that are too big to be water molecules (>3σ) are carefully analyzed since other 
reagents from the crystallization condition or that purified along with the protein could 
have crystallized.  In Rsr, one such site was identified with 6σ positive density and 
Calcium ion was refined into this site.  Model building and refinement are iteratively 
done to obtain the structure that most accurately matches the observed diffraction data.   
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At every stage of refinement, a Reliability factor (R Factor) is calculated (117).  
The R factor is defined as the ratio of sum of differences between observed and 
calculated structure factor amplitudes to the sum of the observed structure factor 
amplitudes (117).  A randomly selected set of reflections (for example, a random 5% of 
reflections) are kept aside as a test set and not used for structure refinement.  After every 
step of refinement, using this test set, an R factor called the Free R Factor (Rfree) is 
calculated (117).  Since Rfree is calculated from data that has not undergone the 
refinement process, its measure is an unbiased indicator of the refinement process.  
Typically, for a well refined structure at a good resolution, the R factor is no more than 
0.25 (or 25%) and the Rfree is no more than 0.30 (30%). 
R = (Σh ||Fobs|-|Fcalc||) / (Σh |Fobs|)   
Rfree = (Σtest set ||Fobs|-|Fcalc||) / (Σtest set |Fobs|)    
 
The X-ray diffraction data sets were integrated, scaled and merged using 
HKL2000 (122).  From the three wavelength MAD data from Se-met Rsr crystals, 13 
out of 14 selenium sites were located using phenix.hyss (121).  Initial phase calculation 
using data from 50 to 2.6Ǻ resolution, followed by density modification was done using 
AutoSHARP (123).  With these density modified phases, the electron density map was 
calculated and initial model was built using TEXTAL (120).  Despite the low resolution 
of the MAD data and poor quality of the phases, TEXTAL built a nearly complete initial 
model.  Improvements in the model were done manually on XtalView (124) using the 
structure of X. laevis Ro as reference (PDB ID 1YVR).  This improved model was 
refined against the native Rsr data first by rigid body refinement and subsequently by 
simulated annealing refinement using phenix.refine (121).  Although the Se-met derived 
crystal is sufficient for the entire process of phase calculation and structure solution, it is 
often the case that heavy atom derived crystals are extra-sensitive to radiation and do not 
produce the best possible quality of diffraction.  In the case of Rsr, the Se-met crystals 
diffracted poorer than the native crystal, hence after phase calculation, the model was 
refined against the native, higher resolution data.  AutoBUILD on the phenix suite was 
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used to improve the model.  Bias minimized maps were created using the TB Bias 
Removal Server (125).  Composite omit maps were created using CNS (126).  Strong 
positive electron density was seen surrounded by the cation binding MIDAS motif 
(DxSxS…T…D) and Ca2+ was refined into this density since the crystallization 
condition contains 200mM Calcium acetate.  The final model was refined with 
crystallographic Rwork and Rfree of 22.3 % and 26.2 % respectively.  Refinement statistics 
are shown in Table 2.3.  99 % of residues are in the allowed region of the 
Ramachandran plot with 1% in the generously allowed region.  Electrostatic surface 
potential was calculated using APBS (127) and UCSF Chimera; all other figures were 
prepared using UCSF Chimera (128),(129). 
 
2.3.10 in vitro transcription of D. radiodurans Y RNA (DrY RNA) 
The region corresponding to DrY RNA template was amplified from D. radiodurans 
genomic DNA (American Type Cell Culture) using primers shown in Table 2.4 and 
ligated into the pETBlue1 vector.  A blunt cutting restriction enzyme (Afe1 or HincII) 
recognition site was incorporated in the primer at the 3’ end.  Prior to in vitro 
transcription, the pETBlue1-DrY RNA123 was digested with Afe1 or HincII.  Analytical 
in vitro transcriptions were performed with varying concentrations of divalent ions (10 
to 20mM), template concentration (10 to 15ng/µl) and dNTPs (4 to 8mM) in the 
reactions. The transcripts were analyzed on 5% denaturing polyacrylamide gels. The 
reaction with 10ng/µl DNA template, 6mM dNTPs, 15mM MgCl2 produced the 
maximum amount of pure Y RNA of the desired size and was repeated on a large scale.  
Large scale transcription was performed at 40ºC for 9 hours following which the 
reaction was quenched using EDTA and Ethanol and frozen at -80ºC.  After thawing, the 
sample was centrifuged at 8000rpm for 30 minutes.  The pellet was dried with Nitrogen 
gas and resuspended in water for subsequent purification on a G-25 column.  The eluate 
from the G-25 column was loaded on 6% preparative denaturing gels.  The bands were 
visualized with UV shadowing, following which the required band was cut and the RNA 
was electro-eluted.  As a final step of purification, a C-18 column was used. The eluate 
81
from the C-18 column was heated to 72 °C for 5 minutes and allowed to fold at room 
temperature for 45 mins prior to use. To determine the homogeneity of the sample, the 
RNA was run on a non-denaturing polyacrylamide gel 
 
2.3.11 Design of truncations of DrY RNA suitable for crystallization 
Based on previous work on X. laevis Ro, where RNAse protection assays have helped 
identify the Ro binding region of Y RNA (89), (90) various truncations of DrY RNA 
were designed.  In order to design truncations of DrY RNA which might adequately 
represent the secondary structure of the full length DrY RNA as well as bind Rsr, parts 
of the variable region of DrY RNA were deleted and the resulting truncated sequences 
were folded using mFOLD.  Three truncations that folded identical to the full length 
DrY RNA were chosen for the study (Figure 2.10).  These included a 35-mer fragment 
(DrY RNA35), a 33-mer (DrY RNA33) and a 39-mer with an engineered GAAA tetraloop 
(DrY RNAGAAA).  The RNA was resuspended in 25 mM Hepes pH 7.0, 10mM MgCl2, 
0.5 mM EDTA and 150mM NaCl and annealed by heating at 85 ºC for 5 minutes 
followed by cooling at room- temperature for 45 minutes.  Folded RNA was subjected to 
non-denaturing gel electrophoresis on a 15% TBE Ready Gel (Biorad) to check for 
formation of alternate dimer conformations (Figure 2.10). 
 
2.3.12 Fluorescence assays to study binding between Ro and DrY RNA35 
Intrinsic tryptophan fluorescence measurements were carried out on an ISS PC1 photon 
counting spectrofluorometer with Ro at a concentration of 50nM.  The reaction buffer 
consisted of 25mM Hepes 7.0, 150mM NaCl, 10mM MgCl2.  With the concentration of 
Rsr equal to 50nM, RNA was titrated in to achieve final concentrations from 5.8nM to 
665nM.  Following each titration, the sample was allowed to equilibriate for 10 mins and 
fluorescence emission spectra (315 to 450 nm) were acquired upon excitation at 295 nm.  
Simultaneous titration of RNA to buffer alone was done and the tryptophan emission 
data was corrected for fluorescence from RNA or buffer components.   
The effect of photobleaching on tryptophan fluorescence was measured by 
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repeatedly exciting the reaction buffer containing Rsr at 295nm and recording the 
fluorescence emission from 315 to 450 nm.  The maximum photobleaching amounted to 
5.8 % of the total fluorescence and was considered negligible. 
To estimate the contribution from the inner-filter effect from RNA, RNA was titrated 
into the reaction buffer and the absorbance of RNA was measured at 295nm and 335nm 
on a Cary100 spectrophotometer.  The fluorescence intensities were corrected for RNA 
inner-filter effect as: 
Icorr = Iobs * antilog [(A295 + A335) / 2]   
Where Icorr is the corrected Intensity, Iobs is the observed Intensity, A295 and A335 are 
absorbance of RNA at 295 and 335nm respectively. 
 
 
The fraction bound (f) was calculated by determining the decrease in corrected 
fluorescence intensity at 335nm of the sample compared to the decrease when Ro was 
completely bound by RNA.  The data were fitted to a single site binding model, using 
the following equation to determine the value of the apparent binding constant (Kd).  
f = [RNA] / ([RNA] + Kd )   
Stoichiometry of binding was calculated as suggested in ref. (130) 
 
2.3.13 Size exclusion chromatography of Rsr:DrY RNA35 
Rsr was purified as described above, on a Ni2+ affinity column. Rsr at 3µM was mixed 
with a five fold molar excess of DrY RNA35 and dialyzed against buffer containing 
25mM Phosphate pH 7.0, 150mM NaCl and 2mM DTT.  Following dialysis, the sample 
was concentrated by 10-fold and injected on a Superdex 200 analytical column 
equilibrated with the same buffer.  All runs on the superdex 200 column were performed 
at a flow rate of 1ml/minute.  Identical elution profiles were obtained with the complex 
at concentrations as low as 1µM.  Different concentrations of protein alone (1µM to 500 
µM) and DrY RNA35 alone (2µM to 590µM) were injected in separate runs on the 
column.  The column was calibrated with a mix of standard protein markers (Biorad # 
151-1901).  A standard curve of elution volumes versus Log10 of Molecular weights was 
plotted and used to calculate the molecular weights of the Rsr, DrY RNA35 and Rsr:DrY 
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RNA complex peaks.  Ratio of Absorbance at 260nm to absorbance at 280nm was 
measured for each fraction.  Ratios greater than 1 were taken to be indicative of RNA.  
To detect protein in the fractions, the fractions were spotted on a nitrocellulose 
membrane, incubated successively with Anti-6his antibodies and Anti-mouse IgG 
Alkaline phosphatase and stained with SigmaFASTTM BCIP/NBT.      
 
2.3.14 Electron microscopy on Rsr:DrY RNA35 complex (by Christos G. Savva and 
Andreas Holzenburg) 
Rsr:Dr YRNA35 (~3µM in 25mM Phosphate pH 7.0, 150mM NaCl, 2mM DTT) samples 
were prepared for electron microscopy according to Valentine (131) and stained with 
2%w/v aqueous uranyl acetate pH 4.3.  Duplicate grids were prepared similarly but 
stained with 2%w/v ammonium molybdate pH 7.0.  Samples were examined using a 
JEOL 1200EX transmission electron microscope operating at 100 kV. Micrographs were 
recorded at a calibrated magnification of 38,030.  Selected micrographs were digitized 
using a Leafscan 45 microdensitometer at a 20-µm scan step corresponding to 5.26 
Å/pixel at the specimen level. Particles were manually selected using the BOXER 
program from the EMAN (132) single particle analysis software package. 
Approximately 1600 particles were chosen and further processed with IMAGIC-5 (133).  
Particle images were normalized, band-pass filtered and subjected to reference free 
classification. Non-redundant class averages were then chosen as references for 
multireference alignment (134).  The process was iterated until stable classes were 
obtained based on visual inspection and intraclass variance.  All class averages are 
displayed without imposing symmetry. 
 
2.3.15 Crystallization of Rsr:DrY RNA complex 
Prior to crystal trials, sample was prepared by  mixing Rsr and DrY RNA35 at equal 
molar ratios (~490µM each) and incubating for 1 hour on ice.  The sample was then 
given a 10 minute spin at 15000Xg and used for crystal trials.  Initial trials were 
performed using screens Crystal Screen 1 and 2 and Natrix purchased from Hampton 
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Research Inc. and Wizard Screen 1 and 2 from Emerald Biosciences. In these screens the 
primary variables are salt, pH and precipitant. Various conditions with different 
precipitants yielded crystals, for example CS1#26.  Optimization of crystals was done by 
a Grid method which consists of systematically varying pH and concentrations of salt 
and precipitant around the initial condition which yielded crystals.  Additive screens and 
Detergent screens purchased from Hampton Research Inc., were also used to optimize 
the crystals.  These screens comprise of a variety of small molecules and detergents that 
affect crystallization by manipulating sample-solvent and sample-sample interactions. 
These crystals were highly reproducible and grew even when Se-met substituted Rsr was 
used in place of native Rsr.  The best crystals after optimization, were obtained in 
Crystal Screen 1#26 (0.2M ammonium acetate, 0.1M Sodium citrate pH5.6 and 30% 
MPD) in hanging drop plates.  The crystals were frozen in mother-liquor as the 
cryoprotectant because of the presence of 30%MPD in the crystallization solution.  The 
best crystal diffracted to 6 Å at beamline 23-ID, with P6 symmetry.  Detector distance 
during data collection was around 700mm for optimal spot separation, considering the 
unusually large cell dimensions.  Data statistics are compiled in Table 2.1.  
Crystals were also obtained by co-crystallization of Y RNA and Rsr post 
Thrombin cleavage.  These crystals looked identical in shape and size to the crystals 
grown with 6his-Rsr:Y RNA, but the diffraction quality did not improve with crystal 
optimization.   
 
2.3.16 Structure determination of Rsr:DrY RNA complex 
Although low resolution, the diffraction data obtained from crystals of the  Rsr:DrY 
RNA complex was used for Molecular replacement, using the structure of Rsr as a 
search model was performed using Molrep, Amore and Phaser programs on the ccp4 
suite.  12 to 14 molecules were searched for in a single asymmetric unit.      
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2.4 ADDITIONAL MATERIAL 
 
2.4.1 Identifying Y RNAs in M. smegmatis and mycobacteriophage Bxz1 
In M. smegmatis and the mycobacteriophage Bxz1, sequences for Ro orthologs have 
been identified in the genome, though there are no reports of the presence of Y RNAs. 
We have developed an in silico method to identify potential Y RNA sequences in these 
genomes, in collaboration with Dr.Thomas R. Ioerger, Department of Computer Science, 
Texas A& M University.  The approach is to write a program which can scan a genome 
sequence given as input, for the presence of sequences following the criteria observed in 
known Y RNAs like size restrictions, presence of conserved residues in the Ro binding 
box and complementarity between the 5' and 3' ends. The hits from the program are then 
folded on mFOLD to select those sequences which when folded, resemble the predicted 
structures of known Y RNAs. The chosen sequences are candidate Y RNAs.   
In collaboration with Dr. Thomas R. Ioerger, a program was written, which looks 
for sequences in genomes, which are 60 to 120 nucleotides long, have complementary 5' 
and 3' ends and have the conserved sequence of base pairs present in the Ro binding 
helix of known Y RNAs.  Using the D. radiodurans genome sequence as a test for this 
program, 11 hits were obtained. One of them was the sequence which has previously 
been identified as a dY RNA (4). This was considered a positive test for the program. 
The M. smegmatis genome showed 13 hits and the Bxz1 genome showed 0 hits. Upon 
folding the MsY RNA hits using mFOLD, at least 3 of them resembled Y RNAs (Figure 
2.21). These candidate Y RNAs will be used for binding studies with MsRo and BzRo.  
                                          
2.4.2 Studies on Ro from the mycobacteriophage Bxz1 
 BzRo with an N-terminal 6his tag followed by an MBP tag was purified on a Ni2+ 
chelating sepharose column (Figure 2.22). The eluate from the Ni2+ column consisted of 
>95% pure fusion protein as judged by SDS-PAGE. The fusion protein at a 
concentration of 1mg/ml was cleaved with TEV Protease at a ratio of 1:100 ( protease: 
fusion-protein) during dialysis for 16 hrs in 4 ºC, against buffer containing 50mM Hepes 
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pH7.0, 500mM NaCl and 2mM DTT. The TEV Protease used, had an N-terminal 6his 
tag and was overexpressed using a construct available in the lab. The protease was 
 
Figure 2.21  mFOLD secondary structures of a candidate Y RNA in the M. 
smegmatis genome.  Putative Ro binding site is boxed. 
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 Figure 2.22  Purification of BzRo 
a.  Plot of absorbance at 280nm versus volume shows the elution profile of BzRo 
from a Nickel column post TEV cleavage. Steps corresponding to increasing 
concentrations of Imidazole (green) are shown. Pure cleaved BzRo elutes at 20mM 
Imidazole. 6his-MBP elutes at 125mM Imidazole.  b.  SDS-PAGE analysis of the 
fractions shows the fusion protein, cleaved BzRo and 6his-MBP.  c. Elution profile 
from an S-200 column shows that freshly purified BzRo is homogeneous.  d.  SDS-
PAGE analysis of cleaved BzRo sample used for crystallization shows >90% pure 
protein.  
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purified on a Ni2+ column followed by gel-filtration on a superdex-75 column. The 
cleaved fusion protein was passed again on a Ni2+ column. BzRo eluted with 20mM 
Imidazole, whereas 6his-MBP eluted with 125mM and 6his-TEVProtease with 400mM 
Imidazole, thereby allowing us to separate Ro from the MBP and TEV protease (Figure 
2.22).  Pure and homogeneous BzRo was concentrated to 3mg/ml but was unstable in 
solution and showed marked precipitation after 3 days. This phenomenon posed a 
hinderance to crystallization, though the protein could still be used for Y RNA binding 
assays.  Led by the results of the Rsr stabilization in phosphate buffer, BzRo was lysed 
and purified in phosphate buffer, but BzRo tended to be unstable and precipitated even 
in this buffer. 
 
2.4.3 Suggested reading 
 “Crystal structure of Rsr, an ortholog of the antigenic Ro protein, links conformational 
flexibility to RNA binding activity.” By Ramesh et al., Journal of Biological Chemistry, 
March 2007, is available at DOI 10.1074/jbc.M611163200.  
89
CHAPTER III 
STRUCTURAL STUDY OF CsoR 
 
3.1 INTRODUCTION 
 
3.1.1 Role of copper in living organisms 
Copper is an essential element required in trace amounts in living cells (135).  Being a 
redox-active element, copper is utilized by many enzymes that catalyze reactions 
involving oxidation and reduction.  In biological systems, copper mostly exists in two 
oxidation states- Cu(I) and Cu(II).  Despite their different sizes and stereochemistries, 
both Cu(I) and Cu(II) have an equal tendency to form complexes with organic ligands 
(135).  Hence, they make a convenient redox-couple that is useful in the range of redox 
potentials that are encountered in biological systems (135).  Unlike ions like Na+ and K+, 
which are very mobile in biological media and form complexes with relatively low 
stability, Cu+/++ ions are static in biological media and form complexes of much higher 
stability (135).  The preferred donor atoms for metal ions are nitrogen, sulfur and oxygen 
making histidine, cysteine/ methionine, aspartic acid/glutamic acid the typical ligands 
present in metal sites of proteins (135).  Of these, Nitrogen and Sulfur are the preferred 
ligands for Cu(I).       
 Copper utilizing enzymes have thus evolved to exploit the Cu+/Cu2+ redox-
couple.  Cytochrome c oxidase, a copper utilizing enzyme and the terminal enzyme in 
the respiratory chain, is present in the inner membrane of mitochondria and bacteria 
(136), (137).  Cytochrome c oxidase catalyzes the reduction of dioxygen to water, and 
contains two heme and two copper sites, CuA and CuB.  While the CuA site primarily 
acts as an electron transfer centre, the CuB site is involved in stabilizing an intermediate 
peroxide bridge which subsequently gets reduced to form water (138).  Cu/Zn 
Superoxide dismutase (SOD) is another enzyme that uses the reduction and oxidation of 
copper.  Cu/Zn SOD dismutates superoxide to oxygen and hydrogen peroxide.  
Superoxide radicals cause oxidative damage in the cell by targeting proteins (139).  
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Hence, by the dismutation of superoxide, SOD acts as a key antioxidant in the cell (140).  
Copper deficiency in cells results in diminished SOD activity and this results in cellular 
oxidative damage.  Yet another class of copper-dependent enzymes are the amine 
oxidases that catalyze the oxidation of biologically important mono and di amines in 
cells (141).  Copper amine oxidases (CAO) are widely dispersed across species and are 
present in bacteria, fungi, plants and mammals (142).  In bacteria and fungi, CAOs are 
involved in the metabolism of amines which act as the primary source of carbon and 
nitrogen for growth (142).  Copper-dependent enzymes include Laccases, Tyrosinases, 
Haemocyanin (involved in transport of O2), Lysine oxidases (Cross linking of collagen), 
Ascorbate oxidase, Galactose oxidase and the Blue proteins (involved in electron 
transfer) (135).  Despite its varied uses in fundamental metabolic processes in the cell, 
uncomplexed copper is highly toxic to the cell. 
     
3.1.2 Damage and toxicity by Cu 
Cu(I) is highly unstable and gets readily oxidized to Cu(II), causing reduction of 
molecular oxygen to form hydrogen peroxide.  Reduction of Cu(II) back to Cu(I) by 
cellular reductants like ascorbate and glutathione results in the generation of reactive 
Oxygen species (ROS) (143).  In the presence of superoxide or reducing agents like 
ascorbate, Cu(II) undergoes reduction to Cu(I) accompanied by the conversion of 
hydrogen peroxide to hydroxyl (˙OH ) free radicals, one of the most oxidizing free 
radicals encountered in biological systems (143), (144).  Transition metals like copper, 
that are more prone to oxidation, have a higher ability to generate harmful free radicals.  
ROS like the hydroxyl radical (˙OH) and superoxide (*O2¯ ) cause oxidation of protein 
side-chains, protein-protein cross links and oxidation of the protein backbone (145,146).   
 DNA strand-breaks and oxidation of nucleic acid bases are also a consequence of 
copper mediated free radical damage in cells (147), (148), (149).  An excess of copper in 
the cell is also known to cause peroxidation of membrane lipids (150).            
Even when bound to protein, copper can react with hydrogen peroxide to form 
hydroxyl free radicals (˙OH) (151).  These free radicals oxidize neighboring amino acid 
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residues in the protein.  This type of metal catalyzed oxidation occurs at sites on the 
protein that bind metal ions.  Metal catalyzed oxidation has been implicated in many 
neurodegenerative diseases like Alzeimers (152), Parkinsons (153), prion diseases (151) 
and aging (154).  The Cu(II) binding prion protein PrP has been shown to switch from its 
soluble cellular form (PrPc) to a scrapie form (PrPsc) and this switch has been shown to 
be critical for prion infectivity (151).  Reduction of Cu(II) by the reductant ascorbate in 
the presence of oxygen results in oxidation of PrP and subsequent aggregation to a PrPsc 
like form (151).  During dialysis related amyloidosis, fiber formation by the β-2-
microglobulin polypeptide has been shown to be catalyzed by Cu(II) (155).  Formation 
of intermediate native-like conformations due to Cu(II) catalyzed backbone 
isomerization and stabilization of amyloid-like conformations by Cu(II) are critical steps 
in fiber formation (155).   
 Considering that copper is an essential trace element for numerous biological 
reactions but is responsible for oxidative damage and cellular toxicity, cells must 
maintain a balance in the amount of copper present in them.  This process of maintaining 
the optimal amount of cellular copper is called copper homeostasis.           
 
3.1.3 Copper homeostasis mechanisms 
In general, maintenance of metal concentrations in the cell occurs in three steps: uptake, 
export, sequestration and regulation. 
 
Copper uptake:  Uptake of copper in bacteria and yeast, is performed by permeases or 
import proteins and is controlled either by regulating the import proteins or by limiting 
the amount of metal available for uptake (156).  Integral membrane permeases or import 
pumps may act in a passive energy-independent manner or may utilize energy from ATP 
hydrolysis to facilitate copper uptake (157), (158), (159).  In mammals, copper uptake is 
mediated by the plasma protein ceruloplasmin or in the free form through a membrane 
bound copper reductase (160).  Both pathways work in an energy independent manner 
with copper being transported into the cell without the intake of the carrier protein 
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ceruloplasmin or other carrier ligands (160).   
 
Copper export:   Export of copper from cells is done by primary and secondary active 
transporters.  While primary active transporters use energy from the hydrolysis of ATP, 
the secondary active transporters couple the export of copper with the membrane 
potential (156).  The most common mechanism of copper export involves the P-type 
ATPases.  The cation transporting P-type ATPases are a superfamily of primary active 
transporters (161).  These are membrane-residing, ATP hydrolyzing pumps that are 
highly conserved in sequence from bacteria to mammals.  In general, the pump consists 
of an N-terminal phosphorylation domain, an ATP binding site, a phosphatase domain 
and the C-terminal ion translocating channel (161).  P-type ATPases undergo 
phosphorylation at a conserved Aspartic acid residue present in a seven residue signature 
motif of D-K-T-G-T-[L I V M]-[T I S] found in all P-type ATPases.  Phosphorylation is 
accompanied by a conformational change that allows ion translocation.  A model based 
on the Menke’s ATPase from humans suggests that the N-terminal regulatory domain 
binds copper at each of its six M-X-C-X-X-C motifs.  Binding of copper to the 
regulatory domain allows the phosphorylation site to be accessible and this allows the 
subsequent steps in translocation to take place (156).  Mutations in the Menke’s ATPase 
and its homologous Wilson’s ATPase in humans are associated with the copper 
excretory disorders called Menke’s and Wilson’s diseases (162). The copper-dependent 
enzymes show diminished activity in these disorders.  Although the general copper 
binding N-terminal fold is conserved among the cation transporting ATPases, the 
number of units composing the N-terminal could differ.  For example, while the 
Menke’s protein has 6 metal binding sites, the CtaA and PacS ATPases from the 
cyanobacterium Synechocystis has only one such fold (163), (164). 
 
Copper sequestration:  Sequestration of copper is important since free copper can be 
toxic to the cell.  There are various mechanisms used for copper sequestration.  One of 
the primary protein components involved in the sequestration of Cu(I) is the 
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metallothionein.  Metallothioneins are cysteine-rich, 25 to 60kDa proteins that form 
polynuclear Cu-thiolate clusters (165).  Cysteines in metallothioneins are arranged in 
repeats of the Cys-Cys, Cys-X-Cys or Cys-X-X-Cys motifs.  Metallothioneins typically 
have few hydrophobic residues and the core of the protein is stabilized by metal-
thiolates.  The number and type of metal bound by the metallothionein often determines 
the fold adopted by the protein. 
Another mode of Cu(I)-sequestration seen in plants, fission yeast and some 
microorganisms involves the phytochelatins.  These are γ-glutamic acid- cysteine 
polymers derived from glutathione, with a general structure of (γ-Glu-Cys)n-Gly (166).  
Phytochelatins are involved in metal detoxification in vivo and possibly in reactivation 
of the copper-dependent enzyme diamino oxidase as seen in vitro (167). 
Copper chaperones represent an important class of proteins involved in copper 
sequestration.  Copper chaperones deliver copper to copper utilizing enzymes or to the 
copper export machinery (168).  In eukaryotes, copper chaperones deliver copper to the 
trans-Golgi network, the Cu/Zn SOD in the cytoplasm and help in the assembly of 
cytochrome c oxidase in the mitochondria (169), (136).  In yeast, the chaperone CCS 
mediates insertion of copper into the Cu/Zn SOD presumably in copper limiting 
conditions in the cell (169).  In prokaryotes, chaperones like Atx1 and CopZ (discussed 
below) deliver copper to specific membrane bound copper export proteins (170).  The 
CCS chaperones carry the Cys-X-X-Cys motif similar to SOD and the Atx1-like copper 
chaperones carry the Met-X-Cys-X-X-Cys motif similar to that found in the regulatory 
N-terminal domains of P-type ATPases (171), (168).  Structural and biochemical 
characterization of a number of copper chaperones has shown that these proteins possess 
similar metal binding folds.  Studies on the Atx1 chaperone suggest that copper is 
coordinated in an exposed loop region which is flexible enough to allow changes in 
coordination number and geometry (172), (173).  These changes probably occur when 
the chaperone interacts with the copper-dependent enzyme or transporter protein. 
 
Regulation:  Regulation of the different proteins involved in uptake, export and 
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sequestration of copper is essential for maintenance of the optimal concentration of 
copper in cells.  In eukaryotes, regulation of these proteins takes place both 
transcriptionally and post-translationally.  In prokaryotic organisms however, majority of 
the regulation happens at the level of transcription (174).  Proteins involved in 
transcriptional regulation respond to copper by directly binding copper and causing 
activation, repression or derepression of one or more copper utilizing enzymes or copper 
homeostasis proteins.  The key factor in regulation is the recognition of the correct metal 
by the regulatory protein.  This specificity for the metal is achieved by virtue of the 
distinct coordination chemistries and geometry presented at the metal binding sites (174) 
since each metal has a preference for certain coordination geometry and coordinating 
ligand types.  Based on structural similarities, prokaryotic transcriptional regulators have 
been classified into six major families (174), (175).  These are the MerR, ArsR/SmtB, 
Fur, DtxR and NikR and the newly discovered CopY families.  Regulatory proteins 
within a family may respond to different metals (174).  Members of the MerR family 
repress the operon until they recognize specific metals.  Upon metal binding, a 
conformational change induced in the operator region allows RNA polymerase to initiate 
transcription.  Recently, in E. coli, a Cu(I) responsive regulator CueR from the MerR 
family has been characterized (14).  CueR regulates the expression of CopA (a P-type 
ATPase) and CueO (a multicopper oxidase).  Cu(I) specificity of CueR is likely due to 
the special coordination environment created at its metal binding site.  CueR binds Cu(I) 
in a linear two coordinate manner, involving two conserved Cysteine residues (176).  
The ArsR/SmtB family of regulators consists of proteins that are bound to the promoter 
DNA region in their apo state, thereby repressing the operon.  Metal binding results in 
allosteric regulation of DNA binding causing derepression of the operon (177).  A 
Cu(I)/Ag(I)/Zn(II)/Cd(II) responsive regulator belonging to this family is the BxmR 
protein from the cyanobacterium Oscillatoria brevis.  BxmR regulates the expression of 
BmtA (a metallothionein) and Bxa1 (a CPx-ATPase) (178).  Most of our understanding 
of this family comes from work on the arsenic responsive ArsR protein from E. coli and 
the zinc responsive SmtB protein (179), (180).  Members of the DtxR, Fur and NikR 
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families possess weak affinity for DNA in their apo state.  In the metal bound state, they 
bind DNA to repress the operon.  For example, IdeR an iron responsive regulator from 
M. tb from the DtxR family regulates iron uptake genes (181).  Upon sensing iron in the 
cytoplasm, IdeR binds DNA to repress iron uptake proteins.  Fur family proteins regulate 
not only proteins required for iron acquisition but also enzymes involved in the synthesis 
of iron sequestering siderophores (182).  The NikR family so far consists of only nickel 
responsive regulators (174).  Copper responsive regulators belonging to the DtxR, Fur 
and NikR families are yet to be identified.  CopY is a copper responsive transcriptional 
repressor of copper ATPases CopA and CopB from Enterococcus hirae (183).         
Regulators from all these families bind DNA as oligomers- either dimers or 
tetramers, with the metal coordinated in a subunit-bridging site (174).  Another feature 
common to many of these families is the presence of a winged helix domain or a 
modified helix-turn-helix motif (174).  Currently no structure is available for a MerR, 
ArsR, Fur, CopY family metalloregulatory protein in complex with DNA.  Biochemical 
characterization and structural similarity with other proteins suggests that these motifs 
are involved in DNA binding.  High resolution DNA bound structures are available for 
DtxR and NikR family members Ni(II)-DtxR (184) and Ni(II)-IdeR (15) and the Ni(II)-
NikR (23).  Mechanisms of copper homeostasis differ in eukaryotic versus prokaryotic 
organisms. 
               
3.1.4 Copper homeostasis in yeast and mammals 
Various Cu resistance mechanisms have been studied in yeast. In Saccharomyces 
cerevisiae sequestration of Cu(I) is done by metallothioneins.  Expression of the S. 
cerevisiae metallothionein (ScMT) is under the control of a Cu(I) sensing transcriptional 
activator (Ace1).  Ace1 binds Cu(I) to form a polynuclear Cu(I)-thiolate cluster (185).  
Upon binding Cu(I), Ace1 undergoes a conformational change that increases its affinity 
for the Upstream Activation Sequence (UAS), thereby increasing transcription of ScMT.  
Although ScMT can bind other metals, its upregulation occurs only in the presence of 
Cu(I).  Another transcriptional factor, Mac1 binds Cu(I) to form a polycopper cluster 
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similar to that formed by Ace1.  Mac1 regulates transcription of at least six genes, two of 
which encode Cu-permeases Ctr1 and Ctr3 and one encoding the metalloreductase Fre1.  
In conditions with limiting Cu, Mac1 activates transcription of these genes.  In the 
presence of excess Cu(I), Mac1 activation of these genes is inhibited, thus controlling 
the level of Cu(I) in the cell (186).  Mac1 possesses a Cu(I) binding motif –C-X-C-X3-C-
X-C-X2-C-X2-H.  A similar motif is found in the Cuf1 transcriptional factor in S. pombe.  
In S. pombe, Cu(I) sequestration is also done using phytochelatins (187).  In Candida 
glabrata although phytochelatins are used for sequestration of other metals like 
cadmium, copper sequestration is done primarily by metallothioneins.  Copper export 
pumps have not been identified in S. pombe and C. glabrata. 
 In mammals, there exist redundant mechanisms for Cu(I) homeostasis.  
Mammals have both metallothioneins to sequester Cu(I) as well as ATPase pumps for 
export of Cu(I).  Metallothioneins from mammals and yeast share little similarity besides 
the Cu(I) binding motif.  In contrast, Cu(I) export ATPases are highly conserved from 
bacteria to mammals (188).  Between the Cu(I) exporting ATPases and metallothioneins, 
common Cu(I) binding motifs have been identified like the M-X-C-X-X-C motif in the 
Menkes ATPase (MNK) from humans.  Post translational control of Cu(I) uptake protein 
Ctr1 during conditions with high cellular Cu(I) ions has been shown (189).  Endocytosis 
of the plasma membrane results in decrease in the concentration of Ctr1 in the 
membrane, reducing the uptake of Cu(I).   
 
3.1.5 Copper homeostasis mechanisms in prokaryotes 
Bacterial cells maintain close to micromolar levels of copper (190). However, most of 
the copper utilizing enzymes are present in the periplasm or attached to the inner or outer 
membranes and there is no evidence yet for copper utilizing enzymes in the cytoplasm of 
bacterial cells.  In E. coli, a gram negative bacterium, copper utilizing proteins like 
amine oxidase, superoxide dismutase and cytochrome oxidase are present in the 
periplasm.  In the gram positive bacterium B. subtilis, in the absence of a periplasmic 
compartment, the cytochrome oxidase is located on the plasma membrane and a copper 
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utilizing laccase is present in spore coats, outside the cytoplasm (191).  In many 
cyanobacteria, membrane bound organelles called thylakoids are present in the 
cytoplasm.  In these organisms, electron transfer during respiration and photosynthesis 
occurs in the thylakoids, with the help of copper proteins like plastocyanin and 
cytochrome c oxidase (192).  Even in these proteins, the copper sites face the thylakoid 
lumen and not the cytoplasm.  Since there is no obvious requirement for copper in the 
cytoplasm of bacterial cells, and unbound Cu(I) in the cytoplasm is highly toxic to the 
cell, bacterial homeostasis mechanisms must be directed towards transport of Cu(I) to 
the periplasm or the plasma membrane and out of the cell.  In the last couple of decades, 
numerous proteins have been identified in the cytoplasm, periplasm and in the 
membranes, that play a role in copper homeostasis in bacterial cells. 
 In E. coli, the CusCFBA system has been identified, controlled by the CusR/S 
system.  CusCBA together form a membrane bound copper export system that traverses 
the periplasm.  CusF is a periplasmic chaperone protein which directs excess Cu(I) in the 
periplasm towards export via CusCBA.  The cus operon itself is regulated by the two 
component system CusR/S which senses excess copper in the periplasm.  Another mode 
of copper homeostasis in E. coli consists of the CueR/CueO/CopA system.  CopA is an 
inner membrane P-type ATPase that exports Cu(I) out of the cytoplasm.  CueO is a 
multi-copper oxidase that binds four copper ions and gets transported from the 
cytoplasm to the periplasm via the Twin Arginine Transporter (TAT) pathway.  
Expression of both CopA and CueO is regulated by a cytoplasmic Cu(I) responsive 
transcriptional regulator called CueR. 
 In B. subtilis and Enterococcus hirae, CopA functions as a P-type ATPase 
transporter of copper while CopZ, a cytoplasmic protein functions as a copper 
chaperone.  Both CopA and CopZ are regulated by copper sensing transcriptional 
regulators viz. CueR in B. subtilis and CopY in E. hirae (14), (175).   
 In the cyanobacterium Synechocystis PCC6803, the presence of copper proteins 
plastocyanin and cytochrome c oxidase in the thylaoids within the cytoplasm requires 
copper to be trafficked though the cytoplasm.  An elegant system has evolved to achieve 
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this trafficking using copper chaperones and copper transporters.  In this system, copper 
is exchanged between transporters and the chaperone without release of free copper in 
the cytoplasm.  Two P-type ATPases CtaA and PacS have been identified in the inner 
menbrane and the thylakoid membrane respectively (163), (164).  CtaA imports copper 
into the cytoplasm but release of copper presumably occurs only upon interaction with 
the cytoplasmic copper chaperone Atx1.  Atx1 then delivers the copper to the PacS 
transporter on the thylakoids membrane and once again release of copper is facilitated by 
the interaction between the two proteins. 
 Copper along with iron and zinc plays an especially important role in 
intracellular pathogens.  Proteins involved in metal homeostasis or metal acquisition are 
known to be virulence factors themselves or regulate expression of virulence factors 
(193), (194), (195), (196).  One such pathogen in which metal-binding is closely 
associated with virulence and pathogenesis is the tuberculosis causing bacterium- 
Mycobacterium tuberculosis. 
  
3.1.6 Role of metals in Mycobacterium tuberculosis 
One of the most remarkable features of M. tuberculosis which makes it such a successful 
pathogen is it’s ability to survive within the phagosomal compartment in the host.  M. tb 
has various mechanisms to counter the oxidative burst in the macrophage upon infection 
of the host (197).  Especially iron, copper and zinc are involved in the oxidative stress 
response in the macrophage.  Superoxide dismutases SodA and SodC in M. tb contain Fe 
and a Cu/Zn pair respectively.  SodA is presumed to be involved in responses to 
endogenous oxidative phosphorylation.  SodC is located in the periplasm and is involved 
in protection against host generated free radicals in activated macrophages (198).  To 
control the level of intracellular metal ions, M. tb uses a variety of transporters including 
at least twelve P-type ATPases.  Sequence based comparisons suggest that M. tb has 
close to 28 metal transporters, amounting to 24% of all the known transporters in M. tb 
(197).  Of the twelve P-type ATPases, seven (ctp A, B, C, D, G, J and V) resemble 
‘typeIB’ ATPases which are  heavy-metal pumps  involved in the transport of Cd2+, 
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Zn2+, Cu+/2+, Ag+, Mn2+.  CtpA, CtpB and CtpV are predicted to be Cu+/2+ transporters.  
While CtpA and CtpB clearly possess an N-terminal metal binding motif of paired 
Cysteine residues characteristic of typeIB pumps, CtpV does not possess any 
recognizable motifs.  ORFs upstream of CtpV contain histidine-rich metal binding 
motifs, suggesting a role for CtpV in metal transport.  Besides transporters and metal 
utilizing enzymes, M. tb also possesses siderophores called mycobactins, a class of 
soluble low molecular weight molecules associated with the cell envelope (199).  
Mycobactins in M. tb have a high affinity for Fe3+ ions and have been shown to play a 
role in its survival in the macrophage.   
Regulation of these key enzymes, transporters and mycobactins is of prime 
importance during survival of M. tb in macrophages.  This regulation is done primarily 
at the level of transcription, by metal responsive transcriptional regulators.  At least three 
such regulators have been identified in M. tb – FurA, IdeR and SirR.  FurA, belongs to 
the Fur family of transcription regulators which responds to the changing amounts of 
iron and regulates expression of the downstream gene encoding KatG (a catalase 
peroxidase) and other virulence factors (200).  IdeR, a member of the DtxR family of 
transcriptional regulators also responds to iron levels and is likely to regulate the 
expression of close to 40 genes including the mbtA, mbtB, mbtI gene cluster that encodes 
mycobactins (201).  Other metal responsive regulators have been characterized in M. tb, 
like the Pb(II)/Cd(II) responsive CmtR (202) and the Ni responsive NmtR (203).  The 
role of Cu as a cofactor in key enzymes like the Cu/Zn SodC and the presence of a 
number of Cu specific transporters in M. tb suggests a requirement for Cu specific 
regulation in M. tb.  Yet, little is known about the mechanisms of Cu responsive 
regulation in M. tb.  As part of the work described in this chapter, a copper responsive 
operon named cso (copper sensitive operon) has been identified in M. tb (3.4.1).         
         
3.1.7 The Cu(I) responsive cso operon of M. tb 
 The cso operon (3.4.1) consists of three genes- rv0967, rv0968 and rv0969.  These three 
genes are transcribed as a single polycistronic message.  Both rv0967 and rv0969 are 
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upregulated in the presence of Cu(I) ions.  rv0969 has been annotated as ctpV and 
encodes a P-type ATPase that is predicted to be involved in copper transport (161).  
Although there have been no studies so far that suggest a role for the protein encoded by 
rv0968, sequence based analysis suggests that the N-terminal region of the rv0968 gene 
product forms a 15-20 amino-acid transmembrane helix (http://www.doe-
mbi.ucla.edu/TB/).  The C-terminal region of this protein is predicted to be unstructured 
and possesses two histidine residues and many glutamate residues.  Based on the 
sequence analysis alone, we speculate that this protein could be involved in Cu(I) 
exchange of some kind, possibly facilitating delivery of Cu(I) to the P-type ATPase 
encoded by rv0969.  Our work shows that the 119 amino-acid protein encoded by 
rv0967 is a Cu(I) sensing transcriptional regulator of the cso operon (3.4.1) and 
consequently, we have named this protein CsoR.  Out of many metals, copper is the 
most potent inducer of the cso operon.  CsoR specifically binds Cu(I) with 1:1 
stoichiometry and an affinity higher than 1019 M-1.  Besides directly binding Cu(I), CsoR 
also directly interacts with DNA.  Our results show that CsoR specifically binds DNA 
upstream of the cso operon.  The upstream sequence bound by CsoR resembles the 
consensus M. tb promoter, with a ribosomal binding site, the -35 and -10 promoter 
elements and a transcription initiation site.  As observed in most prokaryotic 
operator/promoter regions, this segment of DNA is pseudopalindromic.  CsoR binds 
DNA only in the absence of Cu(I) and Cu(I) causes dissociation of preformed 
CsoR:DNA complexes.  Put together our results show that Cu(I) negatively regulates the 
binding of CsoR to the operator/promoter region of the cso operon.  This results in the 
derepression of the cso operon. 
 
3.1.8 Significance of this work 
 Prior to our work, very little was known of the mechanistic details of CsoR regulation of 
the cso operon.  In this chapter, we describe the structural characterization of CsoR.  
Using X-ray crystallography we have solved a high-resolution structure of Cu(I) bound 
CsoR.  The structure not only helps us understand the basis of Cu(I) specificity and the 
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structural requirements for Cu(I) binding, but also provides valuable clues to the 
mechanism of allosteric regulation between Cu(I) binding and DNA binding by CsoR .In 
addition, this work contributes to our overall understanding of copper homeostasis in 
Mycobacterium tuberculosis.    
 
 
3.2 RESULTS AND DISCUSSION 
 
3.2.1 The overall crystallographic structure of Cu(I) bound CsoR 
As described in section 3.3.2, different forms of CsoR were crystallized.  Crystals of 
Apo:CsoR and Cu(I):CsoR are shown in Figure 3.1.  The quality of diffraction from 
native and se-met Apo:CsoR crystals was not good enough for structure determination 
hence the se-met data was used only for phase calculation.  The structure of Cu(I) bound 
CsoR was solved using diffraction data from Cu(I):CsoR crystals.   
 As described in Liu et al., “The structure was determined at a resolution of 2.55 
Å, and the final model was refined to an Rwork of 23.05% and an Rfree of 27.87% with 
good stereochemistry.  The refined model comprises CsoR4–88, one Cu(I) atom and 20 
molecules of water. Clear electron density was not visible for CsoR89–119, which were 
either disordered in the crystals or lost to proteolysis during crystallization.  These 
residues correspond to the C-terminal tail of Mtb CsoR, which is absent in other 
DUF156 homologs. The loop comprising CsoR71–74 also showed weakly defined side 
chain density. Though the crystallographic asymmetric unit consists of one protomer of 
CsoR, applying crystallographic symmetry generated a homodimer (Fig. 5a), which 
buried 3,791 Å2 (29.6%) of the accessible surface area between the two protomers. 
Given the considerably large buried surface area, the participation of conserved residues 
in the dimer interface, and the analytical equilibrium ultracentrifugation experiments that 
suggest a predominantly dimeric assembly state for both apo-CsoR and copper bound 
CsoR in solution, we propose that this crystallographic dimer is the physiologically 
relevant unit of CsoR. A dimer of dimers observed in the crystal buries only 2,407 Å2 
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 Figure 3.1  Crystals of Apo and Cu(I) bound CsoR 
a. Small pellet-like crystal formed by Apo:CsoR is shown.  b. Tiny crystals of 
Cu(I):CsoR from initial screens are shown.  c. Large crystals of Cu(I):CsoR 
obtained after optimization are shown.    
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(13.3%) of the accessible surface area between the dimers and does not involve any 
conserved residues at the interface; hence, it may not be of functional importance.”  
 Secondary structure prediction for CsoR was done using different PSIPRED 
(3.4.1, http://bioinf.cs.ucl.ac.uk/psipred/).  The region from residue 93 to 119 is 
predicted to be a coiled region with no α-helical or β-strand elements.  Although 
residues 90, 91 and 92 are predicted to be α-helical, the confidence associated with this 
prediction is relatively low.  This is consistent with our crystallographic results, since 
regions that form random coils are often flexible and very flexible regions may not 
contribute to X-ray diffraction.  The crystal structure matched the predictions from 
PSIPRED. 
 The crystallographic asymmetric unit composed of a protomer of CsoR is shown 
in Figure 3.2.  The dimer generated due to crystallographic 2-fold symmetry is shown in 
Figure 3.3.   
Each protomer of CsoR contains three α-helices (α1, α2 and α3).  α1 spans 
residues 7 to 32, α2 spans residues 36 to 63 and α3 spans residues 75 to 86.  α1 and α2 
are connected by a 3 residue loop L1 (residues 33 to 35) and α2 and α3 are connected by 
a 10 residue loop L2 (residues 64 to 74).  The secondary structure elements seen in the 
crystal structure have been marked on the CsoR sequence (3.4.1).   The α1-α2 helices of 
one protomer pack against α1’ and α2’ of the protomer generated by symmetry.  
Together, α1-α2 and α1’-α2’ form a compact antiparallel four-helix bundle (Figure 3.3 
and Figure 3.4).  Along the top of the four-helix bundle are multiple salt-bridge 
interactions, for example, Lys17-Glu31’, Arg20-Asp24’, Asp24-Arg20’ and Glu31-
Lys17’.  The core of the bundle is lined with hydrophobic residues (Figure 3.3b).  The 
residues Leu13, Leu16, Val19, Leu23, Val27, Leu30 on the α1 helix and Val39, Val46, 
Leu50 on the α2 helix from each protomer point towards the core of the four-helix 
bundle.  The core is likely to be stabilized by hydrophobic interactions between the α1-
α2 helices of the same protomer as well as between opposite protomers.  Stabilization of 
long α-helices by hydrophobic interactions along the core, is reminiscent of coiled-coil 
proteins with the leucine zipper motif .   
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Figure 3.2  The crystallographic asymmetric unit of Cu(I):CsoR 
The asymmetric unit of CsoR consists of one protomer of CsoR.  Each protomer 
contains 3 helices- α1, α2 and α3 and 2 loops L1 and L2 connecting the helices.  A 
single Cu(I) ion (blue sphere) is present close to a cysteine residue (Cys36) from the 
α2 helix..   
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 Figure 3.3  Overall crystallographic structure of Cu(I) bound CsoR 
a.  CsoR is an α-helical dimer of 2 protomers (pink and teal). A single protomer 
(pink) and is composed of 3 helices- α1, α2 and α3.  The α1, α2 of one protomer and 
α1’, α2’ of the other protomer together form a 4-helix bundle stabilized by salt-
bridge interactions between pairs of oppositely charged residues of  α1 and α1’( 
K17-E31’ , R20-D24’, D24-R20’ and E31-K17’) shown as sticks.  A cluster of 
positively charged residues ( K8, R15, R52,R55 and H59) is shown as sticks on the 
front and back face of CsoR. Cu(I) atoms are shown as blue spheres, coordinated 
by C36, C65’ and H61’ shown as sticks. Residues Y35 and E81’, shown as sticks, 
are close to the active site.  b.  Top view of the dimer shows the four helix bundle 
formed by the α-helices α1 and α2 of each protomer (pink and teal).  Hydrophobic 
residues lining the core of the four-helix bundle are shown as sticks.     
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Figure 3.4  View along the long axis of the Cu(I) CsoR dimer 
 
Viewing along the long-axis of the CsoR dimer (pink and teal) shows a closely 
interacting, compact 4-helix bundle with the two copper-binding sites on either end. 
The two clusters of positive residues can be seen on the outer face of the bundle.  
Residues E81 and Y35 of opposite protomers close-in around the metal site.   
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The α3 and α3’ helices are placed on either end of the long axis of the four-helix bundle.  
α3 packs against the residues at the beginning of α2’ helix of the other protomer 
(residues 37 to 44).  The α3-α2’ interface is small and most pairs of residues are greater 
than 3.7Å apart.   
 A surface representation of the CsoR dimer colored by electrostatic potential 
(3.4.1, Figure 3.5) shows one cluster of positively charged residues.  The main 
contribution to this positive patch comes from residues Arg15 and Lys8 from the α1 
helix and residues Arg52, Arg55 and His59 from the α2 helix of the same protomer.  
Owing to the 2-fold rotational symmetry in the CsoR structure, a corresponding positive 
patch is seen on the other face of the dimer.  This can be seen while looking at the dimer 
from the bottom, as shown in Figure 3.5.   
 
3.2.2 The Cu(I) site in CsoR 
As explained below in section 3.3.5, electron density corresponding to positive 4σ 
contour was observed close to Cys36 at the N-terminus of the α2 helix.  Since the X-ray 
fluorescence scan performed on the crystals had confirmed the presence of copper (see 
section 3.3.4), a Cu(I) ion was refined into this density.  After applying symmetry to 
generate the dimer of CsoR, the Cu(I) ion was surrounded by Cys36 of the α2 helix of 
one protomer, His61’ from the C-terminus of the α2’ helix of the other protomer and 
Cys65’ from the L2’ loop of the other protomer (Figure 3.6).  A second Cu(I) site 
related by 2-fold symmetry is formed by Cys36’ of α2’, His61 from α2 and Cys65 from 
the L2 loop.  As described by Liu et al. (3.4.1), “The Cu(I) ion is bound to an 
intersubunit coordination site formed by the Sγ atoms of Cys36 and Cys65’ (of the 
opposite subunit) and the Nδ1 atom of His61’.”  The Cu(I) ion is 2.66Å away from the 
Sγ atom of Cys36, 2.68Å from the Sγ atom of Cys65’ and 2.4Å away from the Nδ1 atom 
of His61’.  The ligands along with the Cu(I) ion exhibit almost perfect trigonal 
coordination geometry.  The bond angles defining the Cu(I) geometry are 123.7º (Sγ36-
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 Figure 3.5  Electrostatic surface representation of Cu(I) bound CsoR 
a.  The electrostatic surface potential rendering of Cu(I):CsoR shows two distinct 
positively charged surfaces (blue) related by 2-fold rotational symmetry (symmetry 
axis marked in black) .  The negatively charged region is shown in red.  b.  Top 
view of the Cu(I):CsoR dimer.  c.  Bottom view of the Cu(I):CsoR dimer. 
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 Figure 3.6  The subunit bridging metal site in CsoR 
The coordination sphere around Cu(I) in the Cu(I):CsoR structure is shown, with 
the two protomers in pink and teal.  The trigonal metal binding site involves one 
cysteine (C36) from α2 of one protomer and a cysteine (C65’) and histidine (H61’) 
from α2’ of the other protomer.  In the vicinity of the metal binding site, are 
residues Y35 and E81’ at distances of 3.31Å  and 4.28Å respectively, from the 
nearest ligand residue. Electron density contoured at 1σ , from a composite omit – 
map is shown as a grey mesh around the residues and Cu(I) atom.  
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Cu(I)-Sγ65’), 119.8º (Nδ161’-Cu(I)-Sγ65’) and 116.4º (Sγ36- Cu(I)-Nδ161’).  The torsion 
angle between the ligands and the Cu(I) ion is 177.9º which is close enough to a planar 
geometry with a torsion angle around 180º.  Although the bond angles calculated from 
the Cu(I):CsoR structure match well with the ideal angles for trigonal geometry (around 
120º), the metal-ligand distances are larger than typical distances.  Distances calculated 
using Extended X-ray absorption fine structure (EXAFS) analysis of Cu(I):CsoR 
correspond to 2.21 for the Cu(I)-S bonds and 2.06 for the Cu(I)-N bonds (3.4.1).  This is 
consistent with the distances observed in other proteins.  Typically Cu(I) prefers 
tetrahedral, trigonal and sometimes linear geometry.  RcnR, a nickel and cobalt 
responsive metalloregulator from E. coli is predicted to have an all α-helical structure 
(204).  Secondary structure predictions suggest a structure similar to CsoR (204).  In 
RcnR, cysteine35 and histidine 60 are likely to represent part of the metal site.  Residue 
64 varies across the homologs and might affect metal specificity (204).  It is possible 
that structural changes at the metal site involving movement of the ligands helps this 
three-helical fold to offer trigonal versus square planar geometry.  In this way, proteins 
with similar folds may be specific for different metals. 
The role of Cysteine residues as metal coordinating ligands in CsoR was 
expected, as suggested by S¯  to Cu(I) ligand-to-metal charge transfer (LMCT) 
experiments.  The role of His61 however, was first observed in the crystal structure.  
EXAFS analysis of Cu(I) binding by CsoR confirms the role of His61 is directly 
coordinating the Cu(I) ion.  This is consistent with the ligand preference of Cu(I).  Cu(I) 
is classified as a soft acid based on the ionization potential, ionic radius and ionic charge 
(135). Soft ions prefer to coordinate to Sulphur (S) or Nitrogen (N) donors as compared 
to the hard ions like Mg2+ and Ca2+ that prefer to coordinate to Oxygen (O) donors.   
Tyr35, the residue preceeding the metal coordinating Cys36, is in the vicinity of 
the metal site.  Liu et al. describe the changes in the fluorescence properties of this 
residue upon binding of Cu(I) by CsoR (3.4.1).  Considering the distance of 3.3Å 
between Tyr35 and the nearest copper ligand, it is possible that structural rearrangements 
at the metal site are transmitted to the Tyr35 residue, causing a change in its 
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fluorescence. 
Also, Glu81 a conserved residue from the α3 helix is 4.3Å away from the nearest 
copper ligand while the Nδ1 atom of His61 directly coordinates the Cu(I) ion.  Mutation 
of Glu81 to Ala decreases the regulation of DNA binding without affecting Cu(I) 
binding (3.4.1).  Put together, this suggests that Glu81 could be involved in a 
conformational switch that may accompany Cu(I) binding, which may decrease the 
affinity of CsoR for DNA.     
   
3.2.3 Comparison of CsoR structure with other Cu(I) responsive transcriptional 
regulators 
CueR, a member of the MerR family of metalloregulatory proteins, regulates the 
transcription of genes encoding CopA and CueO which presumably constitute the 
primary copper export system in E. coli. CueR is a homodimeric protein (Figure 3.7, 
(176), (14) that binds 3 equivalents of Cu(I) per monomer.  One Cu(I) site is formed by 
residues Cys112 and Cys120 from the same protomer.  These residues lie in a 10 residue 
loop which turns around to bring the two cysteines together to form metal coordinating 
site.  Cu(I) is bound in a 2-coordinate, linear geometry at this site.  Each cysteine residue 
is 2.14Å away from the Cu(I) ion.  This metal site represents a tight binding site relative 
to two other weak metal binding sites close to Cys129 and Cys130 that are present in the 
C-terminus of the protein.  The C-terminus of the protein was disordered and could not 
be resolved in the crystal structure.  It is speculated that the unusual linear 2-coordinate 
geometry might contribute to the metal specificity of CueR, allowing it to bind only 
Cu(I), Ag(I) and Au(I), not Zn(II) or Hg(II).  The Ag(I) and Au(I) bound crystals 
structures of CueR show an almost identical metal site as that bound to Cu(I) except for 
an increase in the metal sulfur bond distances.  This idea is consistent with the features 
of other metalloproteins in which metal specificity is determined by the coordination and 
geometry of the metal site (174).   
 CsoR shows obvious structural differences from CueR.  CsoR possesses only 2 
cysteine residues, both of which take part in metal coordination.  Each Cu(I) site is a 
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 Figure 3.7  Comparison of metal sites in CueR and CsoR 
a.  Crystal structure of CueR bound to Cu(I), PDB 1Q05.  CueR forms a 
homodimer (salmon and blue).  A single Cu(I) (cyan sphere) is coordinated in a two 
coordinate linear geometry by two cysteine residues from the same protomer.  b.  
In CsoR, Cu(I) is present in a subunit bridging site with ligands from both 
protomers.      
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subunit bridging site since ligands from both protomers of the homodimer are required to 
coordinate the Cu(I) ion.  This is in contrast to the Cu(I) site in CueR.  Although the 
metal site is formed at the dimer interface, both cysteines that coordinate Cu(I) belong to 
the same protomer.  Whether in the case of CueR or CsoR, the dimer formation is 
apparently not driven by metal binding since the apo proteins also exist as homodimers.  
However, the location of the metal ion at the subunit interface could help in mediating 
the conformational changes that accompany the switch between metal bound and DNA 
bound states.  In SmtB, a Zn(II) binding transcriptional regulator it has been shown 
(205) that rearrangement of a complex hydrogen bonding network between the subunits 
is likely to drive the structural arrangements that take place between the metal bound and 
DNA bound forms of the protein. 
        
3.2.4 DNA binding fold of CsoR 
Metalloregulators have been classified into six structural families.  Structural and 
biochemical studies have shown that metal specificities, coordination geometries, ligand 
types and number of ligands differ between and even within each family. However, the 
DNA binding domains are highly similar in structure across at least five families and 
mostly consist of the winged helix motif or modifications of the helix-turn-helix motif.  
The winged helix motif is an α/β type of motif with three α-helices (H1, H2 and H3) and 
three β-strands (S1, S2, S3).  Two large loops called wings (W1 and W2) connect S2 and 
S3 strands and lie on either side of helix H3.  In this respect, the structure resembles a 
winged helix (206). The main distinction between winged helix motifs and helix-turn-
helix motifs is the length of the turn connecting helices H2 and H3.  This turn is much 
longer in the winged helix domain.  H3 is called the recognition helix and makes 
contacts with the major groove of the DNA via conserved motifs (Arg-Arg-X-Tyr-Asp).  
The role of the W1 and W2 wings differs with protein.  In CueR, as in all other members 
of the MerR family, an N-terminal winged helix domain interacts with DNA where as 
the effector binding site is at the C-terminus (Figure 3.8a).  Although apart in primary 
structure of the protein, due to the homodimeric arrangement of the protein, the DNA 
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Figure 3.8  DNA binding domains in MerR and ArsR family metalloregulators 
a. Crystal structure of Cu(I) bound CueR (1Q05) shows a winged helix motif with 
the recognition helix shown in red.  b.  Crystal structure of Zn(II) bound SmtB 
(1R23) shows a winged helix-turn-helix motif with the recognition helix shown in 
red.           
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binding N-terminus and effector binding C-terminus are brought together in close 
proximity to each other.  In SmtB, a Zn(II) binding ArsR/SmtB family member, a 
winged helix-turn-helix is the putative DNA binding site protein (PDB ID 1SMT), 
(Figure 3.8b).  Structures of DNA bound metalloregulators are available for 2 members 
of the DtxR and 1 member of the NikR family (184), (15), (23).  As shown in Figure 
3.9, while DtxR type regulators use a winged helix motif to recognize DNA, NikR uses a 
ribbon-helix-helix motif to interact with DNA.      
  In the CsoR homodimer there are no recognizable DNA binding motifs like the 
winged helix or helix-turn-helix motifs.  We speculate that the positive patch of residues 
seen on the electrostatic surface of the dimer along with the 2-fold rotation related patch 
of positive residues represents at least part of the DNA binding site.  Consistent with this 
idea, alanine substitutions of the residues Arg15 and Arg52 that contribute to this 
positively charged patch, lose the ability to bind DNA as effectively.  The positively 
charged surface potential is likely to aid in charge neutralization of the highly negative 
phosphate backbone of the DNA.  Also, a 2-fold related site could accommodate a 
pseudo-palindromic sequence as that recognized by CsoR.  The C-terminus of CsoR was 
not resolved in the crystal structure.  Although absent in other CsoR homologs, it is 
possible that this region contributes to DNA binding in M. tb CsoR.  One possible DNA 
binding site could involve the top of the CsoR homodimer along with the 2-fold related 
sites.  Another possibility is that the DNA could bend around the bottom of the CsoR 
dimer to contact the 2-fold related positive patch consisting of Arg15 and Arg52.  The 
distance between the C-α positions of the two Phe88 residues in the homodimer of CsoR 
measures ~26Å.  This is in the range that could accommodate the width of a DNA 
double helix.  These models for DNA binding are currently being tested.  Although the 
DNA binding site of CsoR is not yet well characterized, structural comparisons suggest 
that CsoR possesses a DNA binding site different from other known metalloregulators.  
In this way CsoR represents a novel class of metalloregulators.    
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 Figure 3.9  DNA binding by DtxR and NikR family metalloregulators 
a.  Crystal structure of iron sensing regulator IdeR from M. tb in complex with 
DNA (2ISZ) shows a dimer of dimers.  Each protomer recognizes the major groove 
of DNA (grey) using a recognition helix (red) from a winged helix motif.  The first 
wing regions (red) also interacts with the DNA.  Iron is shown as magenta spheres.  
b.  Crystal structure of nickel sensing regulator NikR from E. coli in complex with 
DNA (2HZV) shows a homotetramer.  A β-strand from each protomer comes 
together to form 2 β-sheets in the ribbon-helix-helix motif.  2 such motifs (red) per 
homotetramer interact with major grooves of the DNA (grey).  Nickel in magenta.     
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 3.2.5 Crystallization and structure determination of CsoR:DNA complex 
As described by Liu et al. (3.4.1), CsoR binds a pseudo-palindromic sequence upstream 
of the cso operon.  This region resembles a consensus Mtb promoter sequence.  To 
understand the structural basis of the interactions between CsoR and DNA, co-
crystallization trials were set up.  Various DNA oligos were used including a 20mer, a 
24mer, a 28mer and a 33mer encompassing the palindromic promoter region.  Details 
are described in section 3.3.6.  For initial crystal trials, the DNA oligos were annealed to 
form a double stand and then mixed in equimolar ratios with Apo:CsoR at a 
concentration of 420µM.  Crystal screen 1 and 2, Wizard screens 1 and 2 and the Natrix 
screen were used for the trials.  Crystals for the CsoR:33mer were obtained within a 
week in Wizard screen 1 #4, a condition consisting of 2-methyl-2,4-pentanediol, 
imidazole pH8.0 and magnesium chloride.  During optimization to improve the crystal 
quality, drops were also set up using CsoR alone and the 33mer DNA alone as controls.  
Within a week, the drops containing DNA alone also showed crystals identical to the 
original crystals from the crystal screen.  Therefore it was concluded that the crystals 
belonged to the 33mer DNA alone and not the protein:DNA complex.   
 The affinity of CsoR for the promoter DNA is in the µmolar range (3.4.1).  It is 
possible that this relatively low affinity complex is not stablilized enough in the 
crystallization experiments, making it difficult to obtain crystals of the complex. Also, 
given the right conditions, the DNA being a relatively stable double-helix structure may 
nucleate on its own, shifting the equilibrium away from complex formation in the 
crystallization drops.  It is also possible that slow oxidation of the protein occurs in the 
course of the crystallization experiment, further decreasing the affinity of CsoR for 
DNA.  One approach to solving this problem could be to stabilize the reduced state of 
CsoR using Cu(I) chelators or better reducing agents.  Also, rational design of DNA 
oligos which are bound with higher affinity by CsoR could potentially increase the 
chances of obtaining crystals for the complex.  Other methods like NMR and 
fluorescence based techniques might prove more successful in obtaining structural 
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information about CsoR:DNA binding.  
 
 
3.3 EXPERIMENTAL APPROACH AND DESIGN 
 
3.3.1 Purification of Apo, Cu(I) bound and Se-met CsoR 
Purification of Apo and Cu(I) CsoR has been described by Liu et al. (3.4.1).  “To obtain 
phase information for structure determination, seleno-methionine (Se-met) substituted 
CsoR was produced in E. coli B834 (DE3) cells (Novagen).  The cells were transformed 
with the pET3a-CsoR construct, grown in LB media to mid-log phase, transferred to M9 
minimal media supplemented with L-amino acids (Sigma, 50mg/L), L-seleno-
methionine (Acros, 50mg/L), glucose (0.4% w/v), calcium chloride  0.1 mM), 
magnesium sulfate (4 mM), thiamine (5µg/mL) and ampicillin (50 µg/mL), induced with 
0.5 mM IPTG and allowed to grow for 17 h at 25 ˚C.  Following harvesting of culture, 
the same purification protocol was followed as outlined for the native CsoR.”  The final 
purity of the sample used for crystallization was ~70% but despite the low purity, this 
sample yielded crystals. 
  
 
3.3.2 Crystallization of CsoR 
Apo CsoR at a concentration of 8mg/ml was used for initial robotic screening using 
Crystal screens 1 and 2 and Wizard screens 1 and 2.  Intelli plates were set up with 
100µl reservoir solution in a sitting drop method.  Apo CsoR crystallized within a week 
in Crystal screen 1 #39 (0.1M Hepes pH 7.5, 2%v/v PEG 400, 2M ammonium sulfate) 
and subsequently in many different conditions.  Extinction of polarized light can be used 
as a test to determine if material is crystalline or amorphous.  Crystalline material is 
anisotropic, with different axes having different refractive indices. Polarized light splits 
up and travels at different speeds through the crystal because of the different refractive 
indices along different axes in the crystal.  If another polarizer is placed near the eye-
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piece of the microscope, at certain angles between the crystal and the source polarizer, 
the net light passing through the crystal has the same polarization as the incident light 
and gets cancelled by the second polarizer.  This is called extinction of polarized light 
(www.hamptonresearch.com).  As the second polarizer or crystal is turned to another 
angle, light starts to pass through the crystal again.  Amorphous material is isotropic and 
does not produce this effect.  CsoR crystals caused extinction of polarized light. 
To test if the crystals obtained were protein or small molecule crystals, several methods 
were employed.  First, the crystals were stained with the Izit Crystal Dye 
(www.hamptonresearch.com) which stains protein crystals blue, by entering the large 
solvent channels.  Small molecule crystals because of their close packing do not get 
stained.  The Apo:CsoR crystals took up the stain only after almost 1 day.  Crystals of 
small molecules most often are hard, and crack with a characteristic sound as compared 
to protein crystals which are soft and can be cut into.  Apo:CsoR crystals, when 
subjected to this “crack” test provided confusing results.  Lastly, the crystals were 
exposed to X-rays to obtain a diffraction pattern.  Characteristic protein spots were seen 
for Apo:CsoR crystals, confirming that the crystals were protein crystals.  The difference 
between diffraction images obtained from protein versus small molecules is shown in 
Figure 3.10.  The inverse relation between the distances that separate diffraction spots 
and the actual distances within the crystal implies that molecules that are packed closely 
produce spots that are far from each other and vice versa.  Small molecules pack closely 
and hence produce very bright spots at high resolution, with large distances between the 
spots.  Protein crystals produce closely spaced spots since molecules are placed far away 
in the crystal.    
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Figure 3.10  Comparing diffraction patterns from protein versus salt 
a. Diffraction from a single CsoR crystal shows many spots in the low resolution 
(centre of frame) and fainter spots in high resolution (periphery of the circle).  b.  
Diffraction pattern from a crystal of magnesium phosphate shows few spots placed 
far from each other. Few bright spots at very high resolution can be seen.    
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The Apo CsoR crystals were flat and almost plate-like.  To enable the crystals to 
grow along the third dimension, optimization was done by the hanging drop method.  
This also facilitated handling of the crystals.  To further improve the quality of the 
crystals, the ratio of protein to crystallization solution was varied.  A marked difference 
was seen as a result of varying drop ratios, with a ratio of 2:4 (crystallization 
solution:protein) giving much larger crystals (Figure 3.1c) with sharper edges as 
compared to 2:2 or 4:2 ratios.  At ratios of 4:2, the drop did not look homogeneous and 
appeared to show some phase separation.  Despite the outward appearance, crystals of 
Apo CsoR did not diffract well.      
 Hexagonal crystals for Se-met substituted CsoR were grown by the hanging drop 
method in a crystallization solution consisting of 0.1 M Hepes sodium pH 7.5, 2% PEG 
400 and 1.7 M ammonium sulfate.  Diffraction quality crystals were obtained by mixing 
2 µL crystallization solution with 4 µL protein at a concentration of 800 µM, and 
equilibrating against 500 µL of crystallization solution.  A marked difference was seen 
in the size and quality of crystals when the protein was prepared in 25mM MES buffer 
pH5.9 and 300mM NaCl as compared to 25mM Hepes pH 7.0 and 200mM NaCl.   
Crystals for Cu1 wild-type CsoR  were obtained by the hanging drop method in a 
crystallization solution consisting of 0.2 M ammonium acetate, 0.1 M sodium citrate 
tribasic dihydrate pH 5.6, and 30% w/v polyethylene glycol 4000.  Diffraction quality 
crystals were obtained by mixing 2 µL of crystallization solution with 4 µL of protein at 
a concentration of 400 µM and equilibrating against 500 µL crystallization solution.   
 SDS-PAGE analysis of the different crystal forms of CsoR was performed.  
Crystals for each form of CsoR (Apo, se-met Apo and Cu(I) bound) were picked and 
washed at least twice in mother liquor.  This was done to ensure that no contamination 
occurred from the rest of the material in the drop.  Figure 3.11 shows the migration of 
the crystals on a Tris-tricine gel (Biorad) after being dissolved in SDS loading dye.  The 
Apo:CsoR crystals and the Cu(I):CsoR crystals ran similar to the full length ~13kDa 
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Figure 3.11  SDS PAGE analysis of CsoR crystals 
Crystals of ApoCsoR, semet-CsoR and Cu(I) bound CsoR run a 16.5% Tris-
Tricine/Peptide gel and stained with Coomassie BB are shown.  Apo and 
Cu(I):CsoR crystals were intact whereas semet-CsoR was missing the C-terminus 
unstructured tail.   
 
 
 
protein used as starting material for the crystallization.  The Se-met derivatized 
Apo:CsoR crystals appeared to be ~10kDa in size.  This phenomenon was not observed 
only in the crystallization experiment since protein left in solution also showed cleavage 
as shown in Figure 3.11.     
 
3.3.3 Preparing crystals for data collection 
As discussed in Chapter II, section 2.3.7, preparing crystals for diffraction experiments 
in liquid nitrogen requires the crystal to be soaked in a cryoprotectant that prevents 
freezing.  Crystals of CsoR were soaked in many different cryoprotectants and exposed 
to X-rays.  Some of the cryoprotectants tried were- 15 to 30%Peg 400 in mother liquor 
(ML), 15 to 30% Glycerol in ML, 20 to 30% ethylene glycol in ML and paratone.  The 
best diffraction was obtained in paratone.      
 
3.3.4 X-ray data collection and data processing 
The best crystal of Apo CsoR diffracted to 3Å at the 23ID beamline at Argonne National 
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labs, IL.  The best Semet-Apo CsoR crystal diffracted to 2.13 Å at beamline 8.3.1 at the 
Advanced Light Source, Lawrence Berkeley National Laboratory.  Data statistics are 
compiled in 3.4.1.  Consistent with the hexagonal morphology of the crystals, the 
crystals showed 6-fold symmetry and belonged to the P 64 2 2 space group with cell 
dimensions of a = 91.31 Å, b = 91.31 Å, and c = 47.87 Å.  The best Cu(I):CsoR crystal 
diffracted to 2.55 Å at beamline 19-ID at the Advanced Photon Source, Argonne 
National Labs, Illinois and was isomorphous to the Se-met CsoR crystals with cell 
dimensions of a = 91.06 Å , b = 91.06 Å, and c = 46.78 Å.  Completeness of the 
diffraction data, defined as ratio of the number of unique reflections measured to the 
total number of unique reflections, was equal to 99.4% for the overall data and 99.2% at 
a resolution of 2.55Å.  X-ray fluorescence scan of the Cu(I):CsoR crystal showed an 
emission peak at 8.1 keV (Figure 3.12 ) confirming the presence of copper in the 
crystal.  As expected, a similar scan performed on a Se-met Apo CsoR crystal showed no 
peak at 8.1 keV.   
After data processing, symmetry was estimated using Xprep and HKL2000 
(122).  The crystals showed P6 symmetry.  P6 refers to a hexagonal unit cell 
characterized by unit cell dimensions of a = b and α = 90º, β = 90º and γ = 120º (117), 
(118).  In crystals with P6 symmetry, there is 6-fold rotational symmetry parallel to the 
axis along c.  A 6- fold gives rise to 6-fold symmetry both on the zero level and on 
subsequent levels. This can be used to distinguish between 3-fold and 6 –fold 
symmetries since in the case of 3-fold symmetry, the subsequent levels do not show 6-
fold symmetry (118).  Higher symmetries in P6 involve a 2-fold rotational symmetry 
along an axis perpendicular to the 6-fold axis.  This results in another 2-fold rotational 
symmetry being generated along an axis perpendicular to the already existing 6-fold and 
2-fold axes.  As described in Chapter II, section 2.3.8, combinations of rotational and 
translational symmetries give rise to screw symmetry.  The 6- fold rotational axis can 
have 3 different screws- 61 and 65, 62 and 64 and 63 (118).  Screw symmetries give rise to 
absences in diffraction and each screw has a characteristic set of systemtic absences.  By 
looking for systematic absences, the screw symmetry can be determined.  For CsoR 
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Figure 3.12  X-ray fluorescence scans of CsoR crystals 
a.  Scan of a Cu(I):CsoR crystal shows a peak (asterisk) at 8.1keV characteristic of 
copper.  b.  Scan of a Se-met crystal shows a prominent peak from selenium 
(arrow) and no peak at 8.1keV from copper.  
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crystals, both Xprep and HKL2000 gave conflicting results and were unable to 
distinguish between the higher symmetries of P 6422, P 6122, P 6222, P6522 and P6322.  
To resolve this problem, the precession frames from the diffraction were manually 
checked along the axes where systematic absences were expected (Figure 3.13).  The 
precession frames were viewed using the PRECESS_X program from the PHASES 
package (207).  The expected reflection condition for 6122 and 6522 is l = 6n (119).  
However, in the CsoR diffraction data, the 009 (hkl) spot is present along the 00l axis of 
the 0kl frame.  Also, for 6322 the reflection condition is l (119), but none of the even 
spots like the 002, 004 etc were seen.  Hence, the space group assigned was 6422 or 
6222.  Both these space groups were used and only in later steps they were 
distinguishable. 
To estimate the number of CsoR molecules in the asymmetric unit, the “Mathews 
Coefficient” program in the ccp4 suite was used.  A single molecule of CsoR was 
calculated to compose the Asymmetric Unit.  The Mathews coefficient, which represents 
the volume of the crystal per unit mass of the protein, was calculated as 2.2 with a 
solvent content of 42.4%.  This is typical for most proteins, the range being 1.9 to 4.2 
(117). 
  
3.3.5 Structure determination of Cu(I)-CsoR 
One of the important components of scattered X-rays, called the phase is lost in the 
diffraction experiment (117).  This is a required component for calculating the electron 
density from the diffraction data.  Many methods are available to solve the phase 
problem, two of which are described in detail in Chapter II, section 2.3.9.  Since no 
homologous structures are known for CsoR, molecular replacement could not be used to 
calculate phases.  Soaking of crystals to obtain phases using multiple isomorphous 
replacement (MIR) is a cumbersome process.  Very often, the soaking process disturbs 
the crystals so that they are no longer isomorphous to the native crystals, and this poses 
to problem in obtaining phases.  Another problem is that a trial and error method is used 
to find the heavy atoms that specifically bind to sites on the protein.  Only after data 
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 Figure 3.13  Precession frame from CsoR diffraction 
Diffraction spots from the 0kl frame from CsoR diffraction are shown.  Along the 
00l axis (white arrow), presence of the 009 spot (white arrow-head) and absence of 
any even spots (like 002, 004 etc.) confirms the symmetry to be P6422/P6222.      
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collection and processing, can the signal from the heavy atom be detected.  This makes 
the MIR method relatively long and tedious.   
For obtaining phases for CsoR crystals, we considered two options for 
multiwavelength anomalous dispersion (MAD) experiments.  First, the protein could be 
derivatized with Selenomethionine to use the anomalous scattering by selenium to obtain 
phases.  Second, the Cu(I) ion bound to CsoR in the Cu(I):CsoR crystals could be used 
to obtain phases since Cu(I) is a relatively heavy atom and is known to display 
anomalous scattering close to the Cu absorption edge.  The added advantage of using Cu 
to obtain phases was that the diffraction data could be collected at the home-source for 
X-rays since the anode used to generate X-rays is composed of copper and the resultant 
radiation is in the range where anomalous scattering from Cu could be seen.  Since the 
se-met crystals were larger and diffracted to a higher resolution, the phasing was done 
using the data collected at the peak, inflection and remote wavelengths in the selenium 
absorption spectrum.  Details of the MAD data collection and structure solution are 
described in Chapter II, section 2.3.9.   
Diffraction data sets were merged, scaled and integrated using HKL2000.  From 
the three wavelength MAD data from Se-met CsoR crystals, 3 out of 5 selenium sites 
were located using phenix.hyss (121).  Refinement of selenium sites and initial phase 
calculation followed by density modification was done using AutoSHARP (123).  With 
these density modified phases, the electron density map was calculated.  Using this 
electron density as input,  the initial model was built by TEXTAL (120,208), an 
automated model building program.  The initial model built by TEXTAL is shown in 
Figure 3.14a.  This model was refined against the Cu(I):CsoR data first by rigid body 
refinement using REFMAC on the CCP4 suite(209) and then by simulated annealing 
refinement using phenix.refine (121).  At every stage of refinement, difference density 
maps were calculated.  Difference density maps are calculated by comparing the electron 
density calculated from a model to the density map used to build it.  For example, the 
|Fo|-|Fc| map is a difference map in which there is positive density at sites where the 
model is not represented enough and negative density where the model has been placed 
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Figure 3.14  Model building of CsoR 
a. Initial model of CsoR built using TEXTAL, is shown (teal).  Clearly recognizable 
features like α helices (red arrow) in the initial model are shown.  b.  Candidate 
loops (boxed region) built by SwissPDBViewer between helices α2 and α3 are 
shown in different colors.  
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wrongly.  Using the positive and negative peaks from the |Fo|-|Fc| map, corrections were 
made to the model.  One important contribution from the difference maps was the 
appearance of positive density for the α3 helix which was not clear in the initial density 
maps and hence was not built by TEXTAL.  Another map with double the contribution 
from the observed data, called the 2|Fo|-|Fc| map was used.  Since the α3 helix had not 
been built so far, by using the map with more contribution from the observed data the 
density in this region was enhanced.  This made it easier to build the α3 helix.  Since the 
initial model built by TEXTAL was using the se-met Apo:CsoR data and the model 
being built was the Cu(I):CsoR structure, it was possible that the phases being used were 
biased towards the se-met Apo:CsoR structure.  To solve this problem, bias minimized 
maps were calculated using the TB Bias Removal Server (125).  Also, for a more 
complete removal of model-bias, a simulated annealing composite-omit map was 
calculated using CNS (210) and used as a guide for model improvement.  Details of 
simulated annealing have been discussed in Chapter II, section 2.3.9.  An omit map is 
calculated after the atoms in a defined small volume are removed and the remaining 
structure is used to calculate phase angles which are then used to calculate the electron 
density in the omitted volume (117).  A composite omit map uses the principles of an 
omit map, except that different parts of the model are omitted in successive runs, to 
cover the entire model.  Manual model building using XtalView (124) and refinement 
using phenix.refine were iteratively done.  One of the challenges with building the 
Cu(I):CsoR model was the loop region between α2 and α3.  Density in this region was 
not very clear.  To aid in building this loop, we used the build-loop feature in Swiss Pdb 
Viewer (211).  After specifying the residues that define the ends of the loops, the 
sequence of residues in the loop is specified to the program.  A table of possible loops is 
output, along with the associated energies and a clash score which reports on possible 
steric clashes.  Manual inspection of the suggested loops (Figure 3.14b) was done and 
the best fit was used as a starting point to build the final loop.  Positive electron density 
corresponding to the 4σ contour level was observed in the Fo-Fc map.  This density was 
close to a Cysteine residue (Cys36).  Since the X-ray fluorescence scans had confirmed 
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the presence of copper in the crystal, a single copper atom was refined into this density.  
Positive densities less than 3σ were identified and water molecules were manually added 
to these sites to obtain the final model.  As described in Chapter II, section 2.3.9, R- 
factors were calculated at every step of refinement.  The final Cu(I):CsoR model refined 
with crystallographic Rwork and Rfree of 22.63% and 27.62% respectively.  Refinement 
statistics are shown in 3.4.1.  To analyze the geometry of the protein backbone, a 
Ramachandran plot was made (Figure 3.15) with the backbone ψ angle plotted against 
the φ angle.  97.5% of the residues lie in the allowed region and 2.5% of the residues lie 
in the generously allowed region.     
Accessible surface area was calculated using UCSF Chimera(128,129), 
Electrostatic surface potential was calculated using APBS (127) and UCSF Chimera; all 
other figures were prepared using PyMOL (www.pymol.org). 
To analyze the crystal contacts made by CsoR in the crystal, and prompted by the 
biochemical data suggesting a dimeric form of CsoR (3.4.1), the symmetry mates were 
generated.  One of the symmetry mates shared the maximum surface area with the 
original molecule.  Also, upon generating symmetry, the Cu(I) ion was now surrounded 
by Cys36 of the original molecule and Cys65 and His61 of the symmetry related 
molecule.  Since these are possible ligands that coordinate Cu(I), this symmetry mate 
together with the original molecule are likely to form the biological dimer.  Since the 
Cu(I) ion lies on a 2-fold rotation axis, generating symmetry resulted in the site being 
allotted 2 ions of Cu(I).  To resolve this problem, the site was assigned an occupancy 
equal to 0.5 during refinement.  Generating crystallographic symmetry also gave rise to 
higher order structures, as shown in Figure 3.16.   
 
3.3.6 Crystallization of CsoR:DNA complex 
DNA oligos their complementary sequences were purchased from Integrated DNA 
Technologies with standard desalting purification and at a 10µmole scale.  Five oligos of 
different sizes, representing the promoter region were ordered.  These were- a 20 mer 
(5’CCCACCCCC AGTGGGGTGGG), 24 mer 
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Figure 3.15  Ramachandran Plot for the Cu(I):CsoR crystal structure 
Backbone torsion angles of the CsoR structure are shown.  Allowed regions are 
marked in pink and additionally allowed regions are marked in yellow.      
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Figure 3.16  Higher order oligomers of CsoR 
Crystallographic symmetry mates (red, blue, yellow, green) give rise to a dimer of 
dimers.  The three helices- α1, α2 and α3 of one protomer are marked.       
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5’AGCCCACCCCCAGTGGGGTGGGAT), 28 mer (5’GT AGCCCACCCCCAGTGG 
GGTGGGATAC) and a 33 mer (5’GGTAGCCCACCCCCA 
GTGGGGTGGGATACCATG).  The DNA oligos were resuspended in deionized water 
and annealed at room temperature for 30 mins after heating for 5 minutes at 90ºC.  
Double stranded DNA fragments were mixed with CsoR at a concentration of 420µM.  
To remove any aggregates that might have formed after mixing, the sample was 
centrifuged at 13000rpm on a table-top centrifuge for 10 minutes and used for crystal 
trials.  Crystal screens were set up using a robot, on intelli plates with crystal screen 1 
and 2, wizard screen 1 and 2 (Emerald BioSciences) and the Natrix screen (Hampton 
research).  Preliminary crystals grew in 35% 2-methyl-2, 4-pentaneddiol, 0.1M 
imidazole pH8.0 and 0.2M magnesium chloride.  Optimization was performed on 
hanging drop plates, where drop ratios were varied as done for the CsoR crystals 
(described in section 3.3.2).           
 
 
3.4 ADDITIONAL MATERIAL 
 
3.4.1 Suggested reading    
“CsoR is a novel Mycobacterium tuberculosis copper-sensing transcriptional regulator”. 
By Liu et al., Nature Chemical Biology, December 2006, is available at 
DOI:10.1038/nchembio844.  
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CHAPTER IV 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
4.1 STRUCTURAL STUDY OF THE Ro PROTEIN FROM D. radiodurans 
In this work we have determined a high resolution structure of Rsr and shown that Rsr 
binds Y RNA with nanomolar affinity.  The high resolution crystal structure of Rsr when 
compared to the structure of X. laevis Ro suggest obvious structural changes in the Ro 
protein.  These conformational changes suggest that Ro proteins possesses a high degree 
of flexibility at the interface of the two domains.  Re-arrangement of helices at this 
interface results in alterations in the size of the central RNA binding cavity.  This high 
degree of flexibility may be possible due to conserved Glycine-rich motifs as seen in 
other HEAT repeat proteins.  The structural flexibility of Ro may be required to adapt to 
the different RNA substrates that are bound at the central cavity, and possibly for 
facilitating the entry and release of RNA substrates.  Our hypothesis based on the crystal 
structure, needs to be tested.  To test this hypothesis, and show beyond doubt that the 
opening and closing of the central cavity is governed by the H15 to H18 α-helices, many 
solution-state experimental approaches could be used.  Fluorescence based assays could 
be used to report on local movements near the α-helices.  Also, disulphide cross-linking 
experiments have proven particularly useful in observing local conformational changes.  
This would involve introducing cysteine residues at critical places in Rsr, such that only 
certain conformations give rise to disulfide cross-links.  In the presence and absence of 
the disulfide cross-links, the RNA binding activity would have to be tested.  
Crystallography, though a powerful tool to obtain structural detail to an atomic 
resolution, provides a snap-shot or a static image of the macromolecule.  To gain 
detailed mechanistic insights, a series of such snap-shots are required and very often, 
even these may not provide a complete picture.  In such cases, a combination of 
crystallography and solution studies could prove to be more informative.  The structure 
of Rsr provides a solid foundation for future work involving structure based probing of 
Ro RNA interactions and its mechanistic details.                    
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While a wealth of information is available for Ro in eukaryotes, relatively less in 
known about the biological role of Ro in prokaryotes.  The structure of Rsr provides 
clues to its function.  Our results show that structurally the Ro proteins from prokaryotes 
are similar to eukaryotic Ro. Based on this, we expect Ro to be involved in binding 
misfolded or mutant RNAs just like it has been shown for eukaryotic Ro proteins.  
Whether or not Ro is directly involved in the folding of these RNAs is not known, and 
future research needs to address this question.  Interactions between Ro and RNA 
processing enzymes like helicases, nucleases etc. need to be extensively studied to 
understand the role of Ro.  Alternatively, it is possible that Ro simply sequesters 
misfolded RNAs to prevent them from assembling into cellular machinery, thereby 
acting as a quality control protein.  Identification of cognate RNAs that bind at the 
central cavity of Rsr would greatly improve our understanding of the function of Ro in 
prokaryotes.  Preliminary crystal trials using single stranded RNAs that could possibly 
bind Rsr in the central cavity have proven unsuccessful.  Identification of the 
biologically relevant RNAs that bind Rsr in the central cavity would greatly aid not only 
in the crystallization experiments, but also in the overall understanding of prokaryotic 
Ro proteins.   
Our finding that Rsr interacts with Y RNA to form large multimers is intriguing.  
The physiological relevance of this observation needs to be investigated.  Previous work 
on human Ro RNPs suggests that Ro RNPs may exist as large (~350kDa) complexes in 
the cell.  In the cell, the composition of these complexes is not clear yet, since other 
proteins could be associated with the Ro RNPs.  Our in vitro experiments provide clear 
evidence that Ro and Y RNA could associate to form large oligomers in the absence of 
other factors.  It is possible that formation of these large oligomers within the cell acts as 
a trigger for the recognition of this complex by the yet unidentified downstream 
processing events.  Research over the last few decades has helped identify Ro RNPs as 
being the primary antigenic species in many autoimmune disorders.  However, even 
today, it is not known what switches Ro RNPs from being normal cellular components to 
what the immune system recognizes as “foreign”.  It is possible that oligomerization 
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under certain conditions in the cell, could determine this switch from normal cellular 
components to “foreign”.  Research in this direction could provide valuable clues 
towards understanding lupus-like auto-immune disorders.     
Collectively, our structural studies have now provided a strong foundation for 
future research on Ro proteins and the experiments proposed should facilitate better 
understanding of the function of this unique protein, in both prokaryotes and eukaryotes. 
 
4.2 STRUCTURAL STUDY OF CsoR FROM M. tuberculosis 
In this work, we have determined a high resolution structure of Cu(I) bound CsoR.  The 
structure shows that the metal site forms at the dimer interface and involves ligands from 
both protomers.  Research on other metalloregulators has shown that the nature of the 
ligands presented at the metal site, the geometry of the metal site and consequently, the 
chemical environment at the metal site are all determinants of metal specificity in these 
proteins.  The structure of CsoR suggests that metal specificity of CsoR may be 
determined in a similar way.  CsoR presents ligands that are typically preferred by Cu(I), 
like cysteines and histidines, in a geometry that is favorable for Cu(I) binding.  In this 
way, CsoR is likely to distinguish not only between copper and other metals, but also 
between different oxidation states of copper itself.  Further understanding of CsoR’s 
metal binding properties could some from structural studies on the metal-free state of 
CsoR.  Determining the structure of metal-free CsoR using crystallography has proven to 
be a challenge.  Although the protein forms crystals, the crystals are not of high enough 
quality for structure determination.  Another problem is the formation of isomorphous 
crystals for Apo and Cu(I) bound CsoR.  This may be due to trace amounts of metal 
bound to the Apo protein, or a result of the crystallization process, where the protein 
may be trapped in a certain conformation.  Future research needs to address these issues.  
An approach that combines crystallography with solution state techniques like NMR and 
fluorescence, could provide valuable information about the structural changes that CsoR 
undergoes upon Cu(I) binding.   
Comparison of the Cu(I):CsoR structure with previously characterized Cu(I) 
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responsive transcriptional regulators reveals obvious differences in the mode of DNA 
binding.  Based on the crystal structure, CsoR does not seem to possess the typical 
DNA-binding winged helix or helix-turn-helix motifs seen in other metal responsive 
transcriptional regulators.  This suggests that CsoR is the founding member of a new 
structural class of metalloregulators.  DALI searches for structurally similar proteins did 
not yield positive results, suggesting that CsoR may possess a novel DNA binding fold.  
To understand the basis of DNA recognition by CsoR, we have made attempts to 
crystallize the CsoR:DNA complex.  These have proven to be unsuccessful since the 
DNA tends to crystallize on its own.  Of the many metalloregulators that have been 
characterized, high resolution structures in complex with the operator/promoter DNA are 
available only for three proteins.  All three of these belong to the DtxR and NikR 
families that bind DNA in their metal-loaded forms.  Using crystallography to obtain 
structures for DNA complexes of metalloregulators that bind DNA in their apo form 
(like CsoR) may be even more challenging since crystal screening involves many 
hundred conditions often with trace amounts of metal in them.  In this respect, other 
solution based methods like NMR may prove to be more successful for such studies.          
As a Cu(I) responsive regulator of transcription, CsoR must not only bind Cu(I), 
but also modulate its interactions with DNA upon sensing Cu(I).  The mechanism that 
governs the switch between the two states is all important for CsoR function.  Our work 
provides clues to the mechanism.  In the structure, close to the Cu(I) site, a conserved 
glutamate residue is present which can possibly mediate interactions between the Cu(I) 
site and the possible DNA binding surface.  Future work needs to be directed towards 
understanding the mechanistic details of the switch in CsoR from DNA bound to Cu(I) 
bound states.  Structure-based mutational analysis of the protein, along with other 
biochemical techniques to study protein-DNA and protein-metal interactions could 
provide greater mechanistic insights. 
 Preliminary characterization of the cso operon suggests an elegant sequence of 
events when cells are subjected to an excess of Cu(I).  CsoR responds to free Cu(I) in the 
cell, causing derepression of the cso operon.  The genes in the cso operon, whose 
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expression is regulated by CsoR, are predicted to encode a hypothetical conserved 
protein (rv 0968) and a putative Cu(I) translocating P-type ATPase (rv 0969).  A detailed 
understanding of the cellular response to Cu(I) would require a thorough characterization 
of the gene products of the cso operon.  This would help is understand the steps that take 
place after the derepression by CsoR.  It is possible that CsoR interacts with either of the 
two proteins (Rv0968 and Rv0969) to deliver Cu(I) to them, or that the conserved 
hypothetical protein (Rv0968) may act as a Cu(I) chaperone, mediating copper delivery 
to the P-type ATPase.       
Research on Mycobacterium tuberculosis in the last few decades has shown 
beyond doubt, the importance of metals like iron, zinc and copper (197).  However, our 
understanding of copper homeostasis in M. tb in the macrophage environment is still in 
the early stages.  The discovery of CsoR as the primary component of copper 
homeostasis in M. tb and many other pathogenic bacteria, along with the structural 
aspects of Cu(I) binding by CsoR provide a good starting point for future research 
towards understanding copper homeostasis in intracellular pathogens.      
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